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Summary 
This report, written following EMCDDA guidelines1, is divided into two parts. The first 
part (Part A) provides an overview of new developments and trends in the drugs area 
in Ireland for 2003 and in some cases the first six months of 2004. These are covered 
under the following headings: 
1. National policies and context 
2. Drug use in the population 
3. Prevention 
4. Problem drug use 
5. Drug-related treatment 
6. Health correlates and consequences 
7. Responses to health correlates and consequences 
8. Social correlates and consequences 
9. Responses to social correlates and consequences 
10. Drug markets 
 
The second part (Part B) examines three specific issues considered to be important at 
a EU level. The three issues are: 
1. Buprenorphine: treatment, misuse and prescription practices 
2. Alternatives to prison targeting to drug using offenders 
3. Public nuisance: definitions, trends in policies, legal issues and intervention 
strategies 
 
The following are a number of new developments and key findings in the drugs area in 
Ireland that occurred or were made available during 2003 and the first six months of 
2004. 
 
• The National Drugs Strategy 2001–2008 and An Agreed Programme for 
Government (2002) continue to provide the Irish government’s framework for 
addressing the drugs issue.  
• Despite calls from a variety of sources for the merging of the national strategies for 
alcohol and drugs, the government has continued to prefer co-ordination rather 
than integration.  
• A co-ordinating framework within each Garda (Police) District, to liase with the 
community on drug-related matters and to act as a source of information for parents 
and members of the public, has progressed during the last 12 months.  
• Since 2002 initiatives have been set in train to access additional public funds and to 
identify and tap into new sources of funding for social inclusion issues, including 
drug misuse. These include the establishment of the RAPID programme and the 
Dormant Accounts Fund Disbursements Board, and exploring possibilities in 
relation to using the monies and assets seized by the Criminal Assets Bureau and 
harnessing corporate social responsibility.  
• In light of the acknowledged growing prevalence of substance misuse (both illegal 
drugs and alcohol) among young people and children, aged 18 and under, public 
debate on the issue has been frequent and widespread. Among contributions to the 
debate have been explorations of approaches to deterrence – the use of diversions 
such as promoting sport and the arts, and providing alternative recreational 
                                                
1 A copy of the EMCDDA guidelines is available from the EMCDDA’s website at www.emcdda.eu.int 
The guidelines require each Focal Point to write their National Report in a prescribed format using 
standard headings and covering each topic using a check list of items. This helps to ensure comparability 
of reporting across the EU. 
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opportunities – and proposals for the provision of clearer structures, guidance and 
support for young people.  
• The debate over the advantages and disadvantages of substitution therapies and 
harm reduction strategies versus abstentionist approaches to drug treatment, 
already highlighted in the 2003 National Report, has continued over the past 12 
months. Two recently-emerging issues have been the question of the most 
appropriate treatment regime in prisons, and the need for responses targeted at 
poly-drug users.  
• In terms of drug use within the general population one in five adults (15-64 years) 
report ever using an illegal drug, one in eighteen report use within the previous year 
while one in thirty-three report use in the previous month. 
• Cannabis is the most commonly used illegal drug in Ireland. One in six adults (15-
64 years) have used cannabis in their lifetime. This increases to one in four for 
young adults (15-34 years). 
• Prevalence of other illegal drugs is lower and confined largely to the younger age 
groups. Almost twice as many men (24%) as women (13%) reported ever using an 
illegal drug. 
• In terms of problematic opiate use the most recent national estimate of the number 
of opiate users is 5.6 per 1000 persons aged 15-64 years. Rates are higher for men 
than women in all age categories. 
• Opiate use is still predominately a Dublin phenomenon. The rate of opiate use in 
Dublin in 2001 was 15.9 per 1000 persons aged 15-64 years and outside Dublin 
the rate was just under 1.2 per 1000 persons aged 15-64 years. 
• Process evaluation reports that an overloaded curriculum and industrial relations 
issues are obstacles against the implementation of Social, Personal and Health 
Education (SPHE) in secondary schools.  
• Evaluation of SPHE reports that a greater proportion of first year students in 
secondary school receive SPHE than students in third year.  
• Community groups are increasing their use of technology through websites to 
disseminate drug prevention information to communities.  
• Research into selective prevention education in schools reports that children relate 
well to local parents trained as facilitators in delivering drug prevention education in 
the classroom.  
• The most common main problem drugs reported by treated problem drug users 
were heroin and cannabis, and the numbers reporting problem cannabis use 
increased substantially since 2002 while the numbers reporting heroin increased 
but to a lesser extent.   
• Treatment is provided through a network of statutory and non-statutory agencies.  
There are two broad philosophies through which treatment services are provided, 
namely: medication free therapy and medically assisted treatment.  There is a small 
degree of overlap between the two.   
• According to a systematic review by the National Medicines Information Centre, 
lofexidine may be useful as an additional treatment for managed opiate withdrawal 
while there was less evidence to support the effectiveness of naloxone to effect 
rapid opiate withdrawal in Ireland. 
• In Ireland, methadone is the opiate substitute of choice for maintenance therapy.   
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• The numbers enrolled in methadone maintenance therapy continue to increase.  Of 
note the number of new cases treated decreased since 2000.  This reflects a 
substantial decrease in the number of new clients in the Eastern Regional Health 
Authority area, and a small but steady increase the number of new clients treated 
outside the Eastern Regional Health Authority area.   
• The results of two small-scale studies published during the reporting period 
examining the effectiveness of methadone maintenance as a therapy were positive 
with respect to internationally accepted indicators.    
• Two studies examined clients’ satisfaction with methadone treatment services and 
these reported a mixture of both positive and negative experiences.  
• Polydrug use was a common problem for treated drug users.   
• Benzodiazepines, cocaine and ecstasy were the most common secondary problem 
drugs reported by treated drug users, and the numbers reporting benzodiazepines 
or cocaine have increased considerably since 2000.   
• According to general mortality register data, there has been a decrease in drug-
related mortality, from 119 in 2000 to 88 in 2002.  The decrease is mainly 
accounted for by a large decrease in drug-related deaths in Dublin.  There was a 
small but continued increase in drug-related mortality outside the Dublin area.   
• Hepatitis C became a notifiable disease in Ireland in January 2004.  Both 
laboratories and clinicians are required to notify all cases of hepatitis B and C.  
Unfortunately, there are no incident data by risk factor status.   
• Two studies examined morbidity associated with hepatitis C and both suggest a 
significant burden of disease already exist in injecting drug users.   
• A recent national study (2004) reported that the majority of service providers in the 
Eastern Regional Health Authority area said that their services provided information 
and demonstrations on safer injecting practices in line with current evidence.  The 
authors do not report if such information was provided by services outside the 
Eastern Regional Health Authority area.   
• There have been two formal reviews of outreach work with drug users in Ireland.  
Each review examined different but complementary aspects of outreach services.  
Taken together, these evaluations highlight the need to develop the capacity of 
outreach staff and enhance the general management of the services. At the same 
time, the documents present the essential role of outreach workers and the positive 
outcomes of their work, such as success in locating hard-to-reach populations, an 
increase in numbers using safer injecting practices and modest numbers referred 
into treatment.   
• In relation to hepatitis C, there have been two successful pilot studies, one to 
increase access to treatment and the other to increase compliance with treatment.   
• Research shows high levels of drug use and risk behaviour among individuals 
experiencing homelessness leading to social exclusion 
• Responses to individuals engaged in drug misuse and experiencing homelessness 
need to be developed 
• There is a lack of long-term accommodation plans for recovering drug users in 
Ireland. In particular, there is a shortage of halfway houses to accommodate former 
drug users. 
• The National Crime Council has recommended the establishment of a National 
Crime Prevention Model. 
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• The Garda Síochána (Police Co-operation) Act 2003 will facilitate co-operation on 
drug smuggling and organised crime on the island of Ireland. 
• Of the 7,976 drug offences, both headline and non-headline, in which proceedings 
commenced in 2002, just over 75 per cent were for Simple possession (s3 Misuse 
of Drugs Act). The Garda Síochána Policing Plan for 2003 seeks to increase the 
number of offenders dealt with for supply offences. In 2002, the most recent year 
for which figures are available, there were 1,530 supplier/dealer offences in which 
proceedings commenced. This accounted for 19 per cent of the total (n=7976). 
• In 2002, however, the total number of persons prosecuted fell by 19 per cent when 
compared to 2001. Despite this overall decrease there were significant regional 
differences in terms of the number of persons against whom proceedings 
commenced for all drug offences between 1999 and 2002. 
• A recent nationwide survey carried out by the Medical Bureau of Road Safety 
(MBRS) provided an analysis for drug classes in 2000 blood and urine samples 
taken from drivers suspected of intoxicated driving. Sixty-eight per cent of tested 
drivers with essentially zero levels of alcohol were positive for one or more drugs, 
suggesting a strong trend of increasing drug positivity with decreasing levels of 
alcohol 
• A recent Irish study of public order incidents recorded over a five-month period 
found that alcohol had been consumed by the offender in 97 per cent of cases 
where this aspect of the incident was recorded by the Garda Síochána. Drug use 
did not appear from the study to have played any significant role in public order 
offences. 
• A range of studies indicate the significant social costs to individuals, families and 
communities arising from drug misuse. It is clear from such studies that drug 
trafficking and drug use impact disproportionately on those individuals and 
communities characterised by high levels of poverty and social exclusion. 
• The total number of drug seizures reported in the annual reports of the Garda 
Síochána decreased by 39 per cent in 2002, the most recent year for which figures 
are available. Cannabis remains the principal drug seized in Ireland, accounting for 
53 per cent of total drug seizures in 2002. 
• The total number of cocaine seizures has more than doubled since 2000, while the 
quantity of cocaine seized has increased by 77 per cent. There was a reduction in 
the price of cocaine in 2003. It is estimated that a gram of cocaine currently sells at 
approximately €80 to €100. This suggests the potential for a displacement of heroin 
use by cocaine use, given the disparity in price. 
• An increased number of cannabis herb seizures have been made by Customs in 
recent years. 
• Some small studies in inner city areas of Dublin suggest the concentration of drug 
markets in specific areas. Research consistently shows that friends or family 
members are the initial contact through which most people first become involved 
with drugs. 
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Part A: New Developments and Trends 
1. National Policies and Context 
 
1.1 Overview 
This chapter covers the period August 2003 to September 2004. For information on 
developments in drug policy in the first half of 2003, see Ireland’s National Report for 
2003.  
 
The National Drugs Strategy 2001–2008 (Tourism, Sport and Recreation 2001) and An 
Agreed Programme for Government (Taoiseach 2002) continue to provide the 
government’s framework for addressing the drugs issue. 
 
1.2 Legal framework 
Public consultation on crime issues has been facilitated by structures such as the 
National Crime Forum, established by the Minister for Justice, Equality and Law 
Reform in 1998 ‘to canvass comment, assessments and suggestions on crime and 
crime-related issues from the general public and from national and international 
experts’ (Government of Ireland 1998, p. 9). This in turn led to the establishment of the 
National Crime Council (NCC). The NCC, through its public consultation exercises, has 
sought out the views of local communities, many of which relate to concerns about 
drug use and drug-related crime, in developing a future national crime prevention 
strategy (NCC 2003). In May 2003 the NCC published a final paper setting out its 
recommendations to the government regarding the future development of partnership 
approaches in tackling crime: A crime prevention strategy for Ireland: Tackling the 
concerns of local communities (NCC 2003). The NCC recommends the establishment 
of a National Crime Prevention Model. 
 
The Housing Miscellaneous Provisions Act (1997) was introduced to provide measures 
for responding to drug-related anti-social behaviour in Public Authority Housing estates. 
A number of recent studies have considered the implications of this legislation. This will 
be considered in Section 13. 
 
Section 4 of the Criminal Justice Act 1999 inserted a new section, 15A, into the Misuse 
of Drugs Act 1977. This new section introduced the specific offence of possession of 
drugs with a market value of £10,000 (€12,700) and applied for the first time the 
principle of a mandatory minimum sentence with respect to these offences.2 The 
sentence to be imposed ranged from a maximum of life imprisonment to a minimum of 
10 years. The impact of this legislation has recently been assessed. 
 
The Act does leave an element of discretion to the judge to impose a lesser sentence 
in certain circumstances. Ennis (2003) concludes that it is this discretionary element of 
Section 4 of the 1999 Act which has been the most interesting aspect of the relevant 
case law in the Court of Criminal Appeal. From a review of the case law, Ennis (2003) 
found that the Court of Criminal Appeal ‘has showed a general reluctance to impose 
the mandatory minimum sentence in practice.’ He concludes that, ‘On the one hand, 
the discretionary element of Section 27 (3C) (where there are exceptional and specific 
circumstances which would make it unjust to impose the mandatory minimum 
                                                
2 Misuse of Drugs Act 1977, Section 27(3B), as inserted by Criminal Justice Act 1999, Section 5 
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sentence) leads to uncertainty in the area. On the other hand, not to allow such 
discretion could lead to great injustices’ (p. 35). The main ‘exceptional and specific 
circumstances’ which have been applied by the Court include: where the accused has 
pleaded guilty and co-operated with the Gardaí; the timing and nature of the plea; 
whether the co-operation yielded any results (i.e. led to further arrests or prosecutions); 
the actual role played by the person; the amount, and to a limited extent, the type of 
drugs involved; the individual’s family and personal circumstances; the nationality of 
the individual; any pattern of behaviour; and whether there are previous convictions (p. 
35). 
 
The Policy Planning Research Unit of the Department of Justice, Equality and Law 
Reform has commissioned a study on the operation of the above provision of the Act. 
The study involves the analysis of 59 judgements where sentence was imposed under 
the legislation during the period 26 May 1999 to 30 April 2001. The primary scope of 
the project is to identify the circumstances of any case where the convicted person was 
sentenced to more than the minimum ten-year sentence specified in the Act, to 
consider the matters which the court considered when imposing less than the ten-year 
minimum, to identify any ambiguities or difficulties in the application of the relevant 
provisions which are apparent from the cases under review. The study is due to be 
completed in 2004. 
 
In November 2002, in response to a parliamentary question which sought information 
as to the number of those convicted of possession of illegal drugs over the value of 
£10,000 (€12,700) and/or who had received the mandatory minimum sentence as 
stipulated under section 5 of the Act, the Minister for Justice Michael McDowell stated 
in Dáil Éireann that, according to information received from garda authorities:  
 
the number of persons convicted under section 4 of the Criminal Justice Act 1999, 
since it came into force on 26 May 1999 up to 11 November 2002, is 130. The number 
of persons who have received prison sentences of ten years or more, as provided for in 
section 5 of the Criminal Justice Act 1999, is five (2002, 12 November). 
 
As at 6 November 2003, 276 had been convicted under this provision but only 12 had 
received the mandatory minimum sentence. More recently, the Minister for Justice 
Michael McDowell, in response to a question in Dáil Éireann on the judicial approach in 
this area, stated that:  
 
The Judiciary collectively should have regard to the proposition that this House put 
before it, namely, that for possession of drugs with intent to supply on a commercial 
basis, as defined in the statute, the norm was to be a ten-year sentence and that only 
in exceptional cases identified by the Judiciary should there be a lesser penalty. This 
has not happened (2004, 26 February). 
 
The Criminal Justice (Public Order) Act 2003, inter alia, enables persons convicted of 
an offence under certain provisions of the Criminal Justice (Public Order) Act 1994 to 
be excluded from entering licensed premises or premises (including a stall or vehicle) 
used for the sale of food or from areas in the vicinity of those premises. The provisions 
for exclusion orders under the 1994 Act include ‘intoxication in a public place’; and 
intoxication is defined as being ‘under the influence of any alcoholic drink, drug or 
solvent or other substance’. 
The Garda Síochána (Police Co-operation) Act 2003 makes provision, in accordance 
with the ‘Good Friday’ Agreement between the Government of Ireland and the 
Government of the United Kingdom of Great Britain and Northern Ireland on Police Co-
operation, at Belfast on 29 April 2002, in relation to the appointment and secondment 
of members of the Police Service of Northern Ireland to such ranks in the Garda 
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Síochána as may be prescribed, the secondment of members of the Garda Síochána 
to the Police Service of Northern Irealnd, and other connected matters. This Act will 
facilitate co-operation on drug smuggling and organised crime on the island of Ireland. 
 
The Criminal Justice (Illicit Traffic By Sea) Act 2003 gave effect to the Council of 
Europe Agreement on Illicit Traffic by Sea, implementing Article 17 of the United 
Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic 
Substances. The Convention seeks to enhance co-operation between parties in the 
suppression of drug trafficking at sea. The Act makes provision for communication and 
co-operation in drug law enforcement between convention states. Although this Act 
was signed into law by the President in 2003, as a result of a number of technical 
issues, it has not yet been given a commencement order. 
 
Section 36(e) of the Taxi Regulation Act 2003 provides for the mandatory 
disqualification from holding a taxi licence for a conviction for a drug trafficking offence 
(within the meaning of section 3 of the Criminal Justice Act 1994). Minister for 
Transport Seamus Brennan TD, in justifying the inclusion of the section, stated that the 
travelling public must be reassured that taxi drivers ‘are persons that can be trusted 
and … in whose care passengers feel safe’ (2003, 19 June). 
 
A Drug Offenders Bill, intended to include the registration of convicted drug dealers 
with the Gardaí and stiffer penalties for persons found to be involved in the supply of 
drugs to a prisoner, is currently being drafted (B. Ahern 2003, 12 November).  
An Irish Medicines Board (Amendment) Bill is currently being drafted. It will transfer 
responsibility for the licensing, regulation and inspection of controlled drugs and 
precursor chemicals from the Department of Health and Children to the Irish Medicines 
Board (Martin 2003, 4 March). The transfer will see the Irish Medicines Board taking on 
responsibility for ensuring national compliance in regard to the licensing and regulation 
requirements under the Misuse of Drugs Act (1977), and also for providing statistical 
reports to the United Nations as part of Ireland’s national obligation under the terms of 
the various United Nations conventions on controlled drugs and precursor chemicals. 
A Private Members Bill, the Proceeds of Crime (Amendment) Bill 2003, is currently 
being debated. The purpose of this Bill is to make specific changes to the Proceeds of 
Crime Act 1996 by inserting a new definition of drug-related initiatives into the Act. The 
insertion of this definition would enable the Minister for Justice, Equality and Law 
Reform to ensure ‘that the proceeds of crime seized by the Criminal Assets Bureau are 
applied to appropriate organisations and initiatives which are focused on redressing the 
damage caused by those engaged in drug-related activities’ (O’Dowd 2003, 21 
October). 
The Criminal Justice (Joint Investigation Teams) Bill 2003 aims to provide for the 
implementation of the framework decision on 13 June 2002 of the Council of the 
European Union on joint investigation teams to combat trafficking. 
The Garda Síochána Bill 2004 aims to reform the law relating to the administration and 
management of the Garda Síochána and to establish an Ombudsman Commission to 
investigate complaints against members of An Garda Síochána. The Bill also contains 
proposals for the establishment of joint policing committees to consider issues of local 
crime, including drug-related crime. This development will be discussed further in 
Section 13.  
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The Immigration Act 2004 was enacted in February 2004.3 Section 4 (3) (c) provides 
for an immigration officer to refuse to permit a non-national coming from outside the 
state to enter the state, if the officer is satisfied that the person suffers from any of six 
conditions, including drug addiction. In 1975 these six conditions had been inserted, in 
an amendment, as the Fifth Schedule to the Aliens Order 1946.  
 
The Safety, Health and Welfare at Work Bill 2004 was published in June 2004. Section 
9 (1) (a) requires an employee, at work, to ensure that he or she is not under the 
influence of an intoxicant [alcohol or drug, and any combination of drugs or of drugs 
and alcohol] to the extent that he or she endangers his or her own safety, health or 
welfare at work or that of any other person. Section 9 (1) (b) requires an employee, if 
reasonably required by his or her employer, to submit to any appropriate, reasonable 
and proportionate tests by a competent person.  
 
Policing policy and the National Drugs Strategy 2001–2008 
As part of ongoing policy the Garda Síochána fulfils its role in accordance with the 
National Drugs Strategy 2001–2008. Garda members are represented on the National 
Drugs Strategy Team and on local and regional drugs task forces. Of the 100 actions 
identified in the strategy, 14 involve the Garda Síochána. Also, at the beginning of each 
year, the Garda Síochána publish a policing plan, setting out its strategic goals for the 
year. At a more local level each garda district and sub-district is required to produce a 
Drug Policing Plan to include multi-agency participation in targeting drug dealers. 
These plans are in the process of being drafted and it is intended that they will be put 
into a standard format and published on the garda website, www.garda.ie  (Garda 
National Drugs Unit, personal communication, January 2004). 
 
Strategic goal 4 of the Policing Plan for 2003 relates to the enforcement of the laws 
relating to drug abuse. Performance indicators include an increase in the enforcement 
of legislation on the sale and supply of drugs, implementation of the National Drugs 
Strategy 2001–2008 and the establishment of an implementation plan of action based 
on findings from the national study on drugs and crime (Furey and Browne 2004). 
 
The Drug Policing Plan for 2004 continues with the goals of recent years (Garda 
Síochána 2004). Other priorities include: 
• The production of a drug policing plan at district level; 
• The targeting of the assets of middle-ranking criminals involved in drug dealing; 
• The extension of the Community Policing Forum initiative (see Section 13) to all 
local drugs task force areas; 
• The development of benchmarks against which seizures of drugs can be 
evaluated under the European Union Action Plans. 
 
Garda National Drugs Unit (GNDU)– operational deployment 
At the national level, the GNDU now operates under the direct authority of an assistant 
commissioner rather than a detective chief superintendent as was previously the case. 
A detective superintendent represents the GNDU on the National Drugs Strategy 
Team, which oversees the implementation of the National Drugs Strategy 2001–2008. 
There are currently 51 garda members employed in the GNDU. They include one chief 
superintendent, two superintendents, four inspectors, 10 sergeants and 34 ordinary 
garda members. The Minister for Justice, Michael McDowell TD, in response to a 
parliamentary question on 12 November 2002, outlined the number of gardaí detailed 
                                                
3 The Immigration Act 2004 was enacted after a High Court judgement in January 2004 cast serious doubt 
on the constitutional validity of all statutory provisions dealing with the control of entry to and stays in the 
state by non-nationals. 
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to drugs squads throughout the State (Michael McDowell,  2004, 12 Nov; PQ 404). In 
total, three inspectors, 36 sergeants and 202 Gardaí are allocated to drug squads on a 
day-to-day basis. 
 
Objective 7 of the National Drugs Strategy commits the gardaí to ‘increase the level of 
garda resources in Local Drugs Task Force [LDTF] areas by end 2001’ (Tourism, Sport 
and Recreation 2001). With regard to the garda resources in local task force areas, the 
Minister for Justice, Equality and Law Reform Michael McDowell TD stated in the Dáil 
(2003, 19 June) that ‘the current resources within the LDTF areas have remained 
consistent with the levels of 2001’. In a further statement (2003, 25 November) he said 
that the number of personnel ‘in the stations covering local drugs task force areas 
increased by 66 between January 2001 and September 2003’.  
 
1.3 Institutional framework, strategies and policies 
Co-ordination arrangements 
At national level the co-ordination of drug-related policies remains the same as that 
outlined in the last two National Reports. Despite calls from a variety of sources for the 
merging of the national strategies for alcohol and drugs (Long et al. 2004a, p. 12), the 
government has continued to prefer co-ordination rather than integration. Noel Ahern 
TD, Minister of State with Responsibility for the Drugs Strategy, explained the 
government’s position as follows:  
 
My Department has overall responsibility for co-ordinating the implementation of the 
National Drugs Strategy. … The national alcohol policy, is the responsibility of my 
colleague, the Minister for Health and Children who is pursuing several initiatives in this 
area. The national drugs strategy calls for increased links between both policies in 
terms of cross-representation on the relevant committees and working groups to 
ensure complementarity between the different measures being taken. This work is 
ongoing. … I am not aware of any plans at present to merge the alcohol and drugs 
policies. Furthermore, such a proposal would require careful consideration given that 
different policy responses are required for legal and illegal substances (N. Ahern 
2004a).  
 
At regional and local level, efforts to enhance co-ordination structures and 
mechanisms, also noted in the last two National Reports, for example the 
establishment of the Regional Drug Task Forces, have continued. Below are noted 
additional steps that have been initiated in the last 12 months or so. 
 
Delivery of Health Services: In mid-2003 it was announced that the ten regional health 
boards, which have had responsibility for providing treatment and rehabilitation 
services for drug misusers, for support and training for community groups involved in 
drug-related prevention or rehabilitation activities, and for some 25 actions in the 
National Drugs Strategy, are to be abolished.  They are to be replaced with a central 
Health Services Executive (HSE) and four regional offices, which will oversee the local 
delivery of health services.4 This change will have a significant impact on the delivery of 
drug-related services and also on data-gathering activities in the drugs area. The 
restructuring is under way and is scheduled to be completed during 2005. 
 
Garda Síochána–Local Community Co-ordination: A co-ordinating framework within 
each Garda District, to liaise with the community on drug-related matters and to act as 
                                                
4 See Audit of Structures and Functions in the Health System (Prospectus 2003). This report recommends 
the consolidation of fragmented structures and functions to enable the health system deliver sustained 
value for money and a high quality of service for consumers. 
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a source of information for parents and members of the public, has progressed 
(Taoiseach 2004, p. 85). 
• A co-ordinating framework linking Garda District, Divisional and National Drug 
Policing Plans is currently being put in place by the Garda authorities. The Garda 
Síochána Bill 2004 (published in February 2004) provides for the development of 
Joint Policing Committees at local-authority level and for the establishment of local 
policing fora in designated areas under the umbrella of such committees.  
• These bodies are to act as fora where matters relating to local issues of policing 
and crime, including drug-related issues, can be discussed and where strategies 
and recommendations for dealing with issues locally can be formulated. 
• A pilot Community Policing Forum initiative in Dublin’s North Inner City has now 
been positively evaluated and has been approved for mainstreaming from January 
2005 in accordance with procedures under the National Drugs Strategy. Other such 
fora are being supported on a pilot basis. 
 
Review of local community and development structures, including local drugs task 
forces: This initiative, the inception of which was reported in the 2003 National Report, 
was completed in late 2003. On 4 February 2004 the results of the review were 
announced (O Cuiv 2004). Local and community development groups were to be 
asked to propose improvements in their respective areas by mid-2004, which the local 
County/City Development Boards (CDBs)5 would consider and endorse, and funding 
would be earmarked to support measures emerging from this process. In future, 
departments/public bodies wishing to set up new services within the sector are to do so 
within the existing structures. As a consequence of these measures, it is anticipated 
that more money will be earmarked for the actual delivery of services to the customer 
than on administration.  
 
National plan and/or strategies 
No new information. 
 
Implementation of policies and strategies 
National Drugs Strategy 2001–2008: According to the target timeframes set out in the 
Critical Implementation Path (CIP), a plan outlining the implementation of the National 
Drugs Strategy 2001–2008 (Community, Rural and Gaeltacht Affairs 2004), 43 of the 
100 actions identified in the National Drugs Strategy should have been completed, or 
completed and ongoing, by the end of 2003; 35 actions are due for completion during 
2004; and 22 actions are due for completion during the remainder of the period 
covered by the strategy, i.e. by 2007. In March 2004 Noel Ahern TD, Minister of State 
with Responsibility for the Drug Strategy, announced that, ‘approximately one third of 
the 100 actions have been completed or are ongoing for the life of the strategy. With 
the exception of a few actions where work has yet to commence, work is in progress on 
the remainder’ (N. Ahern 2004b). 
 
                                                
5 The Task Force on the Integration of Local Government and Local Development Systems (1998) 
recommended that county and city development boards be established in each of the 29 county councils, 
and in each of the major cities, to bring about an integrated approach to the delivery of both state and local 
development services at local level. The National Development Plan 2000–2006  envisaged that the 
county and city development boards (CDBs) would have a key role in co-ordinating local delivery of social 
inclusion measures (National Development Plan 2000, p. 196), and Action 71 of the National Drugs 
Strategy 2001–2008 called on CDBs ‘to consider the needs of those areas experiencing high levels of drug 
misuse when drawing up city- and countywide strategies for economic, social and cultural development’ 
(Tourism, Sport and Recreation 2001). By 2002 all 34 CDBs had published their strategies for economic, 
social and cultural development. 
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Impact of policies and strategies 
The National Drugs Strategy 2001–2008 is currently being reviewed, and the findings 
are expected in early 2005. Although this review is only occurring at the mid-term stage 
of the strategy, the results may give an indication of the impact of the government’s 
policies and strategies. 
 
1.4 Budget and public expenditure 
In law enforcement, social and health care, research, international actions, co-
ordination, national strategies 
 
The National Drugs Strategy Review Group estimated that for the year 2000, public 
expenditure on development, co-ordination and delivery under the four pillars – supply 
reduction, prevention, treatment and research – approximated to €183 million (para. 
3.7.2).6 The breakdown by government department showed that the Department of 
Justice, Equality and Law Reform accounted for 67 per cent (€123 million) of the 
expenditure, and the Department of Health and Children for 17 per cent (€32 million). 
Equivalent information on departmental expenditures in relation to the drugs issue for 
subsequent years is not readily available. 
 
The level of State spending on drugs-related issues is difficult to estimate and is 
complicated by the fact that expenditure is spread across a number of Departments, 
Local Authorities, Agencies and other statutory organisations. Even within Departments 
and Agencies, it is difficult to arrive at an accurate estimate of costs associated 
specifically with drug misuse as services such as An Garda Síochána, the Prisons, the 
Courts and Probation and Welfare Services and the various health agencies deal with 
drugs issues as part of their wider daily services. 
 
Funding arrangements 
Since 2002 initiatives have been set in train to access additional public funds and to 
identify and tap into new sources of funding for social inclusion issues, including drug 
misuse. These included the establishment of the RAPID programme and the Dormant 
Accounts Fund Disbursements Board, and exploring possibilities in relation to using the 
monies and assets seized by the Criminal Assets Bureau and harnessing corporate 
social responsibility.  
 
RAPID: Launched in February 2001, the RAPID programme targets urban centres and 
provincial towns with the greatest concentration of disadvantage, including drug 
misuse, for priority funding under the National Development Plan. In the 2004 
Estimates  €5.8 million was allocated to the RAPID programme for the implementation 
of the Programme and for co-funding a number of small-scale local projects in RAPID 
areas (O’Cuiv 2003). 
 
Dormant Accounts Fund Disbursements Board: 7 In mid-2002 the Dormant Accounts 
Fund Disbursements Board was established as an independent statutory body. Its 
remit is to formulate a plan for the disbursement of monies from the Dormant Accounts 
Fund for programmes or projects designed to assist the personal, educational or social 
development of persons who are educationally or socially disadvantaged or persons 
with a disability. The Board’s first disbursement plan, for 2003–2005, states that at 
                                                
6 Expressed in punts in the National Drugs Strategy, the costs have been converted here into euro at the 
rate of Ir£1.00 = €1.27. 
7 A ‘dormant account’ refers to monies deposited in a financial institution, including credit institutions and 
insurance undertakings, which have not been claimed by the account holder.   
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least 40 per cent of total annual funding will be allocated to the area of economic and 
social disadvantage, and, in the first year of the plan, this 40 per cent will be wholly 
allocated to RAPID, CLÁR8 and drugs task force areas; in subsequent years, not less 
than 50 per cent of the annual proportion allocated to economic and social 
disadvantage will be allocated to RAPID, CLÁR and drugs task forces (DAFDB 2003, 
p. 7). Valued at €180 million at the end of 2003, it is expected that some €30 million will 
be disbursed annually from the Fund (N. Ahern 2003). In light of the emerging scale of 
the Fund, the government has drawn up amending legislation, the Dormant Accounts 
(Amendment) Bill 2004, to ensure appropriate capacity to evaluate and process 
applications (Community, Rural and Gaeltacht Affairs 2003). 
 
Criminal Assets Bureau: In 2003 a private member’s bill, the Proceeds of Crime 
(Amendment) Bill, was introduced, which, if enacted, would see the release after three 
years of resources seized by the Criminal Assets Bureau to the Minister for Justice, 
Equity and Law Reform for allocation to ‘drug-related initiatives’, rather than into the 
central Exchequer after seven years have elapsed, as at present. It was noted that 
starting from 2004, when monies and assets seized by the Criminal Assets Bureau can 
start to be released, as much as €19 million per annum might begin to flow into the 
Exchequer (Perry 2003). The government opposed the Bill on the grounds that the 
Proceeds of Crime (Amendment) Bill 1999 was already before the House and any 
further amendments could be submitted and debated in reference to that Bill. While not 
opposing the proposal to shorten the period before monies could be released, the 
government raised a number of objections to the ring-fencing of the monies for drug-
related initiatives (Smith 2003).  
 
Corporate Social Responsibility: Progress on the exploration of the possibility of 
applying the concept of corporate social responsibility specifically in relation to the 
drugs issue, noted in last year’s National Report, has not been reported on in the last 
twelve months (Taoiseach 2004).9 
 
1.5 Social and cultural context 
Public opinions of drug issues  
No new information available.  
 
Debates and initiatives in parliament and civil society 
Public debate on the drugs issue has continued through the usual channels – the Dáil 
and Seanad (the national parliament and its upper house, the Senate), conferences 
and workshops organised by both governmental and non-governmental agencies, 
                                                
8 Administered by the Department of Community, Rural and Gaeltacht Affairs, CLÁR (Ceantair Laga Árd-
Riachtanais) is a targeted investment programme for rural areas, complementing RAPID which focuses on 
disadvantaged urban areas and provincial towns. For further information see www.pobail.ie  
9 Along with corporate social responsibility, the term ‘social capital’ came to the fore in the revised National 
Anti-Poverty Strategy as a ‘key objective’ (Social, Community and Family Affairs 2001, 8, p. 18). A few 
months later, under the heading Building an Inclusive Society, An Agreed Programme for Government 
stated that the newly elected Fianna Fáil– Progressive Democrat coalition government would seek to 
collect data on social indicators, including consistent poverty and social capital, and would ‘work to 
promote social capital in all parts of Irish life through a combination of research and ensuring that local 
activity supports the development of social capital, particularly on a local community level’ (Taoiseach 
2002, p. 21). In launching a report on the policy implications of social capital (NESF 2003), the Taoiseach, 
Bertie Ahern TD, defined social capital as ‘networks, relationships and feelings of belonging, of trust and a 
sense of civic responsibility. These are things which shape the spirit of co-operation and quality of life in 
local communities and groups, and enable wider society to achieve desired policy goals more effectively. I 
suppose you could describe Social Capital as a kind of glue that holds society together.’ He went to 
observe:  ‘while Social Capital is hard to quantify, it is a resource that has, in the past, been under-valued’ 
(B. Ahern 2003, 29 October). 
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campaigns and public announcements mounted by organisations concerned with the 
drugs issue, and a wide range of publications. Below are noted the orientation of two 
public debates on drug-related issues that were taken up during the 2003/04 period – 
young people and substance misuse, and drug treatment policy options, particularly the 
issue of drug treatment in prisons, and treatment responses to polydrug users.10 Drug 
testing, which was noted as a topic of debate in the 2003 National Report, is now the 
subject of proposed employment legislation (see Section 1.2). 
 
Young People and Substance Misuse 
In light of the acknowledged growing prevalence of substance misuse (both illegal 
drugs and alcohol) among young people and children, aged 18 and under, in Ireland,11 
public debate on the issue is frequent and widespread. Among contributions to the 
debate have been explorations of approaches to deterrence – the use of diversions 
such as promoting sport and the arts, and providing alternative recreational 
opportunities – and proposals for the provision of clearer structures, guidance and 
support for young people. This latter category of proposals is associated with studies of 
alcohol abuse among young people. They are noted here, given the debate mentioned 
above (Section 1.3) regarding the need to consider drug and alcohol abuse together. 
 
Dáil na nÓg (National Children’s Parliament):12 In November 2003 Dáil na nÓg held its 
third annual conference, with 192 delegates, aged between 12 and 18 years, from 
every county in Ireland. The delegates chose drug and alcohol abuse as one of its two 
topics for debate. The delegates concluded:  
• We need more facilities, leisure centres, discos, youth clubs and other alcohol-free 
activities. 
• Information and education is too late or not at all – we need campaigns on drugs 
and alcohol from primary school up. 
• We want advertising to highlight the dangers of drug and alcohol abuse. 
• We need support to overcome peer-pressure. 
• Alcohol is part of our culture – adults need to change too.  
The Minster for Children, Brian Lenihan TD, told the delegates that he acknowledged 
that the lack of non-pub entertainment facilities for teenagers was a major national 
issue and guaranteed delegates that a recreation policy for 12–18-year-olds would be 
prepared by the National Children’s Office (Dáil na nÓg 2003).  
 
Joint Committee on Arts, Sport, Tourism, Community, Rural and Gaeltacht Affairs: In 
April 2004 this Joint Parliamentary Committee released its Report on the Effectiveness 
of Investment in Sport and the Arts as a Deterrent against Youth Substance Abuse. 
The committee concluded that there is evidence that arts and sports programmes can 
facilitate the holistic development of the individual and reduce the propensity to abuse 
various substances.  Finding that current provision is characterised by dependence on 
pilot schemes, a lack of long-term commitment, and lack of staff and resources, the 
Committee called for a broad, child-centred, multi-tiered strategy for substance abuse 
prevention in Ireland that includes sport and the arts. It recommended that alcohol and 
its abuse should be included in the National Drugs Strategy. 
                                                
10 Debates in the criminal justice area, including supply reduction and public order issues involving illicit 
drugs, reported on in the 2002 National Report, have continued. Further information on these can be 
provided if required. 
11 Recent studies of drug use prevalence among young Irish people, such as ESPAD (Hibell et al.1999), 
Kelleheret al.(2003), and Flanagan et al. (2003) have all indicated growing trends in drug use. 
12 Arising out of the National Children’s Strategy (Health and Children 2000) and in line with Article 12 (1) 
of the UN Convention on the Rights of the Child, Dáil na nÓg was established to provide an annual 
national forum where children can raise and debate issues of concern, under the auspices of the Minister 
for Children.  A report on the outcome of the parliament is submitted to the Cabinet Committee on 
Children, which is chaired by the Taoiseach. For further information see www.dailnanog.ie/  
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Joint Committee on Health and Children:  In June 2004 this Joint Parliamentary 
Committee released its Report on Alcohol Misuse by Young People. The report 
included 10 key recommendations, calling for the establishment of a National Alcohol 
Control Centre to advise on alcohol control measures, for changes to taxation, pricing 
and advertising policies, and for additional steps to be taken by hospital Accident and 
Emergency departments, suppliers of alcohol, local authorities in the administration of 
public parks, and front-of-house security staff, to curb alcohol misuse by young people.  
 
MEAS (Mature Enjoyment of Alcohol in Society Ltd): Established in late 2002, MEAS is 
a drinks industry initiative to combat alcohol misuse and abuse.13 In June 2004 MEAS 
released Underage Drinking is Rarely Black and White. Based on focus group 
interviews with parents and with teenagers, and a nationwide survey of four hundred 
12–17-year-olds, the research found that half the country’s 16- and 17-year-olds are 
drinking alcohol ‘regularly’ and that domestic (at home) drinking by parents is a key 
influencer of their children. Few parents are sure ‘what is the right thing to do’.  There 
appears to be a marked reluctance by parents of minors to discuss the issue with other 
parents; many parents are worried about being too dogmatic, and of setting unrealistic 
rules for their under-18s where drink is concerned. Many feel that there are ‘worse 
things’, such as drug taking or becoming pregnant. MEAS intends to use the research 
findings to inform the content and direction of its work in seeking solutions. MEAS 
identifies the introduction of a tamper-proof, universal identity card which would greatly 
assist parents, publicans, off-licensees and the gardaí to enforce the current law as 
one of the most effective responses.  
 
Drug Treatment Options 
The debate over the advantages and disadvantages of substitution therapies and harm 
reduction strategies versus abstentionist approaches to drug treatment, already 
highlighted in the 2003 National Report, has continued over the past 12 months.14  Two 
recently-emerging issues are highlighted here – treatment regimes in prisons, and the 
need for responses targeted at poly-drug users. 
 
The Minister for Justice, Equality and Law Reform, Michael McDowell TD, has 
consistently argued that prisons must be drug-free and treatment based on 
abstentionist principles: 
 
It is my policy to apply best practice to the prison situation. Best practice, as far as I am 
concerned, is to prevent drugs from being introduced into or used in prisons. The 
programme for Government commits me to creating a drug free Prison Service with 
mandatory drug testing of prisoners. I intend to put this commitment into effect and 
expect to receive shortly, from the Office of the Parliamentary Counsel, a new set of 
prison rules which will make provision for, among other things, mandatory drug testing. 
In addition, a group consisting of Irish Prison Service management, including prison 
governors and health board staff together with relevant clinicians have prepared a draft 
prison drug treatment policy which I am currently considering. 
It is both my policy and that of the Irish Prison Service, in common with most prison 
systems worldwide, not to issue needles or injecting equipment to prisoners. The 
Report of the Group to Review the Structure and Organisation of Prison Health Care 
Services considered the matter of developing a syringe exchange programme within 
Irish prisons and came to the conclusion that such a step could not be recommended. 
(McDowell 2004a) 
                                                
13 For further information on MEAS, visit www.meas.ie  
14 A list of the studies published  and the conferences hosted by government agencies, research bodies 
and groups within the community sector that have contributed to the debate during the past 12 months is 
available if required.  
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In September 2004 the media reported a disagreement over prison drug treatment 
policy between the Minister for Justice and the Minister of State with responsibility for 
the Drugs Strategy, Noel Ahern TD. The latter was reported as suggesting that a 
needle exchange programme should be introduced in prisons to prevent the spread of 
infectious diseases such as AIDS and hepatitis.  The Minister of State was further 
reported as saying that a needle exchange programme would not conflict with 
Government policy as such programmes are envisaged under the National Drugs 
Strategy: The strategy provides that the same types and level of drug treatment 
services be provided to addicts within the prison system as are available in the general 
community. While services ‘aren’t perfect’ in the community, they do provide for needle 
exchange programmes (Reid 2004).   
The Irish Penal Reform Trust (IPRT),15 a non-governmental organisation campaigning 
for the rights of people in prison and the progressive reform of Irish penal policy, 
welcomed Minister Ahern’s support for prison syringe exchange programmes, while 
‘rubbishing’ the Minister for Justice’s opposition to these ‘effective public health 
programmes’. The IPRT is due to release a new report Prison Needle Exchange: 
Lessons from a Comprehensive Review of International Evidence and Experience in 
mid-October 2004. 
The National Drugs Strategy 2001–2008 noted that the perceived emergence of poly-
drug use was a cause for concern in a number of submissions, as was the risk of 
methadone becoming a “street” drug. (Tourism, Sport and Recreation 2001, para. 
5.4.4) However, the Strategy did not identify the need to tailor treatment responses to 
the needs of poly-drug users. In late 2003 the issue began to come to the fore. In 
September 2003, Dublin Citywide Drugs Crisis Campaign organised a general meeting 
for community organisations to discuss ‘the drug crisis in local communities’. The 
meeting found, inter alia, that although heroin presented a particular problem because 
of its devastating impact on communities, most drug users were using a whole variety 
of drugs. Benzodiazepines were regarded as a major problem and concerns were 
expressed about the trade in prescribed drugs. The role of alcohol and the increasing 
use of cocaine were identified as other important factors. It appeared that poly-drug 
use was the norm for drug users, whether they were in treatment or not. It was 
concluded that treatment services should be reshaped to deal with the reality of poly-
drug use (Connolly 2003b). In February 2004 the need to address polydrug use was 
explicitly acknowledged at government level: We have to be aware that most drug 
users engage in poly-drug use and, therefore, projects need to be able to address this 
pattern of usage rather than concentrating on one drug to the exclusion of others. (N 
Ahern 2004c)16  
 
Media representations 
No new information available.  
 
 
 
 
 
                                                
15 For further information on the Irish Penal Reform Trust, visit www.iprt.ie   
16 At a meeting of the Council of Europe’s Pompidou Group in Dublin in October 2003, the management of 
poly-drug use, especially among young people, was one of the main themes under consideration. The 
meeting agreed that there was a need to carry out more research into poly-drug use and develop a co-
ordinated global approach to the problem (Sinclair and Galvin 2003). 
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2. Drug Use in the Population 
 
2.1 Overview 
This section provides an overview of drug use in the population based on prevalence 
surveys published in 2003. 
 
Drug prevalence surveys are important in that they can shed light on the patterns of 
drug use, both demographically and geographically, and if repeated can track changes 
over time. They help to increase our understanding of drug use, and to formulate and 
evaluate drug policies. They also enable informed international comparisons provided 
countries conduct surveys in a comparable manner.  
 
2.2 Drug use in the general population 
Two national surveys of drug use in the general population were published in 2003. 
Both are discussed below. 
 
In April 2003 the results of the second national Survey of Lifestyle, Attitudes and 
Nutrition (SLÁN) were published (C. Kelleher et al. 2003). The SLÁN survey was first 
undertaken in 1998 (Friel et al. 1999) and repeated again in the summer of 2002. In 
both surveys a small number of questions on drug use were asked allowing drug use 
patterns to be examined. As in 1998, the sampling frame was the electoral register, the 
target population thus being adults aged 18 years and over. A proportionate random 
sampling design was used to select the survey sample. The questionnaires were 
posted to respondents and were self-administered. A total of 5,992 questionnaires 
were returned from a valid sample of 11,212 sent out, giving a response rate of 53.4 
per cent. This compares with a response rate of 62.2 per cent in the 1998 survey. The 
report notes that the 2002 survey had fewer younger males (18-34 year olds) than in 
the earlier survey and in the general population as a whole.  
 
The published SLÁN results only provide a limited analysis of the drug use questions. 
Prevalence figures for males and females are reported separately. Combined totals are 
not reported. While the first SLÁN report did not report any drug prevalence data the 
second SLÁN report provides data from both the 1998 and 2002 survey thus allowing 
comparisons over time. 
 
Lifetime (ever used), last year (recent use) and last month (current use) prevalence of 
cannabis use for adult males and females (18+ years) in 1998 and 2002 is shown in 
Table 2.2.1. For both genders there has been an increase in the proportion of people 
claiming to have ever used cannabis or used the drug in the last year or in the last 
month. The largest increase occurred in ‘lifetime’ use and may reflect a growing 
willingness to experiment with cannabis. It should be stressed however that no 
confidence intervals were provided around these estimates so that the differences 
between the two surveys could be due to sampling variation. 
 
Table 2.2.1   Trends in lifetime, last year and last month prevalence of cannabis use for adult males 
and females (18+ years) between 1998 and 2002. 
Cannabis use Adult males 
1998 
% 
Adult males 
2002 
% 
Adult females 
1998 
% 
Adult females 
2002 
% 
During lifetime 21.9 26.2 13.8 19.1 
During last year 11.0 12.1 6.2 6.7 
During last month 6.7 7.8 2.8 3.0 
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Apart from the cannabis figures the report also provides last year prevalence rates for 
amphetamines, cocaine, ecstasy, heroin, LSD, magic mushrooms, and solvent use, 
see Table 2.2.2. There is a notable increase in the recent use of cocaine and ecstasy 
while amphetamine use dropped. Again the lack of confidence intervals makes it 
difficult to determine if these differences are statistically significant. 
 
Table 2.2.2   Trends in last year prevalence of amphetamines, cocaine, ecstasy, heroin, LSD, magic 
mushrooms, and solvent use for adult males and females (18+ years) between 1998 and 2002. 
Used in last year 
(recent use) 
Adult males 
1998 
% 
Adult males 
2002 
% 
Adult females 
1998 
% 
Adult females 
2002 
% 
Amphetamines 3.6 2.4 1.3 0.6 
Cocaine 1.8 3.0 0.6 1.9 
Ecstasy 2.9 3.9 1.5 2.4 
Heroin 0.5 0.4 0.3 0.5 
LSD 1.9 1.6 0.8 0.8 
Magic Mushrooms 2.2 2.3 0.6 0.6 
Solvents 0.5 0.7 0.3 0.6 
 
In October 2003 the National Advisory Committee on Drugs (NACD) and the Drugs and 
Alcohol Information and Research Unit (DAIRU) within the Department of Health, 
Social Services and Public Safety in Northern Ireland published jointly the first results 
from an all-Ireland general population drug prevalence survey (NACD and DAIRU 
2003). 
 
The survey followed best practice guidelines recommended by the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA 2002). The questionnaire, 
based on the ‘European Model Questionnaire’, was administered through face-to-face 
interviews with respondents aged between 15 and 64 years normally resident in 
households in Ireland and Northern Ireland. Fieldwork was carried out by MORI MRC 
between October 2002 and April 2003. The final achieved sample was 4,925 in Ireland 
and 3,517 in Northern Ireland. This represented a response rate of 70 per cent in 
Ireland and 63 per cent in Northern Ireland. The sample was weighted by gender, age 
and health board area to maximise its representativeness of the general population. 
 
Full details of the main results for Ireland can be found in the on-line version of 
Standard Table 1. Key findings for Ireland are described below. One in five (19%) 
adults reported using an illegal drug in their lifetime (see Table 2.2.3). For young adults 
(15-34 years) this rose to one in four (26.4%) people. Twice as many men as women 
reported the use of an illegal drug during the last month or the last year. 
 
Table 2.2.3   Lifetime, last year and last month prevalence of illegal drugs in Ireland 
Ever used an 
illegal drug* 
Adults 
15-64 years 
% 
Males 
15-64 years 
% 
Females 
15-64 years 
% 
Young adults 
15-34 years 
% 
During lifetime 19.0 24.4 13.5 26.4 
During last year  5.6 7.7 3.4 9.7 
During last month 3.0 4.1 1.8 5.2 
* illegal drugs refer to any use of amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic 
mushrooms, poppers and solvents. 
Source: Drug Use in Ireland & Northern Ireland. Bulletin 1: First results from the 2002/2003 Drug Prevalence  
Survey. NACD & DAIRU 2003. 
 
Cannabis was the most commonly used illegal drug. One in six adults had used 
cannabis in their lifetime and this increased to one in four for young adults (see Table 
2.2.4) 
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Table 2.2.4   Lifetime, last year and last month prevalence of cannabis in Ireland 
Ever used 
cannabis 
Adults 
15-64 years 
% 
Males 
15-64 years 
% 
Females 
15-64 years 
% 
Young adults 
15-34 years 
% 
During lifetime 17.6 22.5 12.5 24.4 
During last year  5.1 7.1 3.0 8.7 
During last month 2.6 3.4 1.7 4.4 
Source: Drug Use in Ireland & Northern Ireland. Bulletin 1: First results from the 2002/2003 Drug Prevalence  
Survey. NACD & DAIRU, 2003. 
 
Prevalence of other illegal drugs was lower and confined largely to the younger age 
groups. One in fourteen (7.1%) young adults claimed to have tried ecstasy at least 
once in their lifetime (see Table 2.2.5).  
 
Table 2.2.5   Lifetime, last year and last month prevalence of ecstasy in Ireland 
Ever used ecstasy Adults 
15-64 years 
% 
Males 
15-64 years 
% 
Females 
15-64 years 
% 
Young adults 
15-34 years 
% 
During lifetime 3.8 4.9 2.6 7.1 
During last year  1.1 1.5 0.6 2.2 
During last month 0.3 0.6 * 0.6 
* less than 0.05% 
Source: Drug Use in Ireland & Northern Ireland. Bulletin 1: First results from the 2002/2003 Drug Prevalence  
Survey. NACD & DAIRU, 2003. 
 
Cocaine use (including crack) was much higher in men than women for lifetime, current 
and recent use (see Table 2.2.6). 
 
Table 2.2.6   Lifetime, last year and last month prevalence of cocaine (including crack) in Ireland 
Ever used cocaine 
(including crack) 
Adults 
15-64 years 
% 
Males 
15-64 years 
% 
Females 
15-64 years 
% 
Young adults 
15-34 years 
% 
During lifetime 3.1 4.5 1.7 4.8 
During last year  1.1 1.7 0.5 2.0 
During last month 0.3 0.7 * 0.7 
* less than 0.05% 
Source: Drug Use in Ireland & Northern Ireland. Bulletin 1: First results from the 2002/2003 Drug Prevalence  
Survey. NACD & DAIRU, 2003. 
 
Valid comparisons between the NACD & DAIRU survey and the SLÁN survey are 
made difficult due to differences in survey methodologies, age ranges of respondents, 
and context in which the drug questions were asked. 
 
2.3 Drug use in the school and youth population 
In April 2003 the results of the second national Health Behaviour in School-aged 
Children (HBSC) survey carried out in Ireland were published (C. Kelleher et al. 2003). 
The HBSC survey is a cross-national research study conducted in collaboration with 
the World Health Organization (WHO) Regional Office for Europe. Its aim is to gain 
new insight into, and increase our understanding of young people’s health and well-
being, health behaviour and their social context. A total of six HBSC surveys have been 
conducted across Europe since the early 1980s. The first HBSC survey conducted in 
Ireland was carried out in 1998 (Friel et al. 1999) and repeated again in 2002. In both 
surveys a small number of questions on drug use were asked allowing drug use 
patterns to be examined. 
 
The sampling procedures followed those used in 1998. Individual schools within health 
boards were first randomly selected and classes within schools were subsequently 
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randomly selected for participation. The objective was to achieve a nationally 
representative sample of school-going children. The survey was carried out between 
April and June 2002 and covered children aged 10-17 years present in school on the 
day of the survey. A total of 176 schools out of a valid sample of 347 participated in the 
survey, giving a school response rate of 50.7 per cent. However, only 5,712 
questionnaires from 93 schools received by the end of the summer term were included 
in the second HBSC report to maintain seasonal comparability with the first HBSC 
report. 
 
The published HBSC results only provide a limited analysis of the drug use questions. 
Prevalence figures for males and females are reported separately for lifetime and last 
year use of cannabis and lifetime use of glue or solvents. While the first HBSC report 
did not report any drug prevalence data the second HBSC report provides data from 
both the 1998 and 2002 survey thus allowing comparisons over time.  
 
For school-going boys there was a small drop in both lifetime and last year prevalence 
of cannabis use between 1998 and 2002, Table 2.3.1. School-going girls on the other 
hand experienced an increase in cannabis use. Again the lack of confidence intervals 
around these estimates makes it difficult to determine if these differences are 
statistically significant. 
 
Table 2.3.1   Trends in lifetime and last year prevalence of cannabis use for school-going boys and 
girls (10-17 years) between 1998 and 2002. 
Cannabis use Boys 
1998 
% 
Boys 
 2002 
% 
Girls 
1998 
% 
Girls 
2002 
% 
During lifetime 16.2 14.2 8.6 11.7 
During last year 14.0 13.4 6.7 9.5 
 
Lifetime prevalence of glue of solvent use increased slightly between the two surveys 
for both genders, Table 2.3.2.  
 
Table 2.3.2   Trends in lifetime prevalence of glue or solvent use for school-going boys and girls 
(10-17 years) between 1998 and 2002. 
Glue or solvent 
use 
Boys 
1998 
% 
Boys 
 2002 
% 
Girls 
1998 
% 
Girls 
2002 
% 
During lifetime 6.0 7.7 3.7 4.9 
 
Apart for the above national survey, two regional drug prevalence studies were 
published in 2003.  
 
In January 2003 the Department of Public Health in the Mid-Western Health Board 
(MWHB) published a second survey of smoking, alcohol and drug use by teenagers in 
Counties Clare, Limerick and Tipperary North-Riding (K. Kelleher et al 2003). The 
survey, which was carried out in 2002, covered post-primary school students aged 13-
19 years. Using a multistage stratified random sampling method, the researchers 
surveyed a total of 2,297 students from 23 schools. The anonymous questionnaire 
used in the survey (administered in the classroom setting by the researchers or by 
teachers) allowed comparisons with a previous school survey in the MWHB in 1988. 
The report’s findings are based on 2,279 students with valid responses. 
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In terms of drug use, the survey found that 39 per cent of students had used at least 
one drug17 in their lifetime. This was almost 10 per cent higher than in the 1998 MWHB 
survey. Cannabis was the most commonly used illicit drug: 29 per cent of students 
reported using cannabis at some stage in their lifetime, again an increase of almost 10 
per cent since the previous survey, Table 2.3.3. Fifteen per cent of students stated that 
they had used cannabis in the month prior to the survey, an increase of seven per cent 
since 1998. No confidence intervals were reported for these estimates. 
 
Table 2.3.3   Trends in lifetime and last month prevalence of cannabis use for school-going 
children (13-19 years) in the Mid-Western Health Board (MWHB) between 1998 and 2002 
Cannabis use MWHB (1998) 
% 
MWHB (2002) 
% 
During lifetime 19.0 28.6 
During last month 8.4 15.4 
 
Inhalants (glue, aerosols, etc.) were the second most commonly used drugs in the mid-
west region and both lifetime and last month use increased since 1998, Table 2.3.4. 
 
Table 2.3.4   Trends in lifetime and last month prevalence of inhalant use for school-going children 
(13-19 years) in the Mid-Western Health Board (MWHB) between 1998 and 2002 
Inhalant use MWHB (1998) 
% 
MWHB (2002) 
% 
During lifetime 13.6 21.3 
During last month 2.7 6.4 
 
Most students in the 2002 survey indicated that cannabis was the first illicit drug they 
had used, that a friend was the main source of this drug and that ‘curiosity’ was the 
main reason why they chose to experiment with drugs. In 1998 the most common 
reason for experimenting with drugs was ‘everyone else does it’. These findings 
highlight the potential influence of peers in the first use of drugs. 
 
In November 2003 the Department of Public Health in the North Eastern Health Board 
(NEHB) published a second survey of smoking, alcohol and drug use among young 
people in Counties Cavan, Monaghan, Louth and Meath (Flanagan et al. 2003). The 
survey, which was carried out in 2002, covered post-primary school students aged 12-
19 years. Using a multistage stratified random sampling method, the researchers 
surveyed a total of 1,426 students from 24 schools. The anonymous questionnaire 
used in the survey (administered in the classroom setting by a research officer) allowed 
comparisons with a previous school survey in the NEHB in 1997 
 
In terms of illicit drug use the survey found that 41 per cent had taken at least one illicit 
drug18 in their lifetime. This was six per cent higher than in the 1997 NEHB survey. 
More girls than boys reported that they had ever taken an illicit drug in 2002 (boys 41 
per cent, girls 42 per cent) compared to 1997 (boys 37 per cent, girls 32 per cent). The 
large increase in lifetime prevalence of any illicit drug for girls is a cause for concern 
since it may reflect a growing willingness to experiment with drugs. 
 
Cannabis was the most commonly used illicit drug. Thirty-one per cent of students 
reported using cannabis at some stage in their lifetime, an increase of over six per cent 
since the previous survey, Table 2.3.5. Just under thirteen per cent stated that they had 
used cannabis in the past month and increase of over three per cent since 1997.  
                                                
17 Includes cannabis, inhalants, ecstasy, magic mushrooms, tranquillisers without prescription, 
amphetamines, crack, cocaine, heroin and LSD. 
18 Includes cannabis, inhalants, ecstasy, speed, magic mushrooms, cough syrup, cocaine, LSD, heroin 
and barbiturates (note: not all these drugs are illicit). 
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Table 2.3.5   Trends in lifetime and last month prevalence of cannabis use for school-going 
children (13-19 years) in the North Eastern Health Board (NEHB) between 1998 and 2002 
Cannabis use NEHB (1997) 
% 
NEHB (2002) 
% 
During lifetime 24.6 31.0 
During last month 9.4 12.8 
 
Inhalants (glue, aerosols, etc.) were the second most commonly used drugs in the 
north east region. Lifetime and last month use of inhalants was higher in 2002 than in 
1997, Table 2.3.6. Again the lack of confidence intervals around these estimates 
makes it difficult to determine if these differences are statistically significant. 
 
Table 2.3.6   Trends in lifetime and last month prevalence of inhalant use for school-going children 
(13-19 years) in the North Eastern Health Board (NEHB) between 1998 and 2002 
Inhalant use NEHB (1997) 
% 
NEHB (2002) 
% 
During lifetime 18.9 21.8 
During last month 2.0 2.5 
 
Results from the 2002 survey suggest that younger people were being approached 
with offers of drugs more so than in 1997 and the person offering these drugs was 
someone that their friends knew or was their best or very good friend. This latter finding 
highlights the potential influence of peers in the use of drugs and points to the need for 
strategies aimed at facilitating young people to identify and resist peer influences. 
 
Another notable finding from the survey was the relationship that emerged between 
smoking, alcohol consumption and illicit drug use. Regulars smokers (smoking at least 
one cigarette per day) were more likely to have been offered illicit drugs, to have taken 
an illicit drug and were more than six times more likely to report using an illicit drug in 
the last month than were non-smokers. The same pattern was also apparent among 
regular drinkers (consuming one or more alcoholic drinks per week) though not as 
strong as for regular smokers. The report notes that these findings ‘point to the potency 
of alcohol and especially tobacco, in illicit drug use and serve as support for 
considering these substances as gateway drugs.’ The report goes on to stress that 
‘gateway drugs do not necessarily cause young people to use harder drugs, but using 
these substances may set up patterns of behaviour that may make it easier to progress 
to using other drugs or may result in young people frequenting places where they can 
get or be offered illicit drugs’ (Flanagan et al. 2003, p. 65) 
 
2.4 Drug use among specific groups 
Research carried out in 2003 which has examined drug use among specific groups of 
the population is covered in the Part 8 (Social Correlates and Consequences) of this 
report. 
 
2.5 Attitudes to drugs and drug users 
No new information available. 
 
3. Prevention 
 
3.1 Overview 
An overloaded curriculum and industrial relations issues are reported to be an obstacle 
for the implementation of Social, Personal and Health Education (SPHE) in secondary 
schools. A greater proportion of first year students in secondary school receive SPHE 
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than students in third year. Community based responses targeting families and young 
people with drug education and prevention activities are emerging in regions outside 
the Eastern Region. Groups are increasing their use of technology through websites to 
disseminate drug prevention information to communities. Research into selective 
prevention education in schools reports that children relate well to local parents trained 
as facilitators in delivering drug prevention education in the classroom.  
 
3.2 Universal prevention 
School 
Universal drug prevention is delivered in post-primary schools through the Social, 
Personal and Health Education programme (SPHE). According to a recent evaluation 
(Geary and McNamara 2003) the SPHE programme aims to:  
 
promote self-esteem and self-confidence, personal skills, responsible decision-making, 
opportunities to reflect and discuss and promote physical, mental, emotional health and 
well-being. (p. 7) 
 
The evaluation focused on the implementation of the programme looking at the extent 
of implementation, the methods involved, how it was received in schools and its 
relevance. A postal survey was administered to school principals, teachers/ co-
ordinators with SPHE and teachers with no SPHE involvement. The survey received a 
48 per cent response rate from principals representing the number of responding 
schools. 
 
Sixty-seven per cent of principals offered SPHE in their school, one-third did not offer 
SPHE. The programme was more likely to be offered in mixed schools, with boys’ 
secondary schools faring least well. Principals noted that recent industrial action by the 
teachers' union delayed in-service training for teachers. Additional factors listed by 
principals as contributing to the slow implementation of SPHE were curriculum 
overload, too many courses and timetable constraints. Over 50 per cent of teachers/ 
co-ordinators of SPHE received over 21 hours of in-service training. Over 80 per cent 
of SPHE teachers/co-ordinators who have had contact with the SPHE support service 
indicated that the service is providing 'some' or a 'lot' of help to cope sufficiently with 
the programme.  
 
SPHE was offered in 70 per cent of responding schools in students first year, 
decreasing to 46 per cent by the third year. According to the evaluator, exam subjects 
receiving an increased focus as students approach their Junior Certificate exams may 
explain this decrease. In 75 per cent of cases, SPHE is offered as a stand-alone 
subject with most students receiving one class period per week. Relationships (93%) 
sexuality (90%) and substance misuse (90%) were the main themes of SPHE 
highlighted by SPHE teachers/co-ordinators as being of most relevance to pupil's lives. 
Teachers reported that these issues were also the areas that they focused on most. 
Niney-one per cent of teachers not involved in teaching SPHE were aware that 
attention was being given to the misuse of substances in SPHE. Principals were asked 
to indicate the degree of emphasis placed on substance misuse education in schools; 
65 per cent felt that it was awarded some emphasis, 33 per cent indicated strong 
emphasis with two per cent stating that no emphasis was placed on substance misuse 
education.  
 
Family and Community 
A notable development in recent times has been the consistent theme of community 
involvement in responding to drug misuse in regions outside the Eastern region. 
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Responses primarily target parents, families and young people and include seminars, 
information sessions and social/cultural sessions on the theme of raising awareness 
about drugs. Alternatives to drug use for young people are also provided. Responses 
are organised and delivered at community level by parents trained as facilitators, 
teachers, youth workers and community drug workers. Some examples of community-
based interventions include, County Waterford Community Based Drugs Initiative 
(CWCBDI), The Frontline Community Drugs Project, The County Carlow Drugs 
Initiative (CCDI) and the Waterford Community Based Drug Initiative (WCBDI). For a 
comprehensive overview of these projects see the EDDRA database.  
 
A recent innovation has been the emergence of the Drug Education Workers Forum 
(DEWF) made up of drug education workers from the statutory, voluntary and 
community sectors. The DEWF grew from a need to identify the various agencies 
involved in developing and delivering drug education programmes. The forum provides 
for drug education workers to meet on a regular basis to exchange information, offer 
support to workers and work towards developing an integrated response to drug issues 
to inform national drug policy. A representative of the DEWF has been appointed to 
participate in the National Drug Strategy Team. Currently the DEWF are working on 
developing a template of quality standards to inform the future provision of drug 
education. More information can be found on www.dublin.ie/dewf   
 
The Minister for Health and Children launched the second phase of the three-year 
National Drug Awareness Campaign in January 2004. The second phase includes four 
weeks of television advertisements across eight television channels. An additional 
initiative included in the second phase is the drugs information roadshow that will travel 
to major population centres throughout the country. The roadshow will consist of panels 
of experts in the drugs area meeting with local communities in designated locations 
through a question and answer session. Local press and radio advertising will inform 
people where the roadshows are being held. The campaign has also launched two 
drug information booklets: How do I talk to someone about drugs, aimed at children, 
and A parent's guide to drugs. Both booklets can be received free of charge by ringing 
the campaign information line. In addition, individuals wishing to speak to someone 
confidentially about a drugs problem can also ring the information line and ask to be 
transferred directly to a drugs helpline staff member. Information on drugs is also 
available on the campaign's website; www.drugsinfo.ie .  
 
The use of technology targeting families and communities in drug prevention 
Groups are increasingly using websites to disseminate information on drugs and 
related issues to communities. Recent innovations in this area include the Mid-
Tipperary Drugs Initiative (MTDI), which aims to raise awareness of substance misuse 
amongst young people, parents and the wider community (see www.drugtipps.com ). 
The Athlone Drug Awareness Group (ADAG) provides factual information on drugs and 
advice for youth, parents and schools, information on local services and leaflets on 
drugs information. Also included is emergency advice on first aid and needle stick 
injuries (see www.athlone.ie/drugawareness ).  
 
Ireland's first interactive drug awareness website is operated by Crosscare, the Social 
Care Agency of the Dublin Diocese. The site targets young people, families, parents 
and professionals. The aim is prevention; to help people avoid drug problems and 
support those impacted by drug problems. One key feature is the unique, interactive 
'Live Helper' facility, which is a first in Ireland. This offers the website users the chance 
to make live anonymous, confidential online contact with fully trained members of staff, 
to seek advice and help regarding drug-related issues. Service is available during 
specified hours each day (10.00-14.00). This website has won British Telecom 
 27 
Telephone Helpline Association Award 2003/ 2004. The site also contains an 
interactive map of Irish drug services (see www.dap.ie ). 
 
3.3 Selective/indicated prevention 
Recreational settings 
The 'Club Cork' Alcohol & Drugs Awareness Training Programme 
This programme was launched in Cork City in March 2004; targeting publicans, 
security staff and bar staff in the city. The aim is to increase awareness of the negative 
effects of alcohol and drug misuse and help participants identify possible solutions to 
deal with such issues. The training programme has been piloted in a number of Cork 
City bars/clubs. More than fifty staff comprising publicans, bar staff and security staff 
took part in the two half-day training sessions where training was provided by 
Emergency Medical Technicians; security personnel; Accident & Emergency 
Consultants and gardaí. Feedback from the pilot programme has been very positive, 
with participants and trainers enjoying the interactive and practical nature of the course. 
Participants report to be better informed about the misuse of drugs and alcohol and find 
it beneficial in terms of their working environment. Many expressed an interest in 
further training. 
  
The 'Gaf' Health Advice Cafe 
The provision of drug and alcohol free entertainment in a health promotional setting 
has been developed as a key alternative to drug use for young people in Galway City 
situated in the West of Ireland. The 'Gaf' provides drug and alcohol free entertainment 
in a safe environment and on Friday nights local bands play to a packed house until 
10.30. Latest data from the project shows that an average of 1,000 young people 
attends the project per month with 68 per cent in the 15-17 age group. Slightly more 
females, 53 per cent, to males, 47 per cent, attend the project. As part of an evaluation 
to review and develop the service a survey was recently carried out among participants 
assessing their experiences and perceptions of the service. A total of 115 survey 
questionnaires composed of both open and closed-ended questions were completed. 
The results show that 55 per cent of those surveyed attend the 'Gaf' once a week. 77 
per cent of respondents perceived the 'Gaf' to be either excellent or good. One of the 
thematic responses come from respondents was their reliance on 'peers' for 
information and support on drug- health-related issues. In addition, the responses 
indicate that the young people surveyed see the 'Gaf' as an acceptable alternative 
venue to meet friends for socialising purposes (Fitzmaurice 2002).  
 
At risk groups 
The Killinarden Drug Primary Prevention Group (KDPPG) delivers drug prevention 
activities to third, fourth, fifth and sixth class students in three primary schools in 
Killinarden. Activities designed to enhance the self-esteem of third and fourth-class 
students include a mixture of games, role-play exercises and quizzes. Students in fifth 
and sixth classes receive drug awareness education including information on different 
types of drugs and the consequences of use. A follow-up programme aiming to build on 
the self-esteem and drug education activities is delivered in Killinarden Community 
School to students up to third year. From 1995-2003, an estimated 800 young people 
participated in the various school-based drug prevention activities. A recent evaluation 
(Rourke 2003) reported that: 
• parents trained as facilitators report improved parenting skills, increased 
knowledge about drugs and a perception that their work is making a valuable 
contribution to the prevention of drug misuse in their community. Many parents 
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who were early-school leavers, report that KDPPG was a key motivating factor 
in them returning to adult education.  
• teachers report that young people interact with local parents in a more open 
and discursive way than they might relate to teachers or to external 'experts'. 
Local parents were seen as having the credibility to 'tell it as it is'. Teachers also 
report that local parents are professional, efficient, punctual and well prepared 
when delivering their presentation. 
• young people were seen to relate well to the issues being raised by parent 
facilitators in the schools, e.g. issues about how young people perceive 
themselves, their experience of peer pressure and how to be assertive when 
offered drugs. In addition, young people have become more aware and more 
informed about the dangers and consequences of drug and alcohol misuse and 
many have become more assertive and seem less likely to succumb to peer 
pressure to use drugs.  
For a comprehensive overview of this intervention see the EDDRA database.  
 
Dun Laoghaire/Rathdown LDTF recently commissioned research exploring the current 
and future value of community-based substance prevention courses, now that primary 
schools have the 'Walk Tall' programme available to them through Social, Personal and 
Health Education (SPHE). This research was carried out by Collins (2004) and focused 
on selective prevention courses in local schools.  
 
Research findings and analysis 
Summary of key results from two research questions on drug education in schools. 
 
Table 3.3.1   Key groups first choice preferences, when asked who they believe should teach 
children about drugs 
Key Groups 
 
Children 
 
Parents 
 
Course facilitator 
School personnel 
(teachers) 
Facilitators (55%) Parents (62%) Facilitators 43%) 
 
Parents (63%) 
Parents (22%) Facilitators (20%) 
 
Parents (43%) Facilitators (32%)  
Ex-drug user (20%) Ex-drug user (8%) Others (14%) Ex-drug users (5%) 
Others (3%) Teachers (7%)   
 Others (3%)   
 
Table 3.3.2   Key groups first choice preferences, when asked who they believe children would find 
it easy to talk to about drugs 
Key Groups 
 
Children 
 
Parents 
 
Course facilitator 
School personnel 
(teachers) 
Parents (45%) 
 
Parents (50%) 
 
Facilitators (71.5%) 
 
Facilitators (57%) 
 
Facilitators (30%) Facilitators (22%) Friends (28.5%) 
 
Teachers (16%) 
 
Friends (17%) 
 
Friends (14%) 
 
 Parents 11% 
 
Others (8%) Family (7%) 
 
 Friends (11)%  
 
 Others (7%)  Ex-drug users (5%) 
Source:  Collins 2004 
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It is interesting to note that across the four groups, teachers are rated quite low as an 
option to teach children about drugs or for children to talk with about drugs. Only a 
small percentage of school personnel themselves believe that children would find it 
easy to talk with teachers about drugs. Responses from school personnel included 
comments like 'teachers do not have the expertise on drugs shared by course 
facilitators'; also, reservations were expressed about the priority given to 'social 
subjects' like drug education. Although these findings relate to the perceptions and 
views of these small groups and have limitations in terms of generalising to the national 
picture, they do raise questions for policy makers and educational authorities on the 
exclusive reliance on teachers to deliver drug education through the Walk Tall/SPHE in 
primary schools. Indeed, the position of teachers as providers of drug educators is 
further challenged by the children's view, which rates ex-drug users quite high as key 
teachers on substance use prevention. This, despite the background that teachers 
were delivering the 'Walk Tall' programme in most of the schools covered in this 
research, with no evidence that ex-drug users were involved in drug education.  
 
When children were asked to suggest ways that schools could prevent children getting 
involved in drugs, the most frequent suggestion was information accompanied by a 
video about drugs, the harm caused by drugs to the person and risks of getting 
addicted to drugs. In addition, the children reported that what they 'liked' most about 
the course was the information given about various types of drugs including alcohol 
and nicotine. This would support the view that school-going children want drug specific 
information from credible sources and see course facilitators and ex-drug users among 
such sources.  
 
Early school leavers: support intervention 
A key initiative to prevent early school leaving and the consequent heightened risk of 
substance abuse is the establishment of the Educational Welfare Service. From 
December 1st 2003, six cities and 12 towns have an intensive educational welfare 
service to work with schools and families to ensure that children attend school 
regularly. These cities and towns have been prioritised because they are designated as 
educationally disadvantaged and have significant school going populations. 
 
Ethnic groups 
The Traveller Specific Drug Initiative has been introduced nationally to Traveller 
groups, drug-related service providers and policy makers. This raised the profile of the 
initiative and highlighted the issues of Travellers and drug use, and the distinct needs 
of the Traveller community. The work has included developing an anti-racist focus on 
information and training sessions that are being provided to ensure that information is 
placed within a context of Traveller experience. Training has been delivered to service 
providers via a training programme run by the health boards, focusing on Travellers 
and drug use and issues that affect Travellers such as discrimination, equality, racism 
and diversity. The initiative provides advice and support to local Traveller organisations 
who are looking at developing responses to drug issues and supports them in 
accessing and piloting initiatives in their local areas. A small number of Traveller 
groups have begun developing specific responses to the drug issue within their 
community. For a comprehensive overview of the service see the EDDRA database.  
 
At risk families 
The Ana Liffey Children's project has been operating in Dublin since October 1999 with 
the principal aim to promote and support high quality parenting and enhance the quality 
of life for children of parents who use drugs. The project has developed a number of 
specific objectives in setting out to: (a) respond to the emotional needs of children of 
drug using parents, (b) support and up-skill drug using parents in caring for their 
 30 
children, and (c) to operate a service that is valued by the client base and the wider 
community. The service provides family support, advocacy, mediation, parenting 
interventions, group and individual sessions with children, outreach to B&Bs and drop-
in advice service, after-school programme and a summer project. A recent evaluation 
of the project (Downes and Murray 2002) found that the children (age 7-12) interviewed 
gave overwhelmingly positive responses on the project. They valued the support, 
stability and trusting relationships they formed with staff and the support for family 
relationships. They enjoyed, and appeared to benefit from, the extensive variety of 
sessions available on an individual and group basis. In particular, the children reported 
that they enjoyed the activity sessions at the project, the involvement in activities after 
school, e.g. football, dancing, being able to talk to project social workers and childcare 
worker were particularly helpful. All the children interviewed are now participating in 
regular schooling and in extra-curricular activities such as football and dancing. In 
addition, parents of the children all expressed the view that the project had changed 
their life for the better. The project was viewed in very high esteem by external 
professionals with most of them saying they had great confidence in the project and 
would trust the project to meet the needs of clients they might refer. For a 
comprehensive overview of this service see the EDDRA database.  
 
4. Problem Drug Use 
 
4.1 Overview 
This section provides an overview of the new developments and trends in the 
prevalence and characteristics of problem drug use in Ireland. It reflects the findings of 
new research studies published in 2003 or from data available in 2003 or early 2004. 
 
The EMCDDA define problem drug use as ‘injecting drug use or long duration/regular 
use of opiates, cocaine and/or amphetamines’ (EMCDDA 2003, p. 18) However this 
section, written following EMCDDA guidelines, requires clients in treatment to be 
covered. It should be stressed that not all clients in treatment fit the above EMCDDA 
definition. 
 
4.2 Prevalence and incidence estimates 
In July 2003 the findings of a new study to estimate the number of opiate users in 
Ireland were published (Kelly et al. 2003). The research – the first national study of its 
type – was commissioned by the National Advisory Committee on Drugs (NACD) and 
conducted by a team from Trinity College Dublin. A three-source capture-recapture 
methodology was applied following guidelines recommended by the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA 2000). Three national data 
sources were used for both 2000 and 2001, namely clients in methadone substitution 
treatment, individuals known to be opiate users by An Garda Síochána (Irish police), 
and patients discharged from acute hospitals with an International Classification of 
Diseases code corresponding to drug dependence. A summary of the results for 2000 
and 2001 stratified by age and sex are shown below (see Table 4.2.1). Further details 
can be found in the on-line version of Standard Tables 7 and 8. 
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Table 4.2.1   Prevalence estimates for opiate use in Ireland for the years 2000 and 2001 stratified by 
age and sex 
Year Sex Age Group Estimate Lower 95% 
CI 
Upper 95% 
CI 
Rate/1000 
2000 Males 15-24 3480 3298 3691 10.4 
  25-34 3935 3753 4144 13.7 
  35-64 2344 2013 2803 3.6 
       
 Females 15-24 1866 1664 2142 5.8 
  25-34 1729 1542 1983 6.1 
  35-64 804 614 1120 1.2 
       
 Total 15-64 14158 12884 15883 5.6 
       
2001 Males 15-24 3194 3048 3363 9.5 
  25-34 4376 4206 4570 14.7 
  35-64 2228 2042 2462 3.3 
       
 Females 15-24 1999 1750 2340 6.2 
  25-34 1941 1765 2178 6.6 
  35-64 714 594 906 1.1 
       
 Total 15-64 14452 13405 15819 5.6 
 
While the estimated number of opiate users increased slightly between 2000 and 2001 
the rate per 1,000 population aged 15-64 years remained remarkably stable at 5.6. For 
both years rates were higher for men than women in all age categories. 
 
Opiate use is still predominately a Dublin phenomenon which was reflected in the 
finding that the rate of opiate use in Dublin in 2001 was 15.9 per 1000 population aged 
15-64 years and outside Dublin the rate was just under 1.2 per 1000 population aged 
15-64 years. 
 
In December 2003, the National Advisory Committee on Drugs (NACD) published a 
report entitled An overview of cocaine use in Ireland (NACD 2003).  As part of the 
overview, the NACD commissioned two studies in two different settings so as to 
explore a wider spectrum of cocaine use in Dublin. The first study conducted by UISCE 
(Union for Improved Services, Communication and Education) used a purposive 
sampling technique in that interviewers used their networks and contacts to approach 
people they thought likely to be cocaine users.  Merchant’s Quay Ireland conducted the 
second study. They surveyed 100 clients who presented for treatment at their health 
promotion unit and who had used cocaine or crack in the previous year.  The 
respondents’ average age of first cocaine use was similar in the UISCE study and the 
Merchant’s Quay study, 21 and 22 years respectively. In both studies almost half of the 
respondents used cocaine on a weekly basis.  Twenty per cent of respondents in the 
Merchant’s Quay study reported using cocaine on a daily basis, while this figure 
doubled to 40 per cent in the UISCE study. The discrepancy in the two figures may be 
due to the fact that the majority of respondents in the Merchant’s Quay study (83%) 
reported using heroin in addition to cocaine, with almost three-fifths reporting heroin as 
their main problem drug.  In contrast, just over two-fifths of cocaine users in the UISCE 
study reported heroin use.  Participants in both studies reported high levels of polydrug 
use.  A lower proportion of respondents in the UISCE study reported injecting cocaine 
than their counterparts in the Merchant’s Quay study, 58 versus 82 per cent.  As 
Merchant’s Quay provides a needle exchange facility this finding was not surprising.   
 
In the study at Merchant’s Quay, the majority of injector respondents did not mix the 
cocaine with another drug, while 41 per cent mixed it with heroin (as a snowball). In 
addition, 30 per cent of crack users reported injecting crack. As the authors state, these 
high rates of injecting cocaine, crack and ‘speedball’ indicate the high risks taken by 
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this group.  In this study, it was reported that 45 per cent of crack users and 23 per cent 
of cocaine users had not used the drug in the last month but three-quarters of the 
respondents reported binge use. The authors highlighted the high-risk practices 
associated with binge use and stress this is an important issue for harm minimisation 
interventions.  Many of the injecting cocaine users in the study reported a range of 
mental health problems, such as, depression and hallucinations. The authors stated 
that it was unclear whether the difficulties experienced by cocaine/crack users were 
due to intravenous heroin or cocaine use as 87 per cent of cocaine injectors were also 
using heroin.  These issues were not reported for the cocaine users that participated in 
the UISCE study.   
 
In the Merchant’s Quay study, only 44 per cent of respondents said that their cocaine 
use was problematic, and of these, only 16 per cent had sought treatment. In contrast, 
three fifths of respondents in the UISCE survey felt that their cocaine use was 
problematic as almost all (98%) had experienced changes in behaviour since they 
started using cocaine. Despite this, only a small proportion of these (less than one 
third) had sought treatment. According to the authors, low levels of treatment seeking 
were related to the belief among cocaine users across both studies that treatment for 
cocaine use was futile due to the lack of a pharmacological substitute.  
 
4.3 Profile of clients in treatment 
Substances used 
Drug treatment data are viewed as an indicator of drug misuse as well as a direct 
indicator of demand for treatment services. The National Drug Treatment Reporting 
System (NDTRS) is an epidemiological database on treated problem drug use in 
Ireland.  The NDTRS is co-ordinated by staff at the Drug Misuse Research Division of 
the Health Research Board on behalf of the Department of Health and Children.  For 
the purpose of the NDTRS, treatment is broadly defined as ‘any activity which aims to 
ameliorate the psychological, medical or social state of individuals who seek help for 
their drug problems.’   
 
Numbers treated by place of residence 
The number of cases presenting for treatment and reported to the NDTRS has 
increased steadily, from 6,048 in 1998 to 8,596 in 2002 (Table 4.3.1).  This increase is 
explained by a combination of factors: a true increase in drug use, an increase in 
access to treatment services, and an increase in the number of centres reporting cases 
to the NDTRS.   
 
Table 4.3.1   Number (%) of cases treated for problem drug use, by treatment status, in Ireland, 
1998–2002 
Treatment status 1998 1999 2000 2001 2002 
 Number (%) 
      
All cases 6048 6206 6933 7900 8596 
Previously treated 
cases 
4194 (63.9) 4421 (71.2) 4877 (70.3) 5663 (71.7) 6256 (72.8) 
New cases 1626 (26.9) 1673 (27.0) 1941 (28.0) 2074 (26.3) 2101 (24.4)  
Status unknown 228 (3.8) 112 (1.8) 115 (1.7) 163 (2.1) 239 (2.8) 
Source: unpublished analysis from the NDTRS 
 
The numbers treated for problem drug use and residing in the Eastern Regional Health 
Authority area (Dublin, Kildare, Wicklow) increased by 24 per cent between 1998 and 
2002, while the numbers treated for problem drug use and residing in the seven health 
board areas outside the Eastern Regional Health Authority (ERHA) increased by 263 
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per cent during the same period (Table 4.3.2).  The numbers treated for problem drug 
use and residing in the ERHA area are substantially higher than numbers treated for 
problem drug use residing in the other seven health board areas.  Of note, as a 
proportion of all treated problem drug users, the proportion of treated problem drug 
users living outside the ERHA area increased from 15 per cent in 1998 to 27 per cent 
in 2002 and this suggests that drug misuse is becoming a problem outside the ERHA 
area.   
 
Table 4.3.2   Number (%) of cases treated for problem drug use by health board of residence 1998–
2002* 
Area of residence 1998 1999 2000 2001 2002 
 Number (%) 
      
All cases 6048 6206 6933 7900 8596 
Eastern Regional Health Authority (ERHA) 5083 (84.0) 5152 (83.0) 5323 (76.8) 5868 (74.3) 6248 (72.7) 
Seven Health Boards outside the ERHA* 886 (14.6) 1031 (16.6) 1596 (23.0) 2024 (25.6) 2328 (27.1) 
Non-resident 10 (0.2) 12 (0.2) 9 (0.1) 7 (0.1) 9 (0.1) 
Address unknown 69 (1.1) 11 (0.2) 5 (0.1) 1 (0.0) 11 (0.1) 
      
*The seven health board areas are the: Midland Health Board, Mid-Western Health Board, North Eastern Health Board, 
North Western Health Board, Southern Health Board, South Eastern Health Board and Western Health Board. 
Source: unpublished analysis from the NDTRS 
 
Main Problem Drug   
The profile of main problem drugs reported by treated cases differed by place of 
residence (Table 4.3.3).  Almost 94 per cent of treated cases residing in the ERHA 
area reported that an opiate was their main problem drug, while almost 19 per cent of 
treated cases residing outside the ERHA area reported an opiate as their main problem 
drug.  Just under three per cent of treated cases residing in the ERHA area reported 
that cannabis was their main problem drug, while just under 56 per cent of treated 
cases residing outside the ERHA area reported this as their main problem drug.  In 
both areas the numbers reporting cocaine as a main problem drug increased but the 
increase is greater in the seven areas outside the ERHA.  It is important to note that 
cocaine is mainly reported as a second, third or fourth problem drug.  The reason that 
cocaine was reported as a secondary problem drug is that 85 per cent of cases 
reporting cocaine use are attending opiate treatment services and service providers 
reported opiates as the treated drug user’s main problem drug.   
 
Table 4.3.3   Main problem drug reported by cases treated for problem drug use, by health board of 
residence, 1998–2002 
Main problem drug 1998 1999 2000 2001 2002 
 Number (%) 
      
ERHA 5070 5152 5323 5868 6248 
Opiates 4652 (91.8)  4840 (93.9) 5031 (94.5) 5631 (96.0) 5921 (94.8) 
Cannabis 206 (4.1) 168 (3.3) 137 (2.6) 95 (1.6) 177 (2.8) 
Benzodiazepines 57 (1.1) 27 (0.5) 56 (1.1) 57 (1.0) 42 (0.7) 
Cocaine 56 (1.1) 32 (0.6) 47 (0.9) 43 (0.7) 73 (1.2) 
Ecstasy 46 (0.9) 50 (1.0) 32 (0.6) 30 (0.5) 18 (0.3) 
Amphetamines 24 (0.5) 18 (0.3) 2 (0.0) 4 (0.1) 1 (0.0) 
Volatile inhalants 18 (0.4) 8 (0.2) 11 (0.2) 3 (0.1) 3 (0.0) 
Other substances 11 (0.2) 9 (0.2) 7 (0.1) 5 (0.1) 13 (0.2) 
      
Outside ERHA   886 1031 1596 2024 2328 
Cannabis 419 (47.3) 553 (53.6) 933 (58.5) 1146 (56.6) 1334 (57.3) 
Opiates 160 (18.1) 181 (17.6) 241 (15.1) 397 (19.6) 490 (21.0) 
Ecstasy 148 (16.7) 164 (15.9) 257 (16.1) 271 (13.4) 245 (10.5) 
Amphetamines 48 (5.4) 42 (4.1) 28 (1.8) 17 (0.8) 29 (1.2) 
Benzodiazepines 37 (4.2) 23 (2.2) 42 (2.6) 52 (2.6) 64 (2.7) 
Cocaine 27 (3.0) 24 (2.3) 31 (1.9) 52 (2.6) 79 (3.4) 
Volatile inhalants 17 (1.9) 24 (2.3) 30 (1.9) 37 (1.8) 43 (1.8) 
Other substances 30 (3.4) 20 (1.9) 34 (2.1) 52 (2.6) 44 (1.9) 
Source: unpublished analysis from the NDTRS 
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Opiates  
Just over 98 per cent of treated cases report an opiate as their main problem drug 
(Figure 4.3.1).  The total number of treated opiate cases increased by 31 per cent.  
This is mainly accounted for by an increase in opiate cases that continue in or return to 
treatment, from 3,817 in 1998 to 5,578 in 2002.  The overall number of new opiate 
cases requesting treatment decreased by 12 per cent, from 997 cases in 1998 to 875 
cases in 2002.  The number of new opiate cases in the Eastern Regional Health 
Authority area decreased from 927 in 1998 to 624 in 2002, while the number of new 
opiate cases outside the Eastern Regional Health Authority area increased from 60 in  
1998 to 205 in 2002.   
Figure 4.3.1   Numbers that reported an opiate as a problem drug and attended treatment between 
1998 and 2002 (Source: unpublished analysis from the NDTRS) 
 
Cannabis 
The total number of cases treated for problem cannabis use doubled, increasing from 
2,088 in 1998 to 4,422 in 2002 (Figure 4.3.2).  The proportion of cases reporting 
cannabis as a main problem drug increased over 140 per cent during the reporting 
period, while the proportion reporting it as a secondary drug almost doubled.  There 
was a 75 per cent increase in the number of new cases who reported cannabis as a 
problem drug during the period under review.  The majority of cases treated for 
cannabis as a main problem drug were living outside the Eastern Regional Health 
Authority area (Table 4.3.2).  
Figure 4.3.2   Numbers that reported cannabis as a problem drug and attended treatment between 
1998 and 2002 (Source: unpublished analysis from the NDTRS) 
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Ecstasy 
The numbers attending treatment and reporting ecstasy as a problem drug almost 
doubled, from 835 in 1998 to 1,615 in 2002 (Figure 4.3.3).  There was a sharp increase 
between 1998 and 2001, and a modest increase in 2002 relative to 2001.  The number  
of treated cases reporting ecstasy as a main problem drug followed the overall trend.   
 
Figure 4.3.3   Numbers that reported ecstasy as a problem drug and attended treatment between 
1998 and 2002 (Source: unpublished analysis from the NDTRS) 
 
Cocaine 
Overall, the numbers treated for cocaine as their main problem drug have increased 
considerably from 86 in 1998 to 155 in 2002 (Figure 4.3.4).  However, cocaine is 
mainly reported as a second, third or fourth problem drug and the numbers so reporting 
have increased substantially, from 454 in 1998 to 1,716 in 2002.  The reason that 
cocaine was reported as a secondary problem drug is that 85 per cent of cases were 
attending opiate treatment services and therefore service providers reported opiates as 
the drug user’s main problem drug.   
 
Figure 4.3.4   Numbers that reported cocaine as a problem drug and attended treatment between 
1998 and 2002 (Source: unpublished analysis from the NDTRS) 
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Benzodiazepines 
 
Figure 4.3.5   Numbers that reported benzodiazepines as a problem drug and attended treatment 
between 1998 and 2002 (Source: unpublished analysis from the NDTRS) 
 
The numbers in treatment reporting benzodiazepine misuse increased from 1,533 in 
1998 to 2,666 in 2002 (Figure 4.3.5).  There was a considerable rise between 2000 and 
2002.  Problem benzodiazepine use follows the same pattern as problem cocaine use: 
87 per cent of cases reported it as a second, third or fourth problem drug.  Of those 
who reported an opiate as their main problem drug and used one or more other drugs, 
just under 50 per cent used benzodiazepines as a secondary drug.   
 
Alcohol 
Prior to January 2004, the National Drug Treatment Reporting System did not collect 
data on alcohol as a main problem drug.   
 
In April 2004, the DMRD, in collaboration with the South Eastern and Southern Health 
Boards, published an occasional paper entitled Treatment demand for problem alcohol 
use in the South Eastern and Southern Health Board areas, 2000-2002 (Long et al 
2004a).  It is the first publication that documents treatment demand for problem alcohol 
use in community settings and special residential services and complements the data 
published in the annual reports from the National Psychiatric Inpatient Reporting 
System.   
 
The number of treated cases reporting alcohol as their main problem substance is at 
least double that reporting all other drugs combined in the South Eastern and Southern 
Health Board areas (Table 4.3.4), suggesting that alcohol is the most common 
substance of abuse in Ireland. 
 
Table 4.3.4   Numbers (%) reporting problem substance use that attended treatment in the South 
Eastern Health Board (SEHB) and Southern Health Board areas (SHB), 2000 to 2002 
Main problem substance 2000 2001 2002 
 Number (%) 
 SEHB SHB SEHB SHB SEHB SHB 
Alcohol  1010 (71.2) 719 (67.3) 1472 (76.7) 852 (61.0) 1498 (71.5) 1160 (64.2) 
Drug (licit or illicit) 408 (28.8) 349 (32.7) 447 (23.3) 544 (39.0) 598 (28.5) 647 (35.8) 
Total   1418    1068    1919    1396    2096   1807 
Source: Long et al. (2004a) 
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In both health board areas, 40 per cent of those reporting problem alcohol use had 
been treated previously, indicating that this is a chronic health problem.   
 
In 2001 and 2002, one-fifth of treated cases in both health board areas reported use of 
drugs along with alcohol.  Cannabis was the most common drug used alongside 
alcohol.  Previously treated cases were more likely to use benzodiazepines with 
alcohol than were their newly treated counterparts. 
 
There was an increase in the proportion of new female cases seeking treatment for 
problem alcohol use in both areas, though the increase was higher in the Southern 
Health Board area. 
 
The rate of new cases (incidence) seeking treatment for problem alcohol use varied 
throughout the seven counties included in the study and merely reflected the level of 
service provision in the area and participation in the reporting system.   
 
This analysis demonstrates that it is possible to collect reliable data on problem alcohol 
use through the National Drug Treatment Reporting System, and highlights that the 
exclusion of alcohol from reporting systems leads to an underestimation of problem 
substance use and the workload of addiction services.   
 
The benefit of information on persons with problem alcohol use is that it will permit 
planners to rank problem alcohol use alongside other public health priorities in the 
population and to allocate appropriate resources to its management.   
 
There is momentum gathering that responses to alcohol and illicit drug use should be 
integrated. This is an issue that is being discussed by the ten Regional Drugs Task 
Forces, which have been set up over the last year. These data identify a clear overlap 
between problem alcohol and drug use and point to the need for an integrated 
approach to the management of substance misuse.  
 
Socio-demographic characteristics of problem drug users (excluding alcohol users) 
Table 4.3.5 presents demographic and socio-economic information by health board 
area of residence.  The number of treated drug users living in the ERHA area under 18 
years old decreased between 1998 and 2002, while the number living in the other 
seven health board areas under 18 years old increased considerably.  Those under 18 
years require different approaches to treatment and it is important that this is 
recognised in service planning.  A higher proportion of treated drug users living in the 
ERHA area were female than the proportion living outside the ERHA.  Women drug 
users also have a number of additional requirements that need to be considered during 
service planning (such as childcare issues and high-risk sexual practices).  A higher 
proportion of treated drug users living in the ERHA area left school before their fifteenth 
birthday than their counterparts living outside the ERHA.  Overall there were very low 
rates of employment among treated drug users.  Education and employment are 
important considerations during the rehabilitation phase.   
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Table 4.3.5   Demographic and socio-economic characteristics of cases treated for problem drug 
use by health board of residence 1998–2002 
Characteristic* 1998 1999 2000 2001 2002 
 Number (%) 
      
ERHA† 5070 5152 5323 5868 6248 
Number (%) under 18 years 387 (7.6) 213 (4.2) 180 (3.4) 161 (2.8) 169 (2.7) 
Number (%) males 3423 (68.4) 3445 (67.0) 3601 (67.8) 3949 (68.0) 3972 (67.0) 
Number (%) of early school 
leavers** 
1210 (29.1) 1215 (28.4) 1433 (30.9) 1527 (29.5) 1585 (28.5) 
Number (%) aged 16 to 64 years 
employed 
865 (18.2) 1267 (26.0) 1358 (26.8) 1347 (24.4) 1337 (22.8) 
      
Outside ERHA† 886 1031 1596 2024 2328 
Number (%) under 18 years 137 (15.6) 164 (16.0) 279 (17.5) 346 (17.1) 422 (18.3) 
Number (%) males 690 (80.2) 796 (77.8) 1264 (79.6) 1571 (78.2) 1811 (80.4) 
Number (%) of early school 
leavers** 
94 (15.8) 137 (19.1) 241 (19.7) 320 (21.0) 302 (17.7) 
Number (%) aged 16 to 64 years 
employed 
258 (31.1) 284 (29.2) 507 (34.5) 645 (34.9) 659 (31.3) 
      
* It is not possible to ascertain the percentage with each characteristic of interest from the total number because not all 
forms had complete data.  
† Health boards in the ERHA are: Northern Area Health Board, South Western Area Health Board and East Coast Area 
Health Board.  Health boards outside the ERHA are: Midland Health Board, Mid-Western Health Board, North Eastern 
Health Board, North Western Health Board, Southern Health Board, South Eastern Health Board and Western Health 
Board. 
** Left school before the age of 15 years. 
Source: unpublished analysis from the NDTRS 
 
Centre types  
The numbers attending treatment by centre type is presented in Table 4.3.6.  There 
has been an increase in the number of patients treated at outpatient services and a 
decrease in the numbers treated at inpatient services.  The numbers treated at general 
practitioners were a considerable underestimate as general practitioner returns were 
very low (16%).   
 
Table 4.3.6 Numbers of clients treated by service type and reported to the NDTRS, 1998-2002 
 
Comments  
Between 1998 and 2002, three quarters of treated drug users were polydrug users and 
the patterns of drugs used changed according to availability of drugs and peer 
influences.  In response to such changing patterns of drug use, it is important that our 
services have a broad range of options to adapt to and cope with new substances and 
combinations of substances.   
 
In the Eastern Regional Health Authority the treatment of clients with problem opiate 
use was the predominant service available between 1998 and 2002, even though the 
same clients may be using alcohol, benzodiazepines, cocaine or cannabis in 
combination with their opiate; for many clients there were no specific actions 
documented in the clinical records to address the other substances.  In the Eastern 
Regional Health Authority over 93 per cent of clients treated reported that an opiate 
was their main problem drug, whereas outside this area over 57 per cent of clients 
reported that cannabis was their main problem drug.  Of note, the National Advisory 
Committee on Drugs (NACD and DAIRU 2004) reported that cannabis use in the 
Type of treatment service Year 
 1998 1999 2000 2001 2002 
Outpatient 4566 (75.5) 4497 (72.5) 5583 (80.5) 6688 (84.7) 7271 (84.6) 
Residential 1272 (21.0) 1005 (16.2) 796 (11.5) 725 (9.2) 798 (9.3) 
Low threshold 182 (3.0) 284 (4.6) 280 (4.0) 216 (2.7) 149 (1.7) 
General practitioner 24 (0.4) 413 (6.7) 274 (4.0) 271 (3.4) 370 (4.3) 
Treatment in prison 4 (0.1) 7 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 
Not known 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 8 (0.1) 
      
Total 6048 6206 6933 7900 8596 
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population was higher in the Eastern Regional Health Authority area than outside this 
area while treatment service data report the opposite experience, indicating a bias in 
treatment services.  On the other hand, medication free and behavioural therapies are 
the main models of treatment outside the Eastern Regional Health Authority area and 
counsellors report that clients may have to travel to Dublin on a daily basis to access 
methadone.  The treatment models needs to be client-centred rather than based on the 
availability or beliefs of treatment providers in a geographical area.   
 
4.4 Main characteristics & patterns of use from non-treatment sources 
In Ireland little is known about drug users that are not in treatment.   
 
Substances used 
There is no research data available on substances used.   
 
Injecting drug users 
The injecting drug user population in Ireland is concentrated predominately in County 
Dublin and to a lesser extent in Counties Wicklow and Kildare, although there is 
evidence of spread to counties bordering the Eastern Regional Health Authority area 
(Long et al 2004c).  There are currently no needle and syringe-exchange programmes 
outside the Eastern Regional Health Authority (ERHA) area (Moore et al. 2004).  
 
There are two agencies (ERHA and Merchants Quay Ireland) collating information on 
clients attending needle and syringe-exchange. On the first visit both organisations 
collect baseline information from each client and on each subsequent visit they update 
the client’s record. The minimum information collected includes socio-demographic 
characteristics, history of problem drug use and treatment, risk behaviours and 
services provided at each visit. Each client provides his or her initials and date of birth 
for identification purposes and an identifier code is given based on this information and 
is used to record subsequent visits and avoid duplication of records.  In the Northern 
and East Coast Area Health Boards, they have commenced entering all client contacts 
on the Drugs and AIDS Information System and this will replace the current paper 
submissions to the ERHA.   
 
The data from the needle exchange reporting system was published for the first time in 
2001.  The aim of the study was to identify characteristics and trends over time among 
1,224 young injecting drug users (between the ages of 15 and 19 years) at first 
attendance at needle exchange from 1990 to 1997 (Mullen and Barry 2001). The study 
found that the number and proportion of young injectors, particularly young female 
injectors increased over the eight years. Forty-eight per cent of the young injectors 
were injecting for less than one year. Needle sharing prevalence in the year prior to 
first attendance was 39 per cent and condom use was 61 per cent. The proportion of 
females not using a condom during sexual relationships was significantly higher than 
males. Very few of the young attenders had received any treatment for drug 
dependence. The study concluded that after the first year of injecting drug use the 
likelihood of needle sharing increased, indicating the importance of reducing the time 
interval between commencing injecting drug use and starting treatment.  
 
Other specific sub populations 
There are no research data available on substances used.   
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5. Drug-Related Treatment 
 
5.1 Overview 
Treatment is broadly defined as ‘any activity which aims to ameliorate the 
psychological, medical or social state of individuals who seek help for their drug 
problems.’   
 
5.2 Treatment systems 
Treatment is provided through a network of statutory and non-statutory agencies.  
There are two broad philosophies through which treatment services are provided, 
namely: medication free therapy and medically assisted treatment.  There is a small 
degree of overlap between the two.  Medication free therapy use models such as 
therapeutic communities and the Minnesota Model though some services have 
adapted these models to suit their particular clients needs.  Medication assisted 
treatment include opiate detoxification and substitution therapies, alcohol and 
benzodiazepine detoxification, and psychiatric treatment.  Various types of counselling 
are provided through both philosophies of treatment. 
 
5.3 Drug free treatment 
The bulk of existing drug-free treatment services are provided in residential settings. 
Drug-free treatment is characterised by the approach used, where the ultimate aim is to 
enable individuals to achieve and maintain a lifestyle based on total abstinence from all 
mind-altering chemicals. The Minnesota Model, based on the 12 steps of Alcoholics 
Anonymous (AA), is the predominant model used in drug-free residential treatment 
settings in Ireland.  
 
The model recognises addiction as a disease characterised by a progressive lessening 
of control over the abused substance and a consequent deterioration of all areas in the 
individual's life. The criterion of admission to drug-free treatment mainly consists of the 
following: (a) prior participation in a 'primary treatment programme;'19 (b) alcohol and 
drug free status, including non-use of methadone, for 72 hours prior to admission; (c) 
willingness to pursue a drug-free lifestyle and (d) willingness to partake in the 
therapeutic, educational and vocational aspects of the treatment programme. No 
research has been carried out in Ireland to assess how strict, or otherwise, this criterion 
is applied. The duration of residential treatment can vary between 28 days and 12 
months. A brief overview of an adolescent drug-free treatment is provided below.  
 
The Aislinn Adolescent Addiction Treatment Service 
The Aislinn Adolescent Addiction Treatment Service provides a national addiction 
treatment programme for young people (male and female) aged 15-21 years. The 
programme began accepting participants in October 1998. The programme uses the 
Minnesota Model approach (based on the 12-Steps of AA). The duration of treatment 
consists of a six-week residential stay followed by a two-year aftercare programme. 
The main activities are group therapy, lectures, one-to-one counselling, family 
counselling, and daily practice of the AA/NA (Narcotics Anonymous) programme, 
attending meetings with self-help groups, such as NA, and taking part in recreational 
activity.  
                                                
19 A 'primary treatment programme' means an abstinence-based orientation enabling the individual to 
tackle the nature of their addiction such as counselling, AA, NA etc but can also include methadone and 
detoxification.  
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The specific objectives of the programme are to: (a) attract and retain participants in 
treatment, (b) achieve improvements in participant's quality of life and (c) assist 
participants to become aware of the consequences of substance misuse in their lives. 
An evaluation of the programme (Cox and Cullen 2002) found that from October 1998 
to August 2001, 264 clients presented at, and were accepted into, Aislinn: 28 per cent 
female, 72 per cent male; average age at time of entry is 17.6 years (age range 15-21). 
These data are an indication that Aislinn is successful in attracting young participants, 
the key target group. In addition, the evaluation found that 52 per cent of participants 
completed the residential treatment phase, with a majority going on to use the aftercare 
services. The evaluation also detected improvements in participants’ quality of life in 
the following areas: interpersonal, family relations, employment, education and health. 
In addition, participants reported changes in the way they felt about their alcohol and 
drug misuse, becoming more aware of the consequences of such use. In particular, it 
was noted that participants showed awareness of the effects such misuse and its 
related behaviour had on their families.  
 
For a more comprehensive overview of other drug-free projects e.g. Soilse/Rutland 
Partnership Project, High Park Residential Drug Treatment and Aiseiri, see the EDDRA 
database.  
 
5.4 Medically assisted treatment 
Approximately one-quarter of those who ever use heroin will develop dependence. In 
Ireland opiate dependence is classified using the International Classification of 
Diseases and Related Health Disorders, Tenth Revision. The Code F11.2 which 
describes an opiate dependent client as one with ‘a strong desire to take opiates, 
difficulties in controlling their use, persistence in their use despite harmful 
consequences, a higher priority given to opiate use than to other activities and 
obligations, increased tolerance and physical withdrawals’ (WHO 1992).  
 
Detoxification services 
The first step in the treatment of opiate dependence that aims at abstinence is 
detoxification. The aim of detoxification is to eliminate opiates and other drugs from the 
body. There are two methods of detoxification, a gradual reduction of the drug dosage 
until the individual is drug free, or an abrupt discontinuation of the drug (with or without 
medication to manage subsequent withdrawal symptoms).  
 
In Ireland, drugs used to detoxify opiate users are methadone, buprenorphine and 
lofexidine. Research indicates that all three drugs are effective in reducing withdrawal 
symptoms and completion rates are satisfactory (Amato et al. 2003; Gowling et al. 
2003a,b). Therapy normally continues until all withdrawal symptoms have subsided. 
Counselling and ancillary services help clients cope with withdrawals. Methadone, 
buprenorphine and lofexidine can be used in both inpatient and outpatient 
programmes.  
 
Another form of detoxification is methadone reduction. The aim of methadone reduction 
is to prescribe a gradually reducing dose over time with the ultimate aim that the 
individual achieves abstinence in the medium term rather than the short term. In 
outpatient and general practices, methadone reduction programmes involve the daily 
administration of the (oral opioid agonist) methadone to the individual, tapering off at a 
rate the client can tolerate. The time to abstinence varies for each individual. This 
treatment is usually available to patients already on methadone maintenance and 
wishing to discontinue it.  
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The next step for the individual that has been detoxified is to maintain their abstinence. 
This is much harder than completing the detoxification process. It usually requires 
admission to an inpatient or outpatient rehabilitation programme or attendance at self-
help groups (see Section 5.2). In fact, evidence suggests that detoxification without 
support to prevent relapse is usually unsuccessful.  
 
In Ireland, priority for places in detoxification programmes is given to younger opiate 
users or individuals in the early stage of heroin addiction. Parental consent is required 
for clients less than 18 years old.  
 
Two inpatient units and a number of outpatient treatment centres provide detoxification 
for problem opiate and benzodiazepine users in Ireland. Inpatient treatment centres 
generally provide detoxification and early rehabilitation on a short-term basis (2 to 12 
weeks). Methadone is the most commonly used drug for opiate detoxification; in recent 
years buprenorphine and lofexidine have also been used to detoxify opiate users in 
treatment centres in this country. Subutex® is authorised for use in opiate dependence 
in Ireland since late 2002, but there is no combination of buprenorphine and naloxone 
currently authorised. On completion of inpatient and outpatient detoxification, a number 
of clients go on to residential centres (see section 5.2).  Of the 8,596 cases reported to 
the NDTRS in 2002, 999 (12%) attended an opiate detoxification service.   
 
Effectiveness of detoxification programmes 
Smyth and colleagues followed up a cohort of 100 opiate users admitted to Cuan Dara 
(an inpatient detoxification unit) in order to identify the proportion of individuals that 
were drug free two years after admission and reported that 23 per cent were drug free 
at the time of the follow-up survey. The authors also identified the individuals’ before 
and in-treatment characteristics as predictors of drug-free status at 24 months and 
these will be published in late 2004 (B Smyth, personal communication, 2003).  
 
The Working Party at the National Medicines Information Centre at St James’s Hospital 
in Dublin were commissioned by the National Advisory Committee on Drugs to review 
the use of lofexidine and naloxone in the management of opiate dependence. 
 
A systematic review was undertaken in order to evaluate the potential usefulness of 
lofexidine and naloxone treatment options in the management of opiate dependency.  
All available data were retrieved by means of a comprehensive search of the published 
literature. Contact was made with experts nationally and internationally to evaluate the 
practical issues associated with use of these drugs in a clinical setting. The authors’ 
findings are presented by pharmaceutical agent.   
 
Lofexidine  
According to the Working Party at the National Medicines Information Centre (2003a), 
evaluation of clinical trials data for lofexidine showed that it appeared to be at least as 
effective as clonidine and reducing doses of methadone, the other treatment regimens 
currently used in the treatment of opiate withdrawal. It was not possible to define the 
optimal dosage regimen for this indication because of the lack of data from clinical trials 
but, in general, incremental dosing was used reaching a maximum of around 2.2mg per 
day by day three or four, with gradual tapering-off to zero by day ten. 
 
The authors also reviewed studies of its use in clinical practice and showed that it was 
considered as effective as clonidine for managed withdrawal but had a better safety 
profile (that is, lower number of cases experienced low blood pressure).  Experts have 
suggested that lofexidine detoxification requires intensive input from all members of the 
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drug treatment team and should be followed up by further treatment to prevent relapse.  
Although there were insufficient data to evaluate its use in specific subgroups, most 
workers have suggested that lofexidine was more effective in younger patients and 
those who had a shorter, less entrenched history of opiate use. 
 
The authors reviewed the availability and, where data were available, treatment 
outcomes.   
 
In Dublin, three outpatient treatment centres and one inpatient facility were offering 
lofexidine to clients.  Staff at one of the outpatient centres recorded and analysed the 
treatment outcome data.  In total, 84 clients (98 cases) participated in the ten-day 
treatment regime between December 2000 and December 2002.  Successful 
detoxification was achieved if the client’s urine was free of opiates at the end of the 
programme.  Lofexidine was administered in conjunction with full medical and 
counselling support and patients were seen on a daily basis, including weekends.  
Following successful detoxification, patients were offered naltrexone and counselling to 
prevent relapse.  The overall treatment completion rate for cases was 38 per cent 
(37/98).  Success was highest among those stable on methadone (8/10) and heroin 
smokers (13/33).  Cases that had not yet stabilised on methadone had a very low 
success rate (2/14).  There were no serious episodes of hypotension (low blood 
pressure).   
 
According to the National Medicines Information Centre, lofexidine may be useful as an 
additional treatment for managed opiate withdrawal in Ireland. 
 
Naloxone  
There are two clinical indications for the use of naloxone: to facilitate withdrawal for 
opiates and as part of the management of an opiate overdose.  The review of naloxone 
in the management of opiate withdrawals is presented here.  (A review of the use of 
naloxone in the management of overdose is presented in Section 7.2).  
 
According to the Working Party at the National Medicines Information Centre (2003b), 
naloxone had been used, with or without naltrexone, to effect rapid opiate withdrawal. 
Results of studies have shown that the withdrawal occured earlier and was more 
severe with use of naloxone compared with alpha 2-adrenergic agents such as 
clonidine or lofexidine. According to the authors, the long-term benefits of rapid 
withdrawal had not been compared with those from standard withdrawal regimens. 
Data were insufficient to identify the most appropriate dosage regimen. 
 
The authors reported that a combination preparation of buprenorphine and naloxone 
(4:1 ratio) for sublingual use has recently been developed. It was shown to be effective 
as a maintenance treatment for opiate dependence, while the presence of naloxone 
reduced the risk of misuse of the buprenorphine component. Data were insufficient to 
identify the optimal treatment regimen. The combination was shown to be equipotent to 
buprenorphine alone.  
 
There are no published data on the use of naloxone to effect rapid opiate withdrawal in 
Ireland.  
 
Opiate substitution 
Methadone maintenance involves the daily administration of (the oral opioid agonist) 
methadone as a treatment for opiate dependence. In Ireland, methadone is the opiate 
substitute of choice for maintenance therapy (Methadone Treatment Services Review 
Group 1998). The aim of methadone maintenance therapy is to replace illicit opiate use 
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with a licit oral medication in order to provide the individual with a stable lifestyle and 
reduce the harms associated with problem opiate use. Methadone is taken once per 
day because its long duration eliminates withdrawal symptoms for between 24 and 36 
hours. Given in high doses it reduces the craving for heroin and blocks the euphoric 
effects of heroin if the two drugs are taken together.  
 
Policy and protocols 
In Ireland, the admission criteria for methadone maintenance is opiate dependence 
(Code F11.2) using the International Classification of Diseases and Related Health 
Disorders – Tenth Revision (WHO 1992). In addition, the client must have been 
injecting for at least one year. Although in practice the latter condition is not observed 
and there are many opiate users who smoke or ingest opiates in treatment. Priority is 
given to individuals who are pregnant, have a partner in treatment, or have tested 
positive for HIV. Parental consent is required for clients less than 18 years old and 
these young persons must have a history of at least one failed attempt at detoxification. 
The decision to prescribe methadone to a young person is made by a consultant 
psychiatrist (Eastern Health Board, Policy Number 6). In addition, all clients must 
provide three opiate-positive urines to confirm its use and the individual’s motivation to 
change is also assessed. There is no time limit on the duration of methadone 
maintenance therapy.  Smyth et al. (2003) noted that, in order to prevent infection with 
hepatitis C among injecting drug users, such users need to be in treatment within a 
short time following initiating injecting. Therefore, with respect to injecting drug use, the 
methadone maintenance entry criteria should be reconsidered. 
 
In 1997 a group was established to review the implementation of the Protocol for the 
Prescribing of Methadone 1993 (Health and Children 1998). The recommendations of 
this review endorsed the 1993 protocol and emphasised that methadone continued to 
be a valid treatment for opiate users. The review group stated that methadone would 
be provided free of charge to all opiate-dependent persons living anywhere in Ireland. 
Another important recommendation of this review was the legal obligation to register 
any patient receiving methadone with the Central Treatment List (Statutory Instrument 
No. 225 of 1998). In addition, practice guidelines for general practitioners and 
pharmacists were developed. Under the terms of this review, two types of contract for 
general practitioners (level one and level two) were developed. The level-one contract 
permits general practitioners who have completed appropriate training in the 
management of opiate users to provide care for a maximum of 15 persons, while the 
level-two contract allows experienced general practitioners who have completed 
advanced training to initiate treatment for and treat a maximum of 35 opiate-dependent 
persons. Where two or more level-two general practitioners work in the one practice, 
they are limited to a maximum of 50 clients. The pharmacists are contracted to 
dispense and, if required, to administer Methadone DTF one mg per ml, when 
prescribed on a methadone protocol prescription sheet, to opiate-dependent persons in 
their local area. Training in the management of opiate users is provided for participating 
pharmacists and, ideally, approximately 50 clients can be registered at each 
participating pharmacy. In May 2003, the Irish College of General Practitioners 
developed evidence-based guidelines for general practitioners working with opiate 
users in general practice (ICGP 2003).  
 
One of the limits of methadone maintenance therapy in the 1990s was its 
discontinuation once a client entered prison (Section 9.2.1).  
 
Methadone services and their uptake in Ireland  
The Central Treatment List is held by the ERHA and managed by the Drug Treatment 
Centre Board.  The Central Treatment List is a complete register of all patients 
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receiving methadone (for treatment of problem opiate use) in Ireland. This list was 
established under Statutory Instrument No. 225 following publication of the Report of 
the Methadone Treatment Services Review Group 1998. When a person is considered 
suitable for methadone detoxification or maintenance, the prescribing doctor applies to 
the Central Treatment List for a place (on the list) and a treatment card for the client. 
The card is issued by Central Treatment List staff and retained by the dispensing 
pharmacist. Methadone cannot be dispensed unless the pharmacist has the client’s 
treatment card, therefore, a client can receive their methadone from one source only. 
There are also transfer and exit forms which allow the Central Treatment List to track 
each client’s current treatment status. Each client’s name, address, date of birth, 
gender, date commenced on methadone, type of methadone treatment, prescribing 
doctor and dispensing pharmacist are recorded on the list. Each client is allocated a 
unique identifier. The Central Treatment List is considered complete with respect to the 
number of clients who start or recommence methadone because practitioners have a 
statutory obligation to report the initiation of treatment and, also, they are paid per client 
in treatment. The number of exits from and transfers within the list has never been 
validated. As already mentioned, each client has a unique identifier so duplicates or 
transfers between treatment providers can be identified easily, but it is possible that a 
proportion of exits are not reported promptly. For example, Cullen and colleagues 
(2001) failed to locate 17 per cent of cases registered as attending methadone 
maintenance treatment in selected general practices in Dublin and recorded on the 
Central Treatment List at that time.  
 
Table 5.4.1 presents the number of clients in treatment at the end of December each 
year from 1997 to 2003, which is an indicator of the number of treatment places at a 
point in time. The number of treatment places more than doubled between 1997 and 
2003.  
 
Table 5.4.1   Number of clients on methadone in Ireland by place treated at the end of December 
each year, from 1997 to 2003 (unpublished data from the Central Treatment List)  
 1997 1998 1999 2000 2001 2002 2003 
 Number of clients on 31 December  
ERHA 2859 3610 4269 4936 5466 5813 6204 
Trinity Court 207 504 515 513 510 506 501 
Treatment centres and 
satellite clinics  
 
1182 
 
1939 
 
2502 
 
2849 
 
3174 
 
3346 
 
3543 
General practice  1470 1167 1252 1574 1782 1961 2160 
        
Outside ERHA Not 
available 
Not 
available 
63 96 170 211 277 
Treatment centres Not 
available 
Not 
available 
 41 66 91 123 
General practice  Not 
available 
Not 
available 
63 55 104 120 154 
        
Prisons (national) Not 
available 
Not 
available 
Not 
available 
Not 
available 
229 425 402 
Total 2859 3610 4332 5032 5865 6449 6883 
 
Figure 5.4.1 presents the total numbers of clients by treatment status registered with 
the Central Treatment List from 1994 to 2003. The total number of clients registered for 
methadone treatment increased steadily from 1,529 in 1994 to 8,155 in 2003. The 
number of new cases almost doubled between 1994 and 1998, rising from 831 in 1994 
to 1,650 in 1998. Subsequently, the number of new clients each year almost halved 
between 1998 and 2003. In 2003, there were 753 new clients, which further confirms 
the tapering-off of the heroin epidemic. Assuming that treatment providers promptly 
report the date clients leave treatment, the numbers returning to treatment and retained 
in treatment can be used as a proxy for retention levels in treatment. Of a possible 
8,094 clients who ever received methadone treatment up to 1999, 5,032 (62%) had 
returned to or were still in treatment on 31 December 2000, 12 months or more after 
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entering treatment (Figure and Table 5.4.1). From these data it is not possible to 
ascertain how many remained in treatment without relapse during the period under 
review; this requires further investigation.  
 
 
Figure 5.4.1   Numbers of clients registered with the Central Treatment List in Ireland by treatment 
status, 1994 to 2003 (unpublished data from the Central Treatment List) 
 
Figure 5.4.2 presents the numbers of cases by place of residence on the Central 
Treatment List from 1994 to 2003. As expected, the vast majority of cases are in the 
ERHA area. As can be seen from Figure 5.4.3, the two years with the greatest number 
of new treatments are 1997 and 1998. The most likely explanation for the peak in 1997 
and 1998 is that the number of health board treatment outlets (of which most were in 
Dublin) increased almost fourfold, from 10 to 38, in that two-year time period. Though 
small, there has been a steady increase in the numbers attending treatment outside the 
ERHA area (Figure 5.4.2 and Figure 5.4.3).  
 
 
Figure 5.4.2   Numbers of cases registered with the Central Treatment List in Ireland by place of 
residence, 1994 to 2003 (unpublished data from the Central Treatment List)  
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Figure 5.4.2 and Figure 5.4.3 present the slow spread of methadone treatment outside 
the ERHA area, while Figure 5.4.3 illustrates the decrease in the number of new 
treatments in the eastern region of Ireland.  
 
Figure 5.4.3   Numbers of new cases registered with the Central Treatment List by place of 
residence, 1994 to 2003 (unpublished data from the Central Treatment List) 
 
Figure 5.4.4 presents the proportion of new cases by age and gender registered with 
the Central Treatment List from 1994 to 2003. The proportion of new cases aged less 
than 25 years increased from 50 per cent in 1994 to 68 per cent in 1996. Since 1996 
there has been a steady decline in the proportion of new cases less than 25 years old. 
In 2003, 45 per cent of new cases were less than 25 years old. The proportion of 
females varied throughout the period under review.  
 
 
Figure 5.4.4   Proportion of new cases by age and gender registered with the Central Treatment 
List, 1994 to 2003 (unpublished data from the Central Treatment List) 
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and five consultant psychiatrists provide specialist addiction treatment at this centre. 
The consultant psychiatrists also provide policy and service planning guidance to staff 
at other treatment locations in the eastern region of Ireland. A referral service operates 
between the Centre at Trinity Court and others who provide addiction services. 
Specialist general practitioners provide medical treatment at the remaining nine drug 
treatment centres in this geographical location. There is a multidisciplinary team 
(addiction counsellors, doctors, general assistants, nurses and pharmacists) working in 
each of the treatment centres. Family therapists and childcare workers provide services 
at a limited number of treatment centres. In the ERHA area in August 2003, there were 
64 satellite clinics where staff work with communities severely affected by problem 
opiate use to deliver a local service, and methadone is dispensed through local 
pharmacists. General practitioners in co-operation with retail pharmacists provided care 
for just under one-third of opiate-dependent persons on methadone maintenance in 
December 2002. In the ERHA area, the number of general practitioners providing 
methadone maintenance treatment increased gradually, from 139 in December 1999 to 
167 in August 2003. In 2003, two mobile units provided low-threshold services at four 
locations in the ERHA area.  
 
There are seven health boards outside the ERHA area. Problem opiate use is found in 
the health board areas bordering the ERHA area, namely, the North Eastern Health 
Board area, the Midlands Health Board area and the South Eastern Health Board area. 
There were six health board clinics providing a methadone treatment programme in 
August 2003. In the health board areas outside the eastern region, the numbers of 
general practitioners providing methadone maintenance treatment remained relatively 
stable at 32 at the end of December 1999 and 34 at the end of December 2003. 
 
Effectiveness of methadone services 
There were no national studies measuring the effectiveness of methadone as a 
treatment for problem opiate use in Ireland.  During 2003 and 2004, two studies were 
conducted among cohorts of opiate users to determine the effectiveness of methadone 
maintenance therapy.   
 
Cahill et al. (2003) followed up for three months a cohort of 464 individuals who 
experienced a change in prescriber (from general practitioner to treatment centre) as a 
result of the legislative changes in methadone prescribing that came into effect on 1 
October 1998 (Statutory Instrument No. 225 of 1998). Cahill and colleagues reported 
that the percentage on higher doses (over 90 mg per day) and lower doses (less than 
51 mg per day) of methadone had decreased. For example, the proportion prescribed 
over 90 mg per day decreased from seven per cent in October 1998 to two per cent in 
December 1998. Of those who started treatment in a treatment centre in October 1998, 
92 per cent were still attending the methadone maintenance programme three months 
later.  Of the 464 clients in this study who changed prescriber, 72 per cent tested 
negative for opiates in December 1998, compared to 46 per cent in October 1998 
(Cahill et al. 2003).   
 
Cox and Lawless (2004) followed a cohort of individuals that entered a methadone 
maintenance programme in 1999 and continued in treatment for an eighteen-month 
period.  A validated questionnaire, known as the opiate treatment index, was 
administered to 33 clients at some time following entry to methadone treatment at 
Merchants Quay Ireland in 1999 and to 17 clients who were still in treatment 18 months 
later. The questionnaire collected self-reported data on six domains: drug use, HIV risk-
taking behaviours, social functioning, criminality, health status and psychological 
adjustment. Excluding social functioning, the data collected for all other outcomes was 
based on behaviours in the month prior to each interview. The data on social 
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functioning pertained to behaviours in the six-month periods prior to each interview. 
Each domain had a number of questions and, for each question, there were a number 
of answer options. Each answer option had a score, with the lowest score indicating 
the lowest level of risk-taking or the best experience. The questionnaire collected some 
additional data on each client’s demographic and social situation.  
 
The main findings between baseline and follow-up study were:  
• The mean opiate treatment index scores for HIV-related risk behaviours 
increased, accounted for by an increase in reported sexual risk behaviours, 
rather than in drug-using risk behaviours, in the month prior to the follow-up 
study, compared to respective risk behaviours reported at the time of the 
baseline study.  
• Criminal behaviour decreased substantially, with only one client reporting 
committing one or more crimes during the month prior to the follow-up study, 
compared to six during the month prior to the baseline study. 
• Social functioning scores decreased considerably, indicating an improvement in 
housing, employment and family relationships at the time of the follow-up study, 
compared to the baseline study.  
• Health status remained similar.  
• Psychological adjustment scores decreased, indicating that mental health 
outcomes had improved over the 18-month period.  
 
It is important to note that the sample size was small and that the improvements in 
mean scores were not tested statistically. Nevertheless, the findings suggest a number 
of positive outcomes associated with methadone maintenance therapy.  
 
In Ireland there is very little published information that documents clients’ satisfaction 
with methadone treatment services. This review presents the results of two studies 
published between 2003 and 2004.  The Union for Improved Services, Communication 
and Education (UISCE) collected their data in 2003 while Lawless and Cox collected 
their data in 1999 and 2001.   
 
In October 2003, the Union for Improved Services, Communication and Education 
(UISCE) published a study that examined clients’ experiences and expectations of 
methadone treatment programmes.  The study participants were taking long-term 
methadone maintenance and lived in the Dublin area.  The researchers used both 
quantitative (survey) and qualitative (focus group) approaches to collect the 
information.   
 
The sampling method for the survey, the rationale for the sample size chosen, and the 
response rate were not documented, so the generalisability of the study cannot be 
determined.  Notwithstanding these possible limitations, the high levels of 
dissatisfaction with Methadone DTF compared with Physeptone were in line with 
another study (O’Connor 2002).   
 
Focus groups were conducted as part feedback on the survey results, and part public 
consultation process.  The number of focus groups and the numbers attending each of 
the groups were not presented in the published report.  Several issues emerged from 
the focus groups discussions: once again, respondents expressed high levels of 
dissatisfaction with Methadone DTF compared with Physeptone; respondents’ 
impression of drug treatment service personnel was that they were impersonal and 
uncaring; participants reported over-use of sanctions by health professionals; 
respondents said that the individual pharmacy contracts provide rights for the retailers 
but not for the clients; participants questioned the use of urinalysis as the best method 
for detecting illicit drug use; participants questioned the actions of health professionals 
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based on urinalysis; respondents reported lack of confidentiality among service 
providers; clients reported lack of participation in their treatment plan, and the absence 
of an independent complaints procedure.   
 
Surprisingly, there were no positive experiences with the current methadone treatment 
programme reported in the document, which indicates a possible bias in the 
information presented or in the manner by which it was collected.  Despite potential 
bias, the findings of this study indicate that clients on long-term methadone 
maintenance want: 
• to participate in their treatment plan and its subsequent monitoring and 
evaluation; 
• a service that caters for the other morbidities associated with problem opiate 
use, such as blood-borne viruses and psychiatric disorders;  
• courtesy from service providers;  
• an independent body to decide the course of action in the event of a 
disagreement.   
 
Cox and Lawless (2004) completed a qualitative study that consisted of three focus 
groups.  These were undertaken to ascertain the experience of clients and service 
providers with respect to methadone maintenance. Two focus groups were carried out 
to ascertain the experience of clients who attended the methadone prescribing service 
or the day programme at Merchants Quay Ireland. Those who attended the day 
programme were receiving methadone maintenance in a health board clinic or general 
practice setting. The clients were asked about methadone maintenance and continued 
risk behaviour, use of counselling and other auxiliary services, impact of methadone on 
their lives, and their relationship with service providers. The third focus group 
comprised staff working in the methadone prescribing service or the day programme at 
Merchants Quay Ireland. The service providers were asked about the positive and 
negative aspects of methadone maintenance, issues that positively and negatively 
affect treatment outcomes, and other pharmaceutical treatment options. The data were 
transcribed and five themes were identified.   
 
The five themes and their meanings are:   
 
Theme 1 ‘Key players in methadone treatment’ 
Clients welcomed the improvements in drug treatment services following the 
introduction of the methadone protocol. The most important improvements were the 
increase in number of places available, the removal of all financial charges, the wide 
range of services available in the clinics for the less stable patients, and the transfer of 
stable patients to general practice settings. The clients’ experiences at pharmacies 
were both positive and negative. The negative experiences were long waiting periods, 
lack of privacy and poor communication between the general practitioner and the 
pharmacist.  
 
Theme 2 ‘Methadone treatment and integration’  
The transition between active drug use and stabilising on methadone maintenance is a 
very vulnerable time for drug users. Clients reported that structured day programmes 
and formal training programmes provided them with a regular routine and the skills to 
gain future employment. Many clients reported that they held full-time positions while 
on methadone but it was very difficult to meet both the requirements of a full-time job 
and the competing requirements of the methadone treatment services. In general, 
those with full-time work feared that their employers would discover that they were on a 
methadone treatment programme and that they would lose their position. The majority 
of clients reported that methadone maintenance improved their relationships with their 
families and decreased their criminal activity.  
 51 
 
Theme 3 ‘Responding to methadone’ 
Clients reported that, initially, methadone maintenance was very important when 
moving from active drug use to no drug use, but that they now worried about the long-
term dependence on methadone itself. Some clients who were stable on long-term 
methadone maintenance expressed a desire to detoxify but feared that they would find 
it difficult to tolerate the withdrawal symptoms, or that they would relapse into heroin 
use. They also reported that service providers did not encourage them to detoxify but 
to maintain status quo. Clients requested that a broader range of detoxification 
methods be provided for those wishing to detoxify from methadone maintenance and 
that service providers facilitate their provision.   
 
Theme 4 ‘Managing methadone treatment’ 
Most clients reported that the high turnover of counsellors at drug treatment centres 
was disruptive in maintaining a stable lifestyle or dealing with crises. The clients 
accepted that their drug use had to be monitored but asked for an alternative to 
urinalysis, as it was humiliating for both clients and service providers.  
 
Theme 5 ‘Methadone and health’ 
Many clients on methadone reported dental problems that they associated with their 
methadone therapy. In addition, they reported that opiates were not their only problem 
drugs. Some clients reported dependence on other prescribed drugs, such as 
benzodiazepines, hypnotics and tranquillisers. The clients also reported interactions 
between antiviral therapy and methadone.  
 
Notwithstanding the limitations of the UISCE study, the first Irish study by drug users 
themselves, clients reported high levels of dissatisfaction with aspects of the 
methadone treatment services.  The participants in the Cox and Lawless study also 
expressed dissatisfaction with aspects of methadone maintenance treatment, though 
they expressed a number of positive experiences associated with such treatment.  
While the staff that run the service may be disappointed with the drug users’ 
perceptions, these findings could be turned to opportunity and provide the first step in a 
partnership between clients and service providers to start to address these issues. This 
process could be conducted through the ‘service user charter’ in each health board 
area that was recommended in the current National Drugs Strategy 2001–2008. When 
addressing these issues it is important to strike a balance between repression and 
adherence to services. It is also apparent that clients taking methadone maintenance 
require impartial information on policy decisions that affect their treatment.   
 
6. Health Correlates and Consequences 
 
6.1 Overview 
This section presents new data on the incidence of drug-related mortality, the incidence 
and prevalence of bloodborne viruses.  The definitions used are presented where 
necessary in the relevant sections.   
 
6.2 Drug-related deaths and mortality of drug users 
Direct drug-related deaths  
In Ireland, the Central Statistics Office compiles the General Mortality Register’s official 
statistics on direct drug-related deaths each year. Figure 6.2.1 presents the number of 
direct drug-related deaths in Dublin and the rest of Ireland from 1991 to 2001. Between 
1991 and 2000, there was a steady increase in the number of drug-related deaths, with 
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most occurring in Dublin. Between 1991 and 1994, almost all drug-related deaths 
occurred in Dublin. Between 1995 and 2000, there was a steady increase in the 
numbers of drug-related deaths outside the Dublin area. In 2001, there was a sharp 
decrease in the number of drug-related deaths in Dublin and a continued increase in 
drug-related deaths outside Dublin.  
 
Figure 6.2.1   Number of direct drug-related deaths by place of death in Ireland reported by the 
Central Statistics Office, 1991 to 2001 (unpublished data from the vital statistics) 
 
Between 1991 and 2001, the average age of cases that died as a result of a direct 
drug-related incident has increased steadily from 27 years to just over 37 years (Figure 
6.2.2). This was higher than the average age of those treated for problem drug use and 
indicates the increasing risk of mortality among older drug users.  
 
 
Figure 6.2.2   Average age of cases who died as a result of a direct drug-related cause each year in 
Ireland reported by the Central Statistics Office, 1991 to 2001 (unpublished data from the vital 
statistics) 
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Figure 6.2.3 presents the number of direct drug-related deaths by gender reported to 
the Central Statistics Office from 1991 to 2001. The vast majority of those who died 
were men, but between 1994 and 2001, there has been a steady increase in the 
number of drug-related deaths in women.  
 
Figure 6.2.3   Number of direct drug-related deaths by gender in Ireland reported by the Central 
Statistics Office, 1991 to 2001 (unpublished data from the vital statistics) 
 
The Central Statistics Office categorises the cause of each death using the World 
Health Organization (WHO) diagnostic coding manual on the international classification 
of diseases (known as ICD categories). The ninth revision continues to be used in this 
country. In Ireland, the categories 304 and 965.0 are classified as drug-related deaths. 
The category 304 refers to deaths as a result of drug dependence (including 
dependence on morphine, barbiturates, cocaine, cannabis, psychostimulants and 
hallucinogens), while the category 965.0 refers to poisoning by opiates and related 
narcotics excluding those with a history of morphine dependence (304.0). From 1991 to 
2001, the majority of opiate-related deaths were classified as deaths among persons 
with a history of drug dependence (Figure 6.2.4). The number of cases both among 
those with known drug dependence and among those poisoned by opiates and related 
narcotics increased. The increasing number of deaths from poisoning by opiates and 
related narcotics observed over the period under review could be as a result of 
misclassification of opiate dependant cases to poisoning by opiates and other-related 
narcotics (965.0) rather than morphine dependence (304.0).  
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Figure 6.2.4   Number of direct drug-related deaths by cause of death in Ireland reported by the 
Central Statistics Office, 1991 to 2000 (unpublished data from the vital statistics) 
 
The incidence of drug-related deaths increased twofold, from 0.23 in 1996 to 0.47 per 
10,000 in 2000 but decreased sharply to 0.34 in 2001 (Figure 6.2.5).  
 
Figure 6.2.5   Incidence of drug-related deaths per 10,000 population aged between 15 and 64 
years, 1996 to 2001 (Central Statistics Office 2002) 
 
Between 1991 and 2000, the highest numbers of drug-related deaths in Ireland were 
as a result of opiates (Figure 6.2.6). For example, 57 (65%) of the 88 drug-related 
deaths were opiate-related in 2001. During the period under review, most opiate-
related deaths occurred in Dublin (Figure 6.2.6). Of note, there was a substantial (35%) 
decrease in the numbers of opiate-related deaths in 2001 indicating both a tapering of 
the heroin epidemic and more appropriate responses to problem heroin use in Dublin, 
such as methadone treatment in prison. In contrast, there has been a steady increase 
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in the number of deaths occurring outside Dublin between 1995 and 2001 (Figure 
6.2.6) indicating the spread of problem heroin use outside the Dublin area.  
 
 
Figure 6.2.6   Number of direct opiate-related deaths by place of death in Ireland reported by the 
Central Statistics Office, 1991 to 2001 (unpublished data from the vital statistics) 
 
Indirect drug related deaths 
There were no new data published on indirect drug-related deaths or AIDS-related deaths in 
2003. 
 
6.3 Drug-related infectious diseases 
Incidence 
Important changes to infectious disease legislation were introduced in Ireland on 01 
January 2004. The report, Review of Notifiable Diseases and the Process of 
Notification (Notifiable Diseases Sub-Committee of the Scientific Advisory Committee 
2001) recommended these changes. The Infectious Disease Regulations 1981 were 
amended to establish a revised list of notifiable diseases and, for the first time, their 
causative pathogen (Infectious Diseases (Amendment) (No. 3) Regulations 2003, S.I. 
No. 707 of 2003). As part of the revised legislation, laboratory directors as well as 
clinicians are required to report the named notifiable diseases.  The changes to the list 
of notifiable diseases are consistent with a European Commission Decision on 
communicable diseases (Decision no. 2000/96/EC, under Decision no. 2119/98/EC of 
the European Parliament and of the Council). 
 
Voluntary linked testing for antibodies to HIV has been available in Ireland since 1985.  
The National Disease Surveillance Centre reported that there were 399 newly 
diagnosed HIV infections reported in 2003 (NDSC 2004).  There were 47 new 
diagnoses among injecting drug users during 2003 compared to 50 in 2002 and 38 in 
2001.  There were a higher number of new infections among male injectors (30, 64%) 
than female injectors (17, 36%).  The average age of HIV diagnosis for injecting drug 
users was 29 years.  Of the 47 newly diagnosed cases, 45 were born in Ireland and 43 
lived in the Eastern Regional Health Authority area.  The cumulative total of HIV cases 
reported to the end of December 2003 was 3,408, of whom 1131 (33%) were injecting 
drug users.  
 
4 5
8 9
14
23
50 50
70
63
43
0 0 0 2 2 0
8
11 9 9
14 14
31
61 59
79 77
57
28
28
1611
8
54
0
10
20
30
40
50
60
70
80
90
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
Year
N
um
be
r Dublin 
Outside Dublin
Total
 56 
Hepatitis B was already classified as a notifiable disease but the inclusion of laboratory 
directors as a source of notification will increase the number of the notifications.  There 
are no data by risk factor status.   
 
Hepatitis C occurs mainly in two populations in Ireland: cohorts of individuals who 
became infected through infected blood and blood products, and injecting drug users. 
Up to the end of 2003, hepatitis C could be notified as ‘viral hepatitis type unspecified’, 
it was not a notifiable disease in its own right and there was no national surveillance 
system to monitor the incidence of this infection among the population. As part of the 
revised legislation on 1 January 2004, hepatitis C is now specified as a notifiable 
disease. The inclusion of hepatitis C as a notifiable disease (from 2004 onwards) will 
provide important data on new cases of hepatitis C in the general population but will 
not specify risk populations (such as injecting drug users).  Between 1992 and 1998, 
Smyth et al. (2003) estimated the incidence of hepatitis C among 100 injecting drug 
users who had an initial negative test and a repeat test within 24 months. The authors 
reported that the incidence of hepatitis C was 66 per 100 person years (95% CI 51 to 
84 per 100 person years) over the two-year period; this is 30 per cent higher than 
estimates reported in injecting drug users living in other countries.  
 
Prevalence 
There were no new prevalence studies in 2003 and the first half of 2004.   
 
Morbidity and mortality 
Kavanagh et al. (2003) investigated the hepatitic-related morbidity that may be 
associated with the hepatitis C virus in injecting drug users.  The outcome of end stage 
liver disease for this cohort in Ireland has not been estimated. The objectives of this 
study were: to estimate the prevalence of persistent hepatitis C viraemia and 
distribution of genotypes in a drug using cohort; to measure the frequency of poor 
prognostic co-factors; to extrapolate the burden of hepatitis C related disease nationally 
for this route of infection. A cross section survey of attendees at an East Coast Area 
drug treatment clinic was completed. Of 94 patients studied (63 male), 70 were 
hepatitis C antibody positive and 39 were PCR positive. Twenty-six had genotype 1 
and eleven had genotype 2 or 3. Most displayed factors associated with a poor 
prognosis: 72 per cent male, 83 percent problem drinkers and 87 per cent abnormal 
liver blood tests. Using published data, we extrapolate over 1,214 cases of cirrhosis via 
this route of infection nationally, leading to approximately 35, 60 and 50 cases of 
hepatocellular carcinoma, hepatic decompensation and liver related death respectively 
per annum. A high prevalence of hepatitis C infection in injecting drug users, 
compounded by a high frequency of poor prognostic co-factors, means a significant 
burden of disease can be expected from this group. 
 
Brennan and colleagues published a paper entitled ‘Epidemiology of Hepatitis C in 
Ireland’ in EPI-INSIGHT in May 2004.  The authors collated information on hepatitis C 
from a variety of sources. There were 6,085 discharges from acute hospitals with 
hepatitis C as a primary or secondary diagnosis recorded by the Hospital In-Patient 
Enquiry Scheme.  This scheme is an event-based register so cases may be 
represented more than once. 
   
Of the 6,085 cases:  
• 18 per cent had hepatitis C as a primary diagnosis;  
• 57 per cent had chronic hepatitis C; 
• 21 per cent had a diagnosis of problem opiate use;  
• 7 per cent also had a diagnosis of hepatitis B recorded; 
• 24 per cent also had a diagnosis of HIV/AIDS recorded; 
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• 11 per cent had a diagnosis of chronic liver disease or sequelae; 
• 0.4 per cent had a diagnosis of liver cancer. 
These data suggest the existence of co-morbidity between blood-borne viruses and the 
damage that hepatitis C can do to the liver.    
 
Brennan and colleagues requested the Central Statistics Office to select cases where 
the primary cause of death was hepatitis ICD 9 category 070.4, 070.5 or 070.6.  This 
allowed the authors to calculate the number of deaths with a primary diagnosis of 
hepatitis C using the diagnoses hepatitis ‘other specified’ or ‘unspecified’ as proxy 
diagnoses. Fifty persons died as a result of hepatitis C between 1995 and 2002.  Up to 
2001, the numbers for each year fluctuated between three and seven cases, with a rise 
to 15 cases in 2003.  The main risk factors for hepatitis C cannot be identified 
accurately through mortality data held by the Central Statistics Office.  This suggests 
the need for a special register to record the contribution of hepatitis C to premature 
mortality among injecting drug users.  
 
Taken together, these data suggest hepatitis C is endemic among injecting drug users 
and it has serious health consequences which can be seen in both morbidity and 
mortality statistics.   
 
6.4 Psychiatric co-morbidity 
Figure 6.4.1 presents the rate of first admissions among those aged 16 years or over to 
inpatient psychiatric services with a diagnosis of drug dependence, per 100,000 of the 
population in Ireland between 1990 and 2001. It is notable that the rate increased 
steadily over the reporting period and was almost four times higher in 2001 than it was 
in 1990 and a subsequent fall in 2002.  The analysis presented in the NPIRS does not 
comment on the possible explanations for this trend (Daly and Walsh 2003).    
 
 
Figure 6.4.1   Rate of psychiatric first admissions aged 16 years or over with a diagnosis of drug-
dependence (using the ICD-10 three character categories) per 100,000 of the population in Ireland 
and reported to the NPIRS, 1990 to 2002 
 
Between 1996 and 2001 there were 2,119 new admissions to the psychiatric services 
of clients with a drug-related diagnosis. Of these, 245 were admitted in 2002.  The 
number of clients with dual diagnosis were not reported.   
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6.4 Other drug-related health correlates and consequences 
There are no new data published in this area. 
 
 
7. Responses to Health Correlates and Consequences 
 
7.1 Overview 
This section presents where available new information on responses to the health 
consequences of problem drug use.   
 
7.2 Prevention of drug-related deaths 
Moore and colleagues (2004) reported that the majority of service providers in the 
Eastern Regional Health Authority area said that their services provided information 
and demonstrations on safer injecting practices in line with current evidence.  The 
authors do not report if such information was provided by services outside the Eastern 
Regional Health Authority area.   
 
As part of their routine work, outreach workers in the three area health boards in the 
Eastern Regional Health Authority and Staff at Merchants Quay Ireland’s Health 
Promotion Unit provide information sessions on safe injecting.  The following data was 
obtained during interviews between senior outreach and focal point staff in May and 
August 2004.   
 
During the interviews with the senior outreach workers in May 2004, they reported that 
prevention of infection and overdose were equally important objectives of their work.  
With respect to the prevention of infection, they provide advice on the prevention of 
localised bacterial infections, blood–borne viruses and sexually transmitted diseases.  
The staff at Merchants Quay Ireland, through their Health Promotion Unit, also seek to 
prevent the spread of infection through injecting drug use and to prevent overdose.  
 
In all area health boards, the outreach workers assess each individual’s current 
situation with respect to injecting drug use, and provide appropriate advice.  They do 
not provide a formal course on safe injecting instead they use each contact with clients 
to provide information to increase the safety of the individual’s current injecting 
practices.  Their main opportunity for contact with clients is during needle-exchange 
services which are delivered through a variety of methods The outreach workers 
employed through the area health boards do some house calls and street work.  The 
outreach workers at Merchants Quay Ireland provide a similar service but also provide 
formal safer injection classes.  The issues covered are similar to those covered by Area 
Health Board Staff. 
 
In the Northern Area Health Board, the senior outreach workers have published a 
booklet on safer injecting known as the Safer Injecting Guidebook (Mc Kay and Kenny 
2003).  The booklet was prepared with input from the drug users, clinical team and 
managers.  The booklet provides a comprehensive overview of:  
• the consequences of using unsafe injecting;  
• where to access clean injecting equipment;  
• how to inject safely including injecting technique and hygiene;  
• what to do in the event of an overdose.  
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The authors provide information on disinfecting needles and syringes in the booklet but 
this practice is no longer recommended and has been replaced with more appropriate 
advice on cocaine use.  In the Northern Area Health Board, this booklet is the key text 
that outreach workers use to discuss safe injecting with clients.  Surprisingly this 
booklet is not used in either the South Western or East Coast Area Health Boards  
 
The senior outreach worker in the South Western Area Health Board use materials 
purchased in the United Kingdom.  They have a range of information leaflets and 
booklets available and decide which booklet to use based on the client’s situation 
during the contact interview.  Their booklets cover: safer injecting (HIT 2000, 2003) 
(Lifeline Publications 2002a), actions when things go wrong (Lifeline Publications 
2002b; Preston and Derricott 2003; Southwell 2003), and key points on the prevention 
of infection (Lifeline Publications, no year a,b) and overdose (SWAHB, no year).  They 
provide each injector with a copy of a Better Injecting (Lifeline Publications 2002a), 
which has very little text and is colour coded using green for good practices and red for 
dangerous practices.  The possible consequences of cocaine use are addressed using 
an information card (HIT 2002).   
 
The nurses working in the South Western Area Health Board have produced posters 
and information leaflets covering: 
• prevention and management of overdoses (Addiction Services 2004a);  
• identification and management of an abscess (Addiction Services 2004b).   
There is a good opportunity for the outreach workers and nurses to improve their 
impact through combining their different skills.  
 
The outreach workers in the East Coast Area Health Board use a series of overheads.  
The overheads are copied from publications or printed from the internet and deliver 
messages about safer injecting practices.  They cover the same issues as covered by 
outreach workers in the South Western Area Health Board but report that the language 
used in these materials may not be the same as that used by Irish injectors and 
photocopies may be less clear than original material.  These factors may reduce the 
effectiveness of the message given to clients.    
 
The staff at Merchants Quay Ireland distribute a patient information leaflet with key 
information including the risks associated with injecting drug use.  The patient 
information leaflet is similar to those provided with medication.  The information 
provided recommends using new injecting equipment for each injection.  The dangers, 
signs and symptoms and management of overdoses are presented on the leaflet.  The 
staff distribute literature about blood borne viruses (Health Promotion Unit 1998 and no 
date) and sexually transmitted diseases during contact with clients (Health Promotion 
Unit 2002).   
 
A voluntary agency (DOORS) based in the East Coast Area Health Board have 
produced a small information booklet on the prevention and management of overdose 
(Ryan, no date).  This is distributed at Merchants Quay Ireland but this has not been 
sanctioned for use by management at the Area Health Boards.   
 
In an interview with the senior outreach workers in May 2004, they reported two 
concerns with the current organisation of outreach services.  They reported that  
• outreach workers need to work from 2 pm to 11 pm in order to suit their clients’ 
lifestyle; 
• outreach services needed to be reorganised in order to address the growing 
cocaine problem at weekends.   
 
Such re-organisation would make their services more appropriate.   
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According to the outreach workers, some of the major barriers to increasing the 
effectiveness of the safe injecting are:  
• no hygienic places to inject for the homeless;  
• belief among injecting drug users that they will get hepatitis C even if they inject 
safely; 
• peer pressure among opiate users not to admit loss of tolerance.   
 
In the Eastern Regional Health Authority area, outreach workers and nurses have 
developed health promotion initiatives to inform injecting drug users of the dangers of 
overdose through the development of posters and leaflets as part of their safe injecting 
advice.  There is no documented evidence of such an approach outside the ERHA.    
 
There are no consumption rooms in Ireland.   
 
The National Medicines Information Centre reviewed the use of naloxone in the 
management of opiate-dependence syndrome.  The authors reported that naloxone 
has been used for many years as an emergency room treatment for the management 
of opiate overdose.  According to the authors, evaluation of its use in this setting 
suggests that it was associated with a low rate of serious adverse effects but the data 
involved small numbers of patients.  Its administration by trained ambulance staff in the 
pre-hospital setting resulted in fewer hospital admissions, but follow-up data on the 
patients were lacking in many cases.  Although the availability of take-home naloxone 
for use by friends and relatives of an opiate user has been recommended by several 
workers, the authors report that there were no controlled trials evaluating such usage.  
Furthermore, records of use from pilot studies were insufficient to undertake a benefit 
versus risk analysis of the use of naloxone in this setting.  However, preliminary results 
suggested that it might be of use in these areas.  The authors stressed that naloxone 
administration was just one action in a sequence of actions required to prevent 
overdose and cautioned against a one-dimensional approach.  They highlight the need 
for a combination of the following approaches:  
• education on the effects of polydrug or concomitant alcohol use and the 
usefulness of naloxone in this situation;  
• stressing the dangers of solitary injection;  
• importance of calling an ambulance; 
• knowledge of and practice in basic resuscitation techniques.  
 
Further information on the feasibility of naloxone use as an emergency treatment in the 
community setting would be needed before any such programme could be 
implemented.  According to the authors, there are many logistical and medico-legal 
issues in Ireland that would need to be dealt with before such a programme could be 
implemented in practice. 
 
7.3 Prevention and treatment of drug-related infectious diseases 
Hepatitis B vaccine 
In Ireland hepatitis B vaccine is recommended for several high-risk groups; prisoners 
and injecting drug users are two of the high-risk groups named in the guidelines 
(National Immunisation Committee 2002). The safety, effectiveness and regime are 
well established.  The current vaccine schedule is three doses at zero, one and six 
months, which provides immunity to at least 85 per cent of those immunised (Keating 
and Noble 2003). The effectiveness of hepatitis B vaccination among injecting drug 
users may be lower than that among the general population because of the generally 
poorer health status among this group, including HIV co-morbidity (Keating and Noble 
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2003).  This does not mean that hepatitis B vaccine should not be administered to drug 
users but that serum should be tested to ensure that the recipient has developed an 
appropriate immune response to the vaccine.  There are several accelerated vaccine 
schedules.  The schedule, Day 0, Day 7, Day 21, with a booster at 12 months, results 
in 65 per cent sero-protection at Day 28 and 99 per cent protection at 13 months 
(Zuckerman 2003).   
 
Hepatitis B vaccine is free to all injecting drug users attending drug treatment centres, 
but is not necessarily free to all injecting drug users attending general practice. The 
vaccine has become easily available at drug treatment centres but is more difficult to 
access at general practice. In general, doctors caring for injecting drug users in the 
general practice setting must order an individual dose of vaccine for each injecting drug 
user they intend to vaccinate.  Those injectors without a medical card must pay for the 
vaccine.  This reduces the opportunity for opportunistic vaccination, which is 
considered an important strategy to achieve a high level of immunisation in a 
vulnerable group. 
 
The coverage of hepatitis B vaccination for injecting drug users is not monitored on a 
continuous basis; the coverage estimates presented in this section were taken from ad 
hoc studies in particular settings such as prison, needle and syringe-exchange, 
treatment centres and general practice.   
 
In 2001 Cullen et al. (2003) implemented a pilot project to improve the care of injecting 
drug users attending general practice and at risk of hepatitis C. Prior to implementing 
the project, the authors did a baseline assessment that included hepatitis B vaccine 
coverage. Of the 196 respondents, only 16 per cent had documented evidence of 
receiving three doses of hepatitis B vaccine within a seven-month period. Self-reported 
hepatitis B vaccine coverage was higher than documented coverage: 23 per cent had 
three doses, an additional 11 per cent had two doses and 14 per cent had received one 
dose. At the end of the study in 2002, the completed vaccine rate in the intervention 
group was higher (36%) than the vaccination rate in the control group (21%).  
 
There is no published data on the coverage of hepatitis B vaccine outside the ERHA.   
 
Syringe exchange and condom provision 
The injecting drug user population in Ireland is concentrated predominately in County 
Dublin and to a lesser extent in Counties Wicklow and Kildare, although there is 
evidence of spread to counties bordering the Eastern Regional Health Authority area 
(Long et al. 2004c).  There are currently no needle and syringe-exchange programmes 
outside the Eastern Regional Health Authority (ERHA) area (Moore et al. 2004).  
 
Statutory health services and one voluntary organisation provide needle and syringe-
exchange services. Thirteen of the 14 fixed needle and syringe-exchange sites are 
located in health and drug treatment centres in the ERHA area (Table 7.3.1). One of 
the statutory clinics opens five days per week for 2 hours each week day and the 
remainder have limited opening hours (HIV Services Network 2002). Merchant’s Quay 
provides a fixed-site needle and syringe-exchange through its Health Promotion Unit 
five days per week for two and half hours each day and has a facility that allows limited 
out-of-hours exchange (Cox and Lawless 2000; HIV Services Network 2002); this 
project is situated in the centre of the city and is well known to injecting drug users.  
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Table 7.3.1 Needle and syringe-exchange  facilities in Dublin, Kildare and Wicklow in 2003* 
Type of service Number of units 
1. Clinics 14 sites (including the Merchant’s Quay Project) 
2. Mobile bus 2 bus with several locations in NAHB and ECAHB 
3. Backpacking Outreach teams in Arklow, Bray Celbridge and Dunlaoighre 
4 Homeless shelter Service provided for residents once per week at two inner-city hostels  
*Unpublished data from Louise Mullen, Department of Public Health, Eastern Regional Health Authority.   
 
Two mobile clinics provide low-threshold services (including a needle and syringe-
exchange and a low-dosage methadone programme) to drug users (Table 7.3.1). This 
mobile unit in the Northern Area Health Board provides services for over one hour per 
day five days per week at two locations in the area.  
 
Backpacking refers to the practice of outreach workers bringing sterile injecting 
equipment in a rucksack to a client’s residence and providing a needle and syringe-
exchange service for them. Backpacking is very limited at present and is available in 
areas not served by other needle and syringe-exchange services (Tables 7.3.1).  
 
There are two agencies (ERHA and Merchants Quay Ireland) collating information on 
clients attending needle and syringe-exchange. On the first visit both organisations 
collect baseline information from each client and on each subsequent visit they update 
the client’s record. The minimum information collected includes socio-demographic 
characteristics, history of problem drug use and treatment, risk behaviours and 
services provided at each visit. Each client provides his or her initials and date of birth 
for identification purposes and an identifier code is given based on this information and 
is used to record subsequent visits and avoid duplication of records.  In the Northern 
and East Coast Area Health Boards, they have commenced entering all client contacts 
on the Drugs and AIDS Information System and this will replace the current paper 
submissions to the ERHA.   
 
Staff at the ERHA report that clients used both local needle and syringe-exchange 
services and the needle and syringe-exchange at Merchants Quay interchangeably, 
therefore there is some overlap in the numbers presented in Table 7.3.2 (L Mullen, 
personal communication, 2004). The majority of new clients and client visits were to the 
Merchants Quay Ireland Health Promotion Unit; this may be partly due to its city centre 
location and more extensive opening hours. The demand for needle and syringe-
exchange increased between 2000 and 2002 and decreased subsequently in 2003 
(Table 7.3.2). Overall, there was an increase in needle and syringe-exchange schemes 
in the eastern region of Ireland.   
 
Table 7.3.2 Number of client visits at needle exchange services in Dublin, Kildare and Wicklow, 
2001 to 2003 
 2000 2001 2002 2003  
Total number of client visits ERHA† 3,859 3,014 4,149  3,768 
Number of new clients ERHA† 412 283 364  318 
Total number of client visits 
Merchants Quay Project  
15,512 20,262* 24,058* 26,181* 
Number of new clients ERHA 
Merchants Quay Project 
645 683* 678* 616* 
Total number of client visits 19’371 23,276 28,207 31,949 
Number of new clients 1,057 966 1,042 934 
* Merchants Quay Project Ireland. Annual Review 2003 
†Unpublished data from Louise Mullen, Department of Public Health, Eastern Regional Health Authority, September 
2004.   
 
All needle and syringe-exchange services aim for a one-to-one exchange of syringes 
and needles. However, there is flexibility in order to ensure the service is client-friendly.  
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Each of the three area health boards comprising the ERHA varied in terms of their 
recommendations regarding commodities distributed at needle and syringe-exchange. 
The type of commodities distributed varied also, depending on whether it was a fixed-
site service or a mobile service. Ideally, each injecting drug user was given one 
‘stericup’ (a small aluminium cup containing a filter and swab in a sealed package), one 
syringe and two needles per expected injection. Between five and ten syringes and ten 
and twenty needles are given to each client at their first visit (L Mullen, personal 
communication, 2003).  Clients are encouraged to take one stericup and one 
syringe/needle per injection but clients frequently object to carrying too much injecting 
equipment. Drug users are often afraid of being identified as a drug user by carrying 
injecting equipment.  Drug use is an illicit activity and many drug users wish to conceal 
their use. The presence of injecting equipment can pose a problem for users who; live 
at home with their parents; live with a non-drug using partner; or are homeless and 
have no location to store excess equipment. In addition, drug users accommodation 
status may depend on their concealing their drug use.  (Outreach staff, L Mullen, 
personal communication, 2003).   
 
First-time clients at the Merchants Quay Project are normally given two syringes and 
six needles, or six microfines (Cox and Lawless 2000). For clients making return visits 
the quantity given to each client depends on the quantity returned by the individual at 
the visit. The health promotion team at Merchants Quay Project also provide an 
emergency pack for those who arrive at the service between 4.30 and 5.00 pm from 
Monday to Friday.  
 
According to staff working in the ERHA (L Mullen, personal communication, 2003) and 
published information from Merchant Quay Project (Cox and Lawless 2000), both 
provide their clients with a similar range of services. Apart from needle and syringe-
exchange, the additional services provided are harm minimisation information (through 
leaflet distribution and instruction), condom distribution, first aid and nursing services, 
and referral to medical services. In addition, outreach workers provide health education 
and refer clients to harm-minimisation and treatment services (L Mullen, personal 
communication, 2003).  
 
One indicator of the management of needle and syringe-exchange is the return of used 
needles. Data available on returns are not easy to access but estimates indicate that 
half of the equipment distributed is returned (L Mullen, personal communication, 2003).  
 
Evaluation of outreach work in Ireland 
There have been two formal reviews of outreach work with drug users in Ireland.  Each 
review examined different but complementary aspects of outreach services.  Between 
June and December 2002, Bunning (2003) examined the policy, planning and 
organisation of the services; between December 2000 and October 2001, Corr (2004), 
in partnership with outreach workers, reviewed outreach activities and investigated the 
immediate effects of these activities on drug-users’ practice. The Eastern Regional 
Health Authority (ERHA) commissioned the evaluation done by Bunning in response to 
Action 64 of the National Drugs Strategy, while Corr at Merchants Quay Ireland (MQI) 
completed an internal evaluation.    
 
The main objective of Bunning’s review was to examine the role and functioning of 
outreach services in the drugs and AIDS services in the eastern region.  This involved 
reviewing the outreach service with respect to strategic aims and objectives, general 
management, service provision, quality control and monitoring systems.  The reviewer 
contacted: clients (20), outreach workers (20), senior outreach workers (4), 
representatives from community projects (10), and persons employed by the area 
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health boards (21) whose work had links with outreach services. The review was 
carried out using the following methods:  
 
• Observation of outreach workers during their day-to-day activities, which 
included home visits, street work, and community-based projects;  
• Group interviews with management of the addiction services, health 
professionals and community groups;  
• Individual interviews with outreach workers and clients; 
• Focus groups with senior outreach workers; 
• Feedback sessions with steering committee.   
 
The reviewer found that there was good commitment from staff across the addiction 
services to participating in the review. Outreach workers conceptualised their activities 
as:  
Initiating and maintaining contact with those who are not in contact with services, 
relating to them in an open manner and observing what is going on in the drug 
scene within different local communities (Bunning 2003, p. 10)  
 
The reviewer reported that, due to the unprecedented expansion in drug treatment 
services in the ERHA over the last four years, a lack of strategic planning for outreach 
had resulted. This meant that outreach work was out of focus and that outreach 
workers carried out a broad range of tasks that were often based on personal 
preferences and skills, rather than on clear policy choices or guidelines.  
 
The recommendations for the future development of outreach services within the 
eastern region include:  
 
• Define a clear mission statement; 
• Prioritise primary and secondary tasks based on an allocation of time; 
• Develop wider needle-exchange networks that include options such as 
pharmacies and vending machines; 
• Develop clear links between clinical staff, outreach workers and clients;  
• Formalise the role of outreach workers as advocates for the clients; 
• Organise seminars to stimulate peer education, knowledge transfer and up-
skilling; 
• Set up an outreach association that will work towards the professional 
development of outreach staff; 
• Provide management training to senior outreach workers; 
• Develop a monitoring system that includes quantitative and qualitative 
indicators; 
• Create a steering group to explore innovative approaches to outreach.   
 
The second evaluation was conducted by Corr of the outreach service within 
Merchants Quay Ireland (MQI).  The outreach service was established in the late 
nineties to reduce the levels of drug-related public nuisance in the immediate locality. 
MQI is located in the south-west inner city of Dublin. The outreach service targets 
chaotic drug users in the locality and seeks to change their behaviour in the community 
through one-to-one interactions. The outreach teams work in pairs to ensure workers’ 
and clients’ safety. In order to minimise danger, the outreach workers carry mobile 
phones and identity cards. The majority of the outreach work is done on the streets. 
The team works on building rapport with clients and providing information on health 
issues and accommodation. The team uses motivational interviewing techniques to 
promote safer drug-using practices among clients. The ERHA and Dublin City Council 
fund the service jointly.  
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A combination of quantitative and qualitative methods were used to evaluate the MQI 
service.  Between December 2000 and October 2001, outreach workers completed 
‘contact sheets’ on all clients met each day.  In order to place the quantitative data 
collected in context with the day-to-day realities of outreach work, two outreach 
workers participated in in-depth interviews.  During the 10-month evaluation period, a 
total of 262 clients were contacted at least once. In total, there were 587 separate 
contacts with clients; 163 (62%) were contacted once only and 99 (38%) were re-
contacted an average of four times.  Of those contacted, 31 per cent were female, 52 
per cent were aged 24 years or under and 27 per cent were first-time contacts.  Three-
quarters were homeless at some point during the year. Overall, 88 per cent reported 
using drugs (other than alcohol) and 96 per cent reported the streets as their most 
popular location for taking drugs.  Of those using drugs, 79 per cent were using heroin.  
During the 10-month period, the outreach workers collected and disposed of 2,741 
needles. The outreach workers reported that among the 99 clients who were met more 
than once, almost one-fifth had changed to safer drug-using practices and half had 
adopted less safe practices. In addition, the team reported that approximately fifteen 
per cent of clients contacted were referred to other drug treatment services.  The data 
presented in this document indicates that outreach workers were successful in 
contacting hard-to-reach drug users as a large proportion were homeless and half had 
never been in contact with drug treatment services.   
 
Taken together, these evaluations highlight the need to develop the capacity of 
outreach staff and enhance the general management of the services. At the same time, 
the documents present the essential role of outreach workers and the positive 
outcomes of their work, such as success in locating hard-to-reach populations, an 
increase in numbers using safer injecting practices and modest numbers referred into 
treatment.  However, it may be useful to explore why 50 per cent of those participating 
in the Merchants Quay Ireland study developed additional unsafe injecting practices 
despite receiving safe injecting information.  
 
Counselling and testing 
There is no new information in this area.   
 
HIV treatment 
There is currently no vaccine and no cure for HIV infection. The current standard of 
care for individuals who have HIV is a combination of antiretroviral therapies commonly 
referred to as HAART (Rutherford et al. 2003; British HIV Association Writing 
Committee 2001). Specialists recommended that this be commenced at an early stage 
of the infection and tailored to the individual’s needs.  
 
HIV treatment (HAART) is available to injecting drug users through genito-urinary 
medicine and infectious disease clinics in Ireland. Three treatment sites are situated in 
Dublin hospitals (St James’s Hospital, Beaumont Hospital, and Mater Misericordiae 
Hospital) and a fourth is based in Cork University Hospital.  
 
As demonstrated in the following study, access to and uptake of treatment for HIV is 
better than for hepatitis C among injecting drug users in the eastern region of Ireland, 
but far from ideal. Clarke et al. (2003) report that it is assumed (without significant 
evidence) that injecting drug users are unlikely to comply with treatment. These authors 
interviewed 150 clients who attended the Genito-Urinary Medicine and Infectious 
Diseases Department (GUIDE clinic) in St James’s Hospital. All were HIV positive and 
had at some time injected drugs. Only 57 per cent were receiving antiretroviral therapy. 
Of the 65 who were not receiving antiretroviral therapy, 50 per cent fulfilled the 
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standard criteria to commence therapy. This indicates that over 30 clients were suitable 
for treatment and were not receiving treatment at the time of the study.  
  
In Dublin, Clarke et al. (2002) adapted the direct observed treatment approach 
(recommended by the World Health Organization (WHO) for the management of 
tuberculosis) in order to increase compliance with antiretroviral therapy among injecting 
drug users attending clinics for methadone maintenance. Each individual treated 
received a combination of medication tailored to his or her needs and the medication 
was administered in a daily or twice-daily dose; both of these strategies enhance 
compliance. Of the 39 study participants, 90 per cent were complying with treatment at 
three months, 80 per cent at six months and 69 per cent at 12 months. The authors 
acknowledged that they had no comparison group with which to compare their results 
but when compared with compliance with tuberculosis therapy among the general 
population; this is in line with international experience of compliance with tuberculosis 
treatment. In a subsequent study (Clarke et al. 2003), a higher level of compliance with 
antiretroviral therapy was reported among those attending methadone services than 
among those not attending drug treatment services.  
 
Hepatitis B treatment 
There are no new data on the treatment of hepatitis B 
 
Hepatitis C treatment 
The hepatitis C virus has six major genotypes and several closely related sub-types. 
This has made it difficult to develop both effective treatment and vaccination. 
Genotypes 1 and 3 are the most common in Ireland (Conroy et al. 2003). Treatment is 
more successful for genotype 3 than for genotype 1. Genotype 1 is more common 
among drug users. Hepatitis C is a chronic illness that often has no overt symptoms, 
but this population is likely to experience significant morbidity in the future. 
 
Internationally, interferon therapy has been used for the treatment of chronic hepatitis 
C and inhibits viral replication initially in 39 per cent of those treated, with a sustained 
response in 17 per cent of those treated (Thevenot et al. 2001).  
 
Kjaergaard et al. (2001) conducted a systematic review of treatment options for chronic 
hepatitis C. The authors reported that, compared with interferon alfa alone, 
combination therapy (interferon alfa plus ribavirin) reduced the risk of not having a 
sustained virological response for six months by 26 per cent in newly treated patients, 
by 33 per cent in patients who had relapsed and by 11 per cent in those who previously 
had not responded to treatment. Combination therapy also reduced the risk of not 
having improvement in histology results by 17 per cent in new clients and by 27 per 
cent in those who had relapsed following previous treatment or who had not responded 
to previous treatment. This combination therapy is recommended as the most 
appropriate treatment for hepatitis C and is the current treatment regime in Ireland. The 
treatment offered is pegylated interferon (dosage) by subcutaneous injection once 
weekly and ribavirin (dosage) orally daily.  
  
There are seven specialist hepatology centres for adults and one for children in Ireland: 
• St James’s Hospital  (Consultants: 3); 
• St Vincent’s Hospital (Consultants: 2); 
• Mater Misericordiae Hospital (Consultant: 1); 
• Beaumont Hospital (Consultant: 1); 
• University College Hospital Galway (Consultant: 1);  
• University College Hospital Cork (Consultant: 1);  
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• St Luke’s Hospital Kilkenny (Consultant: 1); 
• Our Lady’s Hospital for Sick Children (Consultant: 1).  
 
There are a number of nurse specialists and counsellors supporting patients at these 
services. There is a liaison medical officer for hepatitis C based at the Drug Treatment 
Centre Board, Trinity Court, Dublin. 
 
Dr Shay Keating of the Drug Treatment Centre Board, has updated the booklet, 
Hepatitis C: A Guide for Drug Users and their Families.  The updated booklet was 
launched on 10 December 2003.  The information in this booklet is essential for drug 
users, in particular injecting drug users at risk of or diagnosed with hepatitis C.  It is 
also a useful tool for doctors, nurses and counsellors who educate drug users about 
hepatitis C.  The booklet is laid out in a question and answer format that addresses 
issues commonly raised by patients and their families.  It provides updated information 
on the condition itself and its treatment.  The booklet also provides transparent 
information on the criteria for entering treatment and the side effects of treatment.  As 
the treatment section has been revised substantially, it is strongly recommended that 
health service providers, drug users and their family members access a copy of the 
revised booklet.  According to the author, treatment is offered to those at greatest risk 
of developing liver cirrhosis; this includes persons with a positive PCR test. It is 
generally recommended that treatment be offered to those who are both drug and 
alcohol free for six months, or stable on methadone and alcohol free for the same 
duration. The individual’s living status is also a consideration and, ideally, a prospective 
patient should be living in stable accommodation. The author clearly states that therapy 
is not offered to those actively abusing drugs or alcohol. Specialists developed these 
criteria but the criteria have not being rigorously evaluated. 
 
The routine assessment procedures for hepatitis C are as follows: initially, the 
individual has a blood test to determine if s/he has antibodies to the hepatitis C virus. If 
antibodies to the hepatitis C virus are detected, the individual will have a PCR 
(polymerase chain reaction) test to determine if the viruses are still detectable in the 
blood, if positive, this indicates active chronic hepatitis C. Then the genotype will also 
be determined. Liver enzymes in blood are measured as high levels indicate damage 
to the liver though low levels do not necessarily indicate there is no liver damage. If 
PCR positive, the hepatologist might recommend an ultrasound of the liver and/or liver 
biopsy (Keating 2003) 
 
Both Dillon (2001) and Long et al. (2003) reported low access to treatment for hepatitis 
C in Irish prisons.  
  
In 2002, Cullen et al. (2003) examined uptake of care (including treatment) for hepatitis 
C by injecting drug users living in the Eastern Regional Health Authority area. Each 
injector had tested positive for hepatitis C and was receiving methadone therapy from a 
general practitioner. The authors reported that, of the 104 clients who were hepatitis C 
positive, 43 per cent had discussed referral to a consultant hepatologist with their 
general practitioner, 32 per cent had the referral process initiated by their general 
practitioner, 25 per cent attended the specialist clinic, 13 per cent had a liver biopsy 
and three per cent commenced treatment for hepatitis C.  
 
The Dublin Area Hepatitis C Initiative Group (2003), along with other interested 
collaborators, developed a protocol to improve uptake of assessment and access to 
treatment for hepatitis C among injecting drug users. The key elements of this protocol 
were that it was developed using a consensus method. It introduced flexibility around 
the period of time opiate users are required to be stable on methadone or opiate free 
and it provided clear referral processes and procedures. It was implemented in the 
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selected general practices with the assistance of a hepatitis C nurse specialist over a 
six-month period. The researchers randomly allocated clients to an intervention or a 
control group. For the purposes of the results presented in this document, the numbers 
in the intervention and control groups were 72 and 35 respectively (Cullen et al. 2003). 
At the end of the six-month intervention period, the authors reported that an increased 
number of clients (who tested positive for hepatitis C) had referral to a specialist 
discussed, had the referral process initiated and had attended the specialist clinic 
(Figure 7.3.1). Among the intervention group, only 25 per cent had a liver biopsy and 
seven per cent had commenced treatment for hepatitis C; these low uptake rates may 
be a reflection of the short time period over which the data were collected. The follow-
up phase indicated that injecting drug users were interested in assessment for hepatitis 
C provided that clinical staff at general practice level actively supported them in 
seeking assessment. 
 
Figure 7.3.1   Comparison of selected indicators between an intervention and control population in 
relation to the management of hepatitis C in a general practice setting  
Adapted from Cullen et al. (2003) 
 
Many clients who are referred to hepatitis C specialist centres do not attend or comply 
with treatment (Cullen 2003). In Ireland the only published data on compliance with 
treatment for hepatitis C is a small on-site hepatitis C treatment pilot study that was 
commenced at the Drug Treatment Centre Board, in liaison with the infectious diseases 
unit in St James’s Hospital.  On 10 December, Dr Shay Keating presented the results 
of this pilot study that examined the potential for ‘treating hepatitis C at the same 
location at which they receive their methadone with a view to retaining the patients in 
treatment.’  Dr Keating cautioned that any centre providing hepatitis C treatment 
required referral pathways to specialist hepatology and psychiatric care.  Access to 
psychiatric care is required because many of those with hepatitis C may have a history 
of psychiatric illness, and depression is a side effect of interferon (one of the two drugs 
used to treat hepatitis C).  The specialist hepatology care included the services of a 
nurse-specialist and a medical officer.  Nine patients commenced treatment during the 
study period and to date only one has defaulted.  Dr Keating concluded that hepatitis C 
treatment in drug treatment centres is ideal as it improves patient compliance and 
permits a rapid response to incidences of illicit drug use and psychiatric illness.  
Hepatitis C treatment alongside methadone treatment was also more convenient for 
clients.  He also said that increased treatment costs at the drug treatment centres could 
be offset by reduced costs at hospital level.  It should be noted that the study methods 
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would have been strengthened by the inclusion of larger numbers of subjects and the 
recruitment of a comparison group receiving treatment through a specialist centre.   
 
7.4 Interventions related to psychiatric co-morbidity 
Interventions related to psychiatric co-morbidity 
 
Policy 
The Psychiatric Services – Planning for the Future 1984 is the most recent strategy 
document guiding Ireland’s policy in relation to mental health services (Study group on 
the development of psychiatric services 1984). Policy on the treatment of problem 
alcohol and drug use stipulated that the emphasis in the management of alcohol and 
drug-related problems should be on community-based intervention, rather than on 
specialist inpatient treatment. Chapter 13 of the report is devoted to ‘Alcohol and Drug-
Related Problems’, but no mention is made of the issue of co-morbidity.  
 
Ireland’s National Drug Strategy 2001–2008 does not specifically mention the potential 
link between problem substance use and mental health. It is alluded to in the context of 
demand-reduction strategies:  
 
…most recent literature points to the need for comprehensive demand reduction 
strategies which include programmes that… link drug-specific interventions with 
interventions in related areas such as youth crime prevention and mental health 
promotion strategies, employment, education and training initiatives. (Tourism, Sport 
and Recreation, para. 6.3.1, p. 98) 
 
In practice, there are locally based referral procedures between the mental health 
services and the addiction services. The National Advisory Committee on Drugs has 
commissioned a study to describe current links and identify opportunities for future 
links between mental health services and addiction services in order to better manage 
the overlap between psychiatric illness and problem drug use. The literature review 
pertaining to this study will be published in 2004. 
 
Psychiatric co-morbid services in the Eastern Regional Health Authority area  
(E Keenan and B Sweeney, personal communication, 2004) 
 
Four full-time psychiatrists and 12 non-consultant hospital doctors are employed at the 
Drug Treatment Centre Board, Trinity Court, to support the provision of addiction 
services and provide psychiatric assessment and treatment for those with drug 
addiction in the Eastern Regional Health Authority (ERHA) area (which comprises 
Counties Dublin, Kildare and Wicklow). This team works closely with the general 
practitioners working in Drug Treatment Centres. When a general practitioner assesses 
a client, he or she determines if the client has a current history of psychiatric symptoms 
or had history of treatment for a psychiatric illness. If the client has a current or 
previous psychiatric illness that is likely to affect their current treatment for problem 
drug use, then the general practitioner will request a psychiatric assessment and 
guidance on appropriate treatment for the client.  
 
At each drug treatment centre, for a half-day each week, a member of the psychiatric 
team assesses patients referred to them by the general practitioners. If, following 
psychiatric assessment, the client’s profile is complex then he or she will be referred to 
Trinity Court for both drug treatment and management of his or her psychiatric illness. 
When the general practitioner at the drug treatment centre can manage the client’s 
case, then the psychiatrist advises him or her on treatment and reviews the client as 
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requested. As a rule, a multi-disciplinary team (including the general practitioner, 
counsellor and psychiatrist) manage all clients with co-morbid conditions attending drug 
treatment services. It has been noted by the psychiatrists that clients with psychiatric 
and drug dependency co-morbidity benefit considerably from counselling.  
 
The psychiatric team at Trinity Court provides a 24-hour emergency service for general 
practitioners working in drug treatment centres. There are no inpatient services 
available for the management of psychiatric co-morbidity in the addiction services in 
the ERHA area and clients attending drug treatment services can have an admission 
arranged at their nearest acute inpatient psychiatrist facility. In the Northern Area 
Health Board, the general practitioner cannot refer the client directly but must confer 
with the addiction psychiatrist. When a client is referred with both a psychiatric illness 
and opiate dependence, a psychiatrist from the addiction services and one from 
general psychiatric services may consult on the management of the client. From the 
addiction psychiatrist’s viewpoint, he or she may provide guidance on the management 
of symptomatic withdrawals or provision of methadone maintenance. Unfortunately, 
this dual management facility is not available at all inpatient facilities and the 
management of clients taking methadone maintenance may not be in line with best 
practice. Some examples of irregular practice include sending the client to their drug 
treatment centre each day for their methadone maintenance or asking the client’s 
relatives to collect, bring in and administer the client’s methadone each day. This is an 
area that requires intervention.  
 
With respect to the management of opiate dependence, the general practitioners 
employed at drug treatment centres are classified, in accordance with the Protocol for 
the Prescribing of Methadone, as level two (Health and Children 1998). The level-two 
contract allows experienced general or in some cases non-specialist medical 
practitioners that have completed advanced training to initiate methadone treatment for 
and treat opiate dependent persons. These practitioners have some training and 
experience in the management of clients with dual diagnosis. However, additional skills 
in the diagnosis and management of those with opiate dependence and a psychiatric 
illness for these level-two doctors are required.  
 
The is little formal support provided to general practitioners working in private practice 
when managing clients with psychiatric illness and drug dependency.  The experience 
and expertise of general practitioners in general practice only has never been 
assessed. This is an area that requires attention from both the general practice co-
ordinators and psychiatrists.  
 
National review 
In 2002 the National Advisory Committee on Drugs commissioned a team at Dublin 
City University to explore the management of individuals with a combination of mental 
illness and substance misuse in Ireland.  The results are due to be published on 
November 1st 2004.    
 
7.5 Interventions related to other health correlates and consequences 
There are no new data published in this area. 
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8. Social Correlates and Consequences 
 
8.1 Overview 
Recent research in Ireland among individuals experiencing homelessness highlights 
the relatively high level of drug use among homeless people, in particular heroin and 
polydrug use. Drug use is reported as a major obstacle to moving out of homelessness. 
In addition, homelessness can contribute to 'chaotic' drug use and a sub-standard diet 
among people using drugs Corr (2003), Lawless (2003), Hickey and Downey (2003), 
Cleary et al. (2004). Early school leavers are over-represented among treatment 
contacts across seven regional health boards and first treatment contacts are more 
likely to be in employment that their previously treated counterparts (Long et al. 2004c).  
 
8.2 Social exclusion 
Homelessness 
Recent research and evaluation studies have revealed evidence to indicate relatively 
high and varied levels of drug misuse and drug related risk behaviour among homeless 
people. Corr (2003) reports that 75 per cent (n=169) of contacts through outreach 
reported to be homeless at some point during the previous year; 44 per cent (n=98) 
reported to sleeping rough and 42 per cent (n=94) reported to staying in an emergency 
hostel, 10 per cent stayed in a B&B, 4 per cent in a squat and 9 per cent stayed with 
friends/relatives. The evaluation notes that accommodation was influenced by gender 
with female clients significantly more likely to have stayed in a B&B, whereas male 
clients were significantly more likely to have slept rough. The influence of age on 
accommodation was also noted, with clients younger than 25 years significantly more 
likely to have stayed in an emergency hostel. Thirty-one per cent of clients were female 
and 52 per cent of clients were under age 25. The majority of clients, 79 per cent, 
reported to have used heroin, with 96 per cent reporting the streets as the most popular 
location for taking their drugs.  
 
Lawless (2003) investigating the health status of female drug users, found that 65 per 
cent (n=11) reported being currently homeless. Clients reported living in a hostel 12 per 
cent (n=2), B&B 29 per cent (n=5),staying with friends 12 per cent (n=2), and sleeping 
rough 12 per cent (n=2), Eighty-two per cent  of the women were under the age of 30. 
Heroin use was the primary drug of choice, with the majority reporting to injecting 
heroin over the previous four weeks. Hickey and Downey (2003) investigated the 
impact of poverty and social exclusion on the food intake, diet and nutrition of people 
who are homeless in Dublin. 25 per cent reported previous drug use but not current 
use while 26.3 per cent reported current use (in the past 30 days including seven 
respondents reporting to injecting heroin. Substance misuse was found to be a 
significant factor in the consumption of foods high in sugar and in the consumption of a 
range of macro and micronutrients including fat, protein, sugar, carbohydrates, starch, 
phosphorous and calcium. The authors noted ‘the significant and ongoing impact of 
drug misuse as a cause of an individual's homelessness’ (Downey and Hickey 2003, p. 
40).  
 
Cleary et al. (2004) conducted in-depth interviews with twenty men aged 18-30 
attending a drop-in centre for homeless men in Dublin. These revealed that the majority 
had engaged with drug misuse prior to becoming homeless with some participants 
noting that their drug related anti-social behaviour and criminal activity meant they were 
removed from the family home. The experience of homelessness contributed to more 
chaotic drug use, which then became the main obstacle to moving out of 
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homelessness. Chaotic drug use carried major risks for some with a number of 
participants experience overdose leading to hospitalization. Within this small group of 
homeless men a high prevalence rate of heroin use was observed with 65 per cent 
reporting current or past addiction to heroin. 35 per cent were current intravenous (IV) 
heroin users while several participants reported polydrug use using a mixture of 
benzodiazepines, sleeping tablets, Valium, alcohol and heroin. Smyth and O'Brien 
(2004) analysed socio-demographic and drug misuse data from children under 18 who 
were first time contacts with drug treatment services in Dublin from 1990-99. The study 
reported that 6.5 per cent of all child contacts compared with 1.9 per cent of adults 
presented as homeless. In particular it was noted that child heroin users were more 
likely to be female and homeless compared to their adult counterparts. The authors 
concluded that homelessness was encountered in child heroin users more frequently 
as the decade progressed.  
 
O’Loingsigh (2004) carried out 20 in-depth interviews and four focus groups with ex-
prisoners. This research highlights the crucial nature of the first 24 hours after release 
when according to participants, exposure to homelessness and a return to drug use 
and crime were heightened. Lack of preparation for release by prison authorities, in 
terms of linking ex-prisoners in with accommodation and drug treatment services, were 
cited by individuals as being key to them becoming homeless and returning to drugs 
and crime following their release.  
 
Unemployment 
There is a lack of research into the association between unemployment and drug 
misuse. However, socio-demographic data on drug treatment contacts across the 
seven regional health boards outside the Eastern Regional Health Authority (ERHA) 
show that from 1998 to 2002, employment rates were higher among new cases 
compared to their previously treated counterparts. Long et al. (2004b,c) contend that 
this may indicate those with chronic drug problems may be less likely to find or retain 
employment.  
 
School dropout 
Anecdotally, the association between early school leaving and drug misuse is well 
recognised. However there is a lack of up-to-date research into the nature and extent 
of this association in an Irish context. In one of the few studies done in this area, 
Comiskey and Miller (2000) found among 112 early school leavers interviewed, 51.1 
per cent reported to using drugs prior to leaving school. Of those who had used drugs 
before they left school 46.5 per cent reported that their drug use affected them at least 
sometimes while they attended school. Interestingly, one or two respondents reported 
that their use of drugs had a definite effect on them leaving school early with six 
respondents noting that their drug use was a secondary effect on them leaving school 
early. A recent report published by Collins et al. (2004) draws attention to the strong 
association between cannabis use and early school leaving, as one of the best 
established findings in the literature on the consequences of cannabis use. In 
particular, the report highlights the involvement of cannabis use in a large number of 
suspensions/expulsions from school as being a key emerging factor in the literature.  
 
Recent studies by Long et al. (2004b,c,d), referred to above, focused on treatment 
services, treatment contacts and trends in treated problematic opiate use in seven 
health board areas outside the ERHA 1998 to 2002. They include socio-demographic 
data on the proportion of treatment contacts reporting to leaving school before age 
fifteen. In the first study looking at treatment demand across the seven health board 
areas, the authors note that early school leavers are over represented among 
treatment contacts but the direct relationship is unclear (see Table 8.2.1).  
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Table 8.2.1  Percentage of early school leavers among cases treated in the seven health board 
areas, by treatment status, and reported to the NDTRS* 1998-2002 
 1998 1999 2000 2001 2002 
All cases 14.5% 19.2% 19.4% 20.8% 17.6% 
Previously treated cases 16.3% 19.8% 20.1% 23.5% 20.2% 
New cases 13.2% 18.2% 18.6% 18.4% 15.5 
Source: Long et al (2004 b)  
*NDTRS: National Drug Treatment Reporting System 
 
The second study examined trends in treated problem drug use in the seven regional 
health areas. The study shows that overall 19 per cent of cases treated in the period 
were early school leavers (see Table 8.2.2). Again the authors draw attention to the 
over-representativeness of early school leavers and they argue that this can have 
implications for social reintegration initiatives that seek to assist clients to secure 
employment.  
 
Table 8.2.2 Percentage of early school leavers among cases living and treated in the seven health 
board areas, by treatment status, and reported to the NDTRS 1998-2002 
 1998 1999 2000 2001 2002 
All cases 15.1% 18.9% 19.8% 20.7% 17.4% 
Previously treated cases 17.6% 20% 20.4% 23.6% 20.1% 
New cases 13.7% 17.4% 19.2% 18.4% 15.2% 
Source: Long et al (2004 c)  
 
The third study in this series examined trends in problem opiate use among treatment 
contacts in the seven regional health boards 1998 to 2002. The authors note that the 
proportion of opiate cases that left school before age fifteen increased substantially, 
from 12 per cent in 1998 to 23 per cent in 2002 (see Table 8.2.3). In addition, the study 
found that few opiate cases under eighteen reported to being still in school. The 
authors contend that individuals who leave school early might be more likely to become 
problem opiate users, or the lifestyle of problem opiate users renders it difficult to stay 
in full-time education, or a combination of both factors.  
 
Table 8.2.3: Percentage of early school leavers among opiate cases living and treated in the seven 
health board areas, by treatment status, and reported to the NDTRS 1998-2002 
 1998 1999 2000 2001 2002 
All cases 11.8% 20% 22.7% 24% 22.9% 
Previously treated cases 10.5% 19.2% 20.5% 27.5% 21.4% 
New cases 14.8% 20.7% 25.8% 18.6% 26.2% 
Source: Long et al. (2004d)  
 
8.3 Drug-related crime 
Drug Offences 
Data are routinely published in the garda annual reports for both ‘headline’ and ‘non-
headline’ offences, on the number of cases in which criminal proceedings commenced. 
The terms ‘headline’ and ‘non-headline’ in relation to drug offences were first used in 
the Garda Report for 2000 and replaced the previously used terms ‘indictable’ and 
‘summary’. An offence is termed indictable or summary by the statute that creates it. In 
general, a summary offence is less serious than an indictable one. Summary offences 
are heard in the District Court by a judge without a jury. Indictable offences are tried in 
front of a jury. Up until 2002, information on the outcome for specific offences was 
provided. However, with regard to drug offences, outcomes were only presented in 
relation to ‘headline’ offences. The Garda Report for 2002 provides details for the first 
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time of certain outcomes for ‘non-headline’ drug offences. Using the Annual Report for 
2002, we will now consider the outcome of specific drug offences where criminal 
proceedings commenced. 
Table 8.3.1   Headline offences which became known to the Gardaí in 2002 
Headline Offences 2002 Cultivation or 
manufacture of 
drugs 
Importation Obstruction 
under 
Drugs Act 
Possession of 
drugs for sale 
or supply 
Totals 
Offences reported or known to 
the Gardaí 
 
63 54 347 2515 2979 
Offences detected 
 
63 48 341 2515 2967 
Offences in which criminal 
proceedings commenced 
 
51 28 193 1530 1800 
Convictions 
 
0 25 3 160 188 
Acquittals 
 
0 0 0 8 8 
Nolle prosequi 
entered 
 
0 12 0 30 42 
Results of 
proceedings 
in cases 
dealt 
with on 
indictment 
Committed for trial 
and still awaiting 
trial 
 
0 2 1 61 64 
Convictions 
 
0 7 81 231 319 
Dismissals 
 
0 3 19 111 133 
Charge proved 
and order made 
without conviction 
 
0 0 1 5 6 
Results of 
proceedings 
in cases 
dealt 
with 
summarily 
Still pending in 
District Court 
0 4 28 307 339 
Source: Annual Report of An Garda Síochána 2002 
 
Table 8.3.1 presents the outcomes for the headline offences which became known to 
the Gardaí in 2002. A total of 2,979 headline offences were reported to, or became 
known to the Gardaí in 2002. 
 
Of the 1,800 headline drug offences for which criminal proceedings commenced in 
2002, 302 were dealt with on indictment and 486 were dealt with summarily, with a 
further 339 still pending in the District Court. The majority of cases on indictment result 
in a plea of guilty (Walsh 2002, p. 796). In 2002, of those cases dealt with on 
indictment, 188 resulted in a conviction and 8 in an acquittal. Of the cases dealt with 
summarily, 319 resulted in a conviction and 133 were dismissed. The data presented in 
Table 8.3.1 do not provide information on the outcome for 701 of the offences where 
criminal proceedings commenced in 2002. 
 
The vast majority of drug offences that come before the courts are dealt with summarily 
in the District Court. Table 8.3.2 presents the non-headline offences where 
proceedings commenced as reported in the annual report of the Garda Síochána for 
2002. 
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Table 8.3.2    Non-headline offences where proceedings commenced in 2002 
Non-headline offences 2002 
Proceedings 
commenced Convictions 
Dismissed/ 
withdrawn Pending
 
Unlawful possession, Section 3 MDA 6038 1998 756 1299
 
Forging or altering a prescription 111 27 15 36
 
Other  27 7 5 6
 
Totals 6176 2032 776 1341
Source: Annual Report of An Garda Síochána 2002 
 
It can be seen that the majority of non-headline drug offences where proceedings 
commenced in 2002 are for Section 3, Misuse of Drugs Act (MDA) possession or 
‘simple possession’. Of the 7,976 drug offences, both headline and non-headline, in 
which proceedings commenced in 2002, just over 75 per cent were for Section 3 
offences. It can also be noted that of the total number of drug offences in which 
proceedings commenced, both headline and non-headline, the vast majority were 
disposed of summarily, with only 302 (3.7%) being dealt with on indictment. Again, of 
the 6,176 non-headline drug offences where criminal proceedings commenced in 2002, 
the data are silent on the outcome of 1,985 of these cases. 
 
The Garda Síochána Policing Plan for 2003 seeks to increase the number of offenders 
dealt with for supply offences. However, the way in which the figures are presented in 
the annual report does not enable us to determine how many offenders were involved 
in respect of each specific offence. In 2001, criminal proceedings commenced in 
respect of 1,520 supplier/dealer offences (Section 15 MDA). This accounted for 17 per 
cent of the total drug offences in which proceedings commenced in 2001 (n=8,768). In 
2002, the most recent year for which figures are available, there were 1,530 
supplier/dealer offences in which proceedings commenced. This accounted for 19 per 
cent of the total (n=7976). 
 
In 2002, however, the total number of persons prosecuted fell by 19 per cent when 
compared to 2001, down from 7,959 in 2001 to 6,678 in 2002. Despite this overall 
decrease, it can be seen from Figure 8.3.1 that there were significant regional 
differences in terms of the number of persons against whom proceedings commenced 
for all drug offences between 1999 and 2002. 
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Figure 8.3.1   Number of individuals against whom proceedings were taken, by garda region, 1999 
to 2002 
Source: An Garda Síochána Annual Reports 1999 – 2002 
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Table 8.3.3   Persons prosecuted for drug offences by Garda region 
Region 1999 2000 2001 2002 
Eastern Region 720 1502 898 852
Dublin Metropolitan Region 2342 2653 2955 2029
Northern Region 240 602 660 429
South Eastern Region 571 855 966 1457
Southern Region 1423 1547 1819 1333
Western Region 726 694 661 578
Total 6022 7853 7959 6678
Source: Annual Reports of An Garda Síochána, 1999–2002 
 
For example, in the Eastern Region, which includes counties Carlow, Kildare, Laois, 
Offaly, Longford, Westmeath, Louth and Meath, the number of persons against whom 
criminal proceedings commenced doubled between 1999 and 2000. In the Dublin 
Metropolitan Region there was a 30 per cent drop in the number of persons prosecuted 
in 2002. The only region where there was an increase for 2002 was the South Eastern 
Region, where the total number of persons prosecuted increased by just over 50 per 
cent on the previous year. The South Eastern Region incorporates Tipperary, 
Waterford, Kilkenny, Wexford and Wicklow. 
 
Drug-related crime 
Drugs and driving 
A recent nationwide survey carried out by the Medical Bureau of Road Safety (MBRS) 
provided an analysis for drug classes in 2000 blood and urine samples taken from 
drivers suspected of intoxicated driving (Cusack et al. 2004). Of the 2,000 specimens 
chosen, 1,000 were under the legal limit for alcohol and 1,000 were over. The drugs 
involved were: amphetamines, metamphetamines, benzodiazepines, cannabinoids, 
cocaine, opiates and methadone. The purpose of the study was to determine current 
trends in driving under the influence of drugs (DUID) in Ireland and also to establish an 
evidence-based model to inform future road safety strategies. 
The results demonstrate that there is a significant DUID problem in Ireland. Sixty-eight 
per cent of tested drivers with essentially zero levels of alcohol were positive for one or 
more drugs, suggesting a strong trend of increasing drug positivity with decreasing 
levels of alcohol. Cannabinoids were the most common drug class encountered. Of the 
15.7 per cent tested drivers who were positive for some drug, six out of ten gave a 
positive result for cannabinoids. The study found no significant gender difference in the 
overall drug-positive results, although over 90 per cent of apprehended drivers were 
male. The typical profile of the apprehended and tested DUID driver is young, male, 
driving in an urban area with low or zero alcohol level, with a specimen provided 
between the hours of 6 am and 9 pm and with a presence of cannabinoids. The study 
also identified a pattern of middle-aged drivers under the influence of benzodiazepines 
– a legally prescribed drug which can also impair driving. 
 
The authors conclude that the study highlights the need for an education and 
awareness campaign in relation to DUID. There should also be an emphasis, they 
suggest, on the dangers associated with driving while under the influence of prescribed 
drugs. The study recommends that if the Gardaí suspect a case of DUID and obtain a 
negative or low alcohol reading then they should take a separate blood or urine 
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specimen so as to detect the presence of a drug or drugs other than alcohol. One of 
the outcomes of the study will be an evidence-based review of the legislation on driving 
under the influence of drugs. The study also highlights the difficulties of law 
enforcement in this area, and concludes that, ‘the goal of producing a valid, reliable 
and convenient roadside testing device for drugs is still paramount and not yet 
achieved’ (Cusack et al. 2004, p. 2). 
A limitation of the study is that no random sampling of motorists occurred. Given that all 
of the blood and urine samples were taken from drivers apprehended by the Gardaí 
and suspected of driving under the influence of an intoxicant, the authors state that the 
information ‘does not provide a full picture of use of drugs in the general driving 
population’ (p. 6). 
 
Alcohol and public order 
A recent Irish study of public order incidents recorded over a five-month period found 
that alcohol had been consumed by the offender in 97 per cent of cases where this 
aspect of the incident was recorded by the Garda Síochána (Institute of Criminology 
2003). Of the 50 garda members interviewed as part of the study, 98 per cent believed 
that alcohol was the primary causal factor in public order offending. However, an in-
depth analysis of a number of observed public order incidents (n=177) found that 
alcohol played a role in just over half of the total. The study also considered information 
contained on the new garda computer information system PULSE (Police Using 
Leading Systems Effectively), which became operational in 2000. The system has a 
facility whereby information can be recorded as to whether the Gardaí believed the 
offender had consumed alcohol or drugs. Although the Institute of Criminology study 
found that in 66 per cent of cases such information was not recorded, in 97 per cent of 
the cases where such information was recorded, alcohol was identified as a 
contributory factor. Drug use did not appear from the study to have played any 
significant role in public order offences. 
 
A recent study which considered the Irish drinking culture and related harm in 
comparison with other European countries concluded that adverse alcohol-related 
consequences (fights, accidents and regrettable conduct) were particularly related to 
the tendency to ‘binge’ drink in Ireland (Ramstedt and Hope 2003). 
 
Drug use and acquisitive crime 
Another form of crime with a link to drug use is the forging of prescriptions. The Annual 
Report of the Garda Síochána recorded only 16 such offences for the year 2001 
(Garda Síochána 2002). For 2002 however, 111 such offences were recorded (Garda 
Síochána 2004).  This is an area which requires further analysis. For example, there is 
evidence to suggest a large increase in the problematic use of benzodiazepines among 
treated drug users. Reports from drug users suggest the wide availability of these 
drugs, particularly in the vicinity of drug treatment clinics (Personal Communication, 
Drug Users Service Coordinator).  In a study of drug use in the Blanchardstown area of 
Dublin (D’Arcy 2000), respondents reported using between 3 and 13 benzodiazepine 
tablets per day. Although clients in treatment are often prescribed benzodiazepines as 
part of their treatment, respondents reported purchasing many of these tablets on the 
black market. 
 
Local drug markets, crime, nuisance and security fears 
Another related aspect of the systemic crime dimension relates to street-level drug 
markets and the degree to which the crime and nuisance associated which such 
markets can contribute to significant community disintegration and heightened security 
fears. A number of recent Irish studies have looked at the impact of local drug markets 
on community life (See Section 13). 
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In May 2003 the European Commission published the results from a Eurobarometer 
survey on public safety, exposure to drug-related problems and crime in the European 
Union (EU) (European Commission 2003). The survey, carried out in autumn 2002 
among approximately 1,000 people aged 15 years and over in each of the 15 member 
states, included a question previously asked in similar surveys in 1996 and 2000. The 
question asked in all three public opinion surveys was: 
 
Over the last 12 months, how often were you personally in contact with drug-related 
problems in the area where you live? For example seeing people dealing in drugs, 
taking or using drugs in public spaces, or by finding syringes left by drug addicts? 
Was this often, from time to time, rarely or never? 
 
When the results from respondents choosing the ‘often’ and the ‘from time to time’ 
options were combined, exposure to drug-related problems in the EU as a whole rose 
from 14 per cent in 1996, to 17 per cent in 2000, and to 19 per cent in 2002 (see Table 
8.3.4).  
Table 8.3.4   EU survey respondents’ contact with drug-related problems, 1996, 2000, 2002 
Survey 
year 
Contact with drug-related problems (EU average) 
 
 ‘often’ % ‘from time to time’ % 
 
‘rarely’ % ‘never’ % ‘don’t know’ % 
1996 5 9 12 73 1 
2000 5 12 16 66 1 
2002 6 13 17 63 1 
Source: European Commission (2003)  
This steady growth in exposure to drug-related problems was not observed in all EU 
countries however. Ireland was one of eight countries where exposure dropped 
between 2000 and 2002. Figures for Ireland show that the proportion of respondents 
choosing the ‘often’ and the ‘from time to time’ options rose from 16 per cent in 1996 to 
21 per cent in 2000 but then dropped to 14 per cent in 2002 (see Table 8.3.5). 
Table 8.3.5   Irish survey respondents’ contact with drug-related problems, 1996, 2000, 2002 
Survey 
year 
Contact with drug-related problems (Ireland) 
 
 ‘often’ % ‘from time to time’ % ‘rarely’ % ‘never’ % ‘don’t know’ % 
 
1996 5 11 10 72 2 
2000 5 16 11 65 3 
2002 6 8 14 64 8 
Source: European Commission (2003) 
In Ireland the proportion of people who stated that they were ‘often’ exposed to drug-
related problems remained remarkably constant over time: five per cent in 1996 and 
2000 and rising slightly to six per cent in 2002. This is identical to the overall trend in 
the EU. However there was a dramatic drop in the proportion who stated that they were 
exposed to drug-related problems ‘from time to time’: down from 16 per cent in 2000 to 
8 per cent in 2002. This was the largest drop in this option experienced by any EU 
country.  
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Some words of caution about interpreting these results are required. The Commission 
noted that Ireland was the only country with a significant ‘don’t know’ response (8%) for 
this question in 2002. Why such a large proportion of Irish people replied in such a 
manner is unclear. For other questions, such as perception of street safety after dark, 
the proportion of Irish people replying ‘don’t know’ was almost negligible. The 2002 
survey was conducted using telephone interviews, while the earlier surveys used face-
to-face interviews. It could be argued that the use of telephone interviews may have 
had an influence on the type of person responding in Ireland. 
 
The recent drop in reported exposure to drug-related problems in Ireland requires 
further investigation. A lessening of such exposure may be the result of improved law 
enforcement efforts. Alternatively, following the high levels of public anxiety in the 
middle of the1990s, fuelled by such events as the murder of journalist Veronica Guerin, 
we may be witnessing a moderation in public perceptions as to the seriousness of the 
drugs problem. Another possibility is that the large proportion of Irish people 
responding ‘don't know’ to the Eurobarometer question may reflect an increased 
uncertainty among the public as to the nature of the problems being encountered in 
their areas. Also, in recent years some of the inner city areas which experienced 
serious drug problems in the 1980s and 1990s have undergone significant 
refurbishment and local regeneration. Drug dealing and related problems, which have 
tended to be concentrated in specific locations, may have migrated out to more 
marginal areas on the periphery as a result. 
 
A number of recent Irish studies have sought to provide this micro perspective and 
have shown the way in which the problems associated with drug trafficking and drug 
use impact disproportionately on certain sections of the population or in specific 
locations. This suggests that analyses of the extent of the drug problem which rely on 
figures based only on national data provide only part of the story of the impact of drug 
problems on individuals and communities (See Section 13).  
 
8.4 Drug use in prison 
Long and colleagues (2004) described and explored injecting practices, strategies 
taken to deal with risk of infection (2003)  and actions necessary to address this 
situation (2004); 31 (16 injectors and 15 non-injectors) were interviewed.  
 
Injectors reported and non-injectors observed that ‘injectors take a number of risks 
during detention that they would not take outside prison’. For example, the low 
availability of heroin encouraged the change from smoking to injecting; the scarcity of 
injecting equipment meant that sharing circles were far wider than outside prison; 
cleaning practices were inadequate for injecting equipment, and those who owned a 
syringe and needle rented them to other injectors as a means of acquiring the drugs to 
maintain their habit. The non-injectors in prison said they knew which prisoners were 
current injecting drug users. Almost all non-injectors had observed injecting drug use in 
prison and their reported observations of injecting practices were consistent with those 
reported by respondents who had injected in prison. During the in-depth interviews, 
prisoners (both injectors and non-injectors) were asked how they dealt with the risk of 
either contracting or testing positive for hepatitis C. Two dominant themes emerged: 
denial and fear.  
 
Injector respondents dealt with the possibility of contracting or experiencing 
consequences of infection with hepatitis C by: living in the moment; distancing its 
effects in time; generalising the condition to all injectors; and comparing its 
consequences to those of HIV. This process allowed them to continue injecting without 
considering the consequences. According to most injector respondents, hepatitis C is 
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common among those who inject drugs and, to date, its consequences have not been 
serious.  
 
The fears expressed by injectors and non-injectors were in the main well founded. Fear 
of contracting, or actually contracting, blood-borne viruses deterred a number of heroin 
users from starting or continuing to inject heroin. Similar numbers of non-injector and 
injector respondents reported that they feared contracting blood-borne viruses while in 
prison.  
 
All respondents were asked: ‘What action is required by the prison authorities to deal 
with drug use in prison?’   
 
Respondents suggested a number of interventions, including routine daily activities 
(such as education, work, and exercise), drug awareness programmes, individual 
counselling sessions and harm reduction services. Non-injectors were sympathetic to 
the plight of injectors, and both non-injectors and injectors supported harm reduction 
interventions and thought that the range of drug services in prison should mirror that 
currently available in the community, although half opposed or had reservations about 
needle exchange.  
 
Prisoners viewed time in prison as an opportunity to address substance misuse and 
stabilise viral infections; health professionals should not miss this opportunity. 
 
8.5 Social costs 
No cost-analysis studies have been conducted in Ireland. However, a range of studies 
indicate the significant social costs to individuals, families and communities arising from 
drug misuse. It is clear from such studies that drug trafficking and drug use impact 
disproportionately on those individuals and communities characterised by high levels of 
poverty and social exclusion. 
 
Homeless ex-prisoners  
A recent survey of 20 ex-prisoners (14 male and 6 female) (O’Loingsigh 2004, p. 37) 
concluded that many ‘turned back to crime within hours of being released in search of 
money to pay for a bed & breakfast’. 
 
Impact on families 
A study by Connolly (2003) in Dublin’s north Dublin inner city considered intra-familial 
drug use. While nine respondents, or 22 per cent of the sample that answered the 
question, had used drugs themselves, with four of those long-term users, over half of 
the sample had a family member or relative who had used drugs. Over 50 per cent of 
the latter were long-term users. The survey question did not specify the type of drug 
being used however. The majority of survey respondents stated in response to a 
different question that, with regard to drug use and drug-related problems, their priority 
concern was heroin. 
 
For many of the survey respondents, a dominant concern was the negative impression 
street- level drug dealing and use had upon younger children. There was a fear that, for 
children, drug use and drug dealing would be seen as a way of life. The presence of 
bereavement, the difficulties in attempting to manage families where one or more 
member is a drug user, and the difficulties for those who are attempting to come off 
drugs, particularly when they are regularly exposed to drugs in their community are all 
significant impressions. 
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Impact on children of drug-using parents 
Hogan (2003), from a consideration of the parenting beliefs and practices of opiate-
addicted parents found that parents adopted strategies to conceal their drug-related 
activities from their children and to maintain a strict family taboo about these activities. 
This was found to be difficult given the exposure of children to their parents’ drug-
related activities and was ultimately counter-productive for children in that it led to 
interpersonal mistrust and greater vulnerability for the child.  
 
Hogan concludes that the strategies adopted by drug-using parents to conceal their 
drug use from their children left their children in an impossible situation. ‘They are 
bound to silence by loyalty to their parents and their desire to protect themselves, their 
parents and their families from social censure and exclusion’ (p. 118). In this way, we 
can see how relations between families, where a member of the family is a drug user, 
and their immediate community can suffer as a result of their family members’ drug 
use. 
 
Impact on communities 
The tensions created by drug trafficking and drug use in such communities has, on 
many occasions, led to the emergence of forms of community-based direct action and 
informal justice (See section 13). 
 
9. Responses to Social Correlates and Consequences 
 
9.1 Overview 
There is a clear lack of long-term accommodation plans for recovering drug users in 
Ireland. In particular, there is a shortage of halfway houses to accommodate former 
drug users. A small amount of transitional housing is provided by voluntary 
organisations, with some funding allocation from the statutory sector. The bulk of 
mainstream hostels operate exclusionary orders against active drug users with only 
two hostels providing emergency accommodation to active drug users. No emergency 
accommodation provider will allow drugs to be consumed on the premises. Education 
and labour market training is provided to individuals who have stabilised their drug use 
through methadone.  
 
9.2 Social Reintegration 
Housing 
Transitional Housing 
Merchants Quay Ireland, a voluntary organisation working with homeless drug users, 
provides transitional accommodation through the Integration Programme. This service 
targets drug users who experience homelessness following their completion of 
residential drug treatment. Clients reside in a transitional house in Dublin for a period of 
twelve weeks. During the first six weeks, clients are provided with a structured 
programme including relapse prevention skills, life skills and opportunities to consider 
vocational and career choices. In the remaining time clients are encouraged to access 
employment, training and longer-term accommodation. The Arrupe Society, also a 
voluntary organisation working with homeless drug users, provides transitional 
accommodation through the Avoca project. Residents include individuals that have 
completed residential treatment. The project encourages residents to maintain a drug-
free lifestyle.  
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Emergency accommodation 
DePaul Trust Ireland is responsible for opening the first hostel in Dublin to provide 
accommodation to individuals engaged in intravenous drug use and experiencing 
homelessness through 'sleeping rough'. DePaul Trust Ireland was established in 2002 
with the support of the Society of St. Vincent De Paul, the Daughters of Charity and the 
Vincentian Fathers. The hostel, known as the Clancy Night Shelter, opened in February 
2002. The hostel is a low threshold, harm reduction hostel for young rough sleepers, 
many of whom are intravenous drug users. Facilities include: 16 beds in seven twin 
and two single rooms. Opening hours are from 19.00 to 9.00. The service 
accommodates men and women between 18-35, who due to their challenging 
behaviour have been excluded from other services.  
 
The Caretakers Hostel is operated by Focus Ireland and targets out of home young 
people 16-21 who are misusing drugs, those with experience of being in care and 
those in transition from youth to adult homeless services. The hostel provides 
emergency accommodation between the hours of 20.15 and 9.30. No alcohol or drugs 
are allowed within the project or surrounding area. Accommodation includes nine beds, 
five for males and four for females. Facilities include:: one shower per four people, one 
toilet per three people. Evening meal and breakfast are provided. Support services: 
there are 11 staff; young people are provided with advice and referral to drug treatment 
and other relevant services.  
 
Haven House targets single homeless women with children including women with 
alcohol or drug problems. No alcohol is allowed on premises and prescribed 
medication must be handed to staff on arrival. Women with children must be in by 
20.00 and without children 00.30. Accommodation includes: 24 beds in 10 rooms, cost 
of a two bed is €1.27 per night and a family room is €1.27 per night. Facilities include 
one bathper 15 people, one showerper 15 people, one toiletper eight people, laundry. 
Breakfast and lunch are provided.  
 
The Northern Area Health Board operate the 'Out Of Hours Service' providing 
emergency social work service to young people, 12-18 years, presenting as out-of-
home outside office hours. Returning home or placement in emergency care is 
negotiated. Young people are provided with emergency accommodation in Lefroy 
House Nightlife Service and referrals are accepted through social workers or Garda 
stations. No alcohol or drugs are allowed on the premises. Residents must be in 
between 20.00 and 00.02 and must leave by 09.30. Accommodation consists of seven 
beds and facilities include three showers and three toilets. Evening meal and breakfast 
are provided. Support services include one project manager, seven childcare workers 
and four childcare leaders providing waking cover.  
 
For a consideration of the impact of the Housing (Miscellaneous Provisions) Act, 1997, 
in particular its consequences vis a vis social reintegration, see Section 13. 
 
Education/training and employment 
Specific education and training for recovering drug users is primarily provided through 
the Special FAS Community Employment Programme. This programme is run by FAS 
the National Training Agency and was designed to provide labour market training to 
recovering drug users. The programme is primarily targeted at local drug task force 
areas and aims to assist individuals to access mainstream employment opportunities. 
During 2003 there were 54 Special FAS Community Employment Programmes for 
recovering drug users up and running throughout the 14 local drugs task force areas. 
During 2003, between 800 and 850 individuals participated in the scheme. (M. 
Donnelly, Personal Communication, 2004) A drug-awareness training programme for 
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CE supervisors has been developed with Merchants Quay Ireland. This programme is 
currently being piloted and, providing evaluation is successful, will be available to all 
CE supervisors. FAS have recently commissioned an evaluation of this ongoing 
programme. Examples of projects providing education and training to assist individuals 
access the labour market include Soilse, SAOL, Addiction Response Crumlin/Athru, 
Merchants Quay Social Reintegration programme and Tallaght Rehabilitation 
Programme. For a comprehensive overview of these projects including evaluation 
results see the EDDRA database.  
 
The Linkage programme works with individuals who have been sanctioned by the 
criminal justice system. Clients tend to be ex-prisoners or individuals who have been 
working with the Probation and Welfare service in the community. The programme is 
not exclusive to drug users but a significant number of its clients would have a history 
of drug use. (P. Richardson, Personal Communication, 2003) The number of referrals 
to the programme doubled to over 766 in 2002, with 507 referrals of offenders in the 
community and 259 referrals of ex-prisoners. Of the total number 766, 160 were placed 
in employment and 155 were placed in training and education. In 2002, from a total of 
259 ex-prisoners referred to the programme, 68 were placed in employment and 45 in 
full-time training and education. No data are available for 2003.  
 
Drug treatment in prison 
In 1999, the Department of Justice, Equality and Law Reform instituted a Steering 
Group on Prison-Based Drug Treatment Services. This Steering Group has outlined 
ten intentions that underpin the introduction of prison-based drug treatment services 
(Irish Prison Service 2000). Importantly, the Steering Group noted that ‘the prison 
service must replicate in prison the level of medical and other supports available in the 
community for drug-dependent people to the maximum extent possible’. This is a 
formal statement of support for the principle of equivalence of care with community 
drug treatment services. At present, the plan includes strategies for prevention, 
detoxification, methadone maintenance, counselling and education. The intentions of 
the Steering Group are encouraging, although the plan does not specify deadlines, 
targets or budgets. As a result of the plan, evidence based methadone maintenance 
and detoxification services have been introduced in five Dublin prisons.  Twenty-four 
prisoners were receiving methadone at the end of January 2001, whereas 402 
prisoners were receiving methadone at the end of December 2003 (unpublished 
information from the Central Treatment List 2003).   
 
By the end of 2002, the Prison Service was at an advanced stage of drafting an Irish 
Prison Drug Service Policy that would be in line with the current Irish drugs strategy 
Building on Experience: the National Drugs Strategy 2001– 2008 (Tourism Sport and 
Recreation 2001) and the World Health Organization’s Health in Prisons Project: 
Prisons, Drugs and Society 2002.  This policy is still awaiting approval from the Minister 
for Justice, Equality and Law Reform.  
 
9.3 Prevention of drug-related crime 
For a consideration of responses in relation to young offenders and alternatives to 
prison see Section 12. With regards to other interventions for prevention of drug related 
crime see the EDDRA database. There have been no new entries for this year. 
 
 
10.  Drug Markets 
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10.1 Overview 
The total number of drug seizures reported in the annual reports of the Garda 
Síochána decreased by 39 per cent in 2002, the most recent year for which figures are 
available. Cannabis remains the principal drug seized in Ireland, accounting for 53 per 
cent of total drug seizures in 2002. However, in 2002, there was a 51 per cent 
decrease in cannabis seizures compared to the previous year. Although the number of 
heroin seizures increased between 2000 and 2002, the total quantity seized decreased 
by 21 per cent. However, we have seen an upward trend in cocaine seizures in recent 
years. The total number of cocaine seizures has more than doubled since 2000, while 
the quantity of cocaine seized has increased by 77 per cent. 
 
It is estimated that a kilogram of cannabis is sold wholesale for approximately €3,250 
and, when sold at retail level, can reach approximately €4,000. The price of ecstasy 
decreased from €22 in 1995 to between €10 and €15 in 2003. Heroin in Ireland 
remained quite expensive relative to the overall European drugs market, selling at 
between €180 and €200 per gram. There was a reduction in the price of cocaine in 
2003. It is estimated that a gram of cocaine currently sells at approximately €80 to 
€100. This suggests the potential for a displacement of heroin use by cocaine use, 
given the disparity in price.  
 
Information provided by the Forensic Science Laboratory, based on a sample of heroin 
seizures in 2000, suggests that there might not be a significant difference in drug purity 
levels between middle and local market stages, thus suggesting a relatively stable drug 
market. However, such conclusions await a more systematic purity analysis of drug 
seizures for confirmation. A small number of crack cocaine seizures were made in 
2003. 
 
Both the Gardaí and customs report an increase in the trafficking of cocaine in 2002. 
The Garda National Drugs Unit believes this is probably due to a more mainstream use 
of the drug. A strong decrease in cannabis trafficking has been reported in recent 
years. This, it has been suggested, may be due to Ireland becoming less significant as 
a transit route for cannabis destined for the UK market. An increased number of 
cannabis herb seizures have been made by Customs in recent years. 
  
Some small studies in inner city areas of Dublin suggest the concentration of drug 
markets in specific areas. Research consistently shows that friends or family members 
are the initial contact through which most people first become involved with drugs. 
 
10.2 Availability and supply 
Two local drugs and crime surveys conducted by Connolly (2001, 2003) in Dublin’s 
north inner city considered the issue of drug availability. The first survey was conducted 
among 40 local residents who had been participating in meetings as part of a process 
of establishing a Community Policing Forum in the area (Connolly 2002). Those who 
took part in the survey represented 29 different streets or flat complexes throughout the 
area. The survey was conducted between October and November 2000. Eighty per 
cent of the sample stated that they had witnessed drug selling in the previous year; 78 
per cent stated that it was ‘quite likely’ or ‘very likely’ that they would witness drug 
selling in the following six months. None of the respondents were of the view that it 
would be ‘not at all likely’ that they would witness drug selling. 
A subsequent door-to-door survey was conducted in a specific location of the north 
inner city. The survey, Drugs, crime and community – Monitoring the quality of life in 
the north inner city, was carried out between August and December 2001 (Connolly 
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2003). The area, encompassing five streets and a local authority flats complex, is one 
where illicit drug use and dealing is prevalent, and contains a mixture of public and 
private housing. The sample involved 44 local residents. 
Thirty-six per cent of the total sample had been offered drugs and 53 per cent had 
witnessed drugs being sold in the year preceding the study; 76 per cent responded that 
they were likely to witness drug selling within the following six months. 
In a small study conducted by the DMRD in collaboration with the Garda Síochána 
National Drugs Unit in April 2003, police respondents from three Dublin stations were 
asked how easy or difficult it would have been in the previous year, in their view, for 
young adolescents or young adults, excluding regular drug users, to acquire specific 
drugs. One police respondent believed that cannabis was ‘fairly easy’ to obtain while 
two of his colleagues in other city centre locations regarded it as ‘very easy’ to obtain. 
One respondent regarded heroin as ‘fairly easy’ to obtain, while two said it would be 
‘very easy’ to obtain. One regarded cocaine as ‘fairly easy’ to obtain while two said it 
was ‘very easy’ to obtain. All regarded crack cocaine as either ‘fairly difficult’ (n=1) or 
‘very difficult’ (n=2) to obtain. One regarded amphetamines as ‘fairly difficult’ to obtain 
while another officer regarded it as ‘very easy’ to obtain. All regarded ecstasy as either 
‘fairly easy’ (n=1) or ‘very easy’ to obtain (n=2). Another drug mentioned in the survey, 
benzodiazepine, was perceived as ‘very easy’ or ‘fairly easy’ to obtain.The co-ordinator 
of a drug-users’ group who had regular contact with drug users throughout the city 
regarded cannabis as ‘very easy’ to obtain, while heroin, cocaine powder and crack 
were all seen as ‘fairly easy’ to obtain. Benzodiazepines were regarded as ‘very easy’ 
to get (Personal communication, Tommy Gorman, Drug Forum Coordinator, UISCE). 
 
A survey conducted by the Dublin-based CityWide Drugs Crisis Campaign (2004) of 59 
community-based drug projects, 27 of which responded (46%), found evidence of an 
increased availability and use of cocaine. Almost one-third of respondents claimed that 
cocaine was cheap and easily available; three respondents stated that heroin supplies 
were decreasing in their areas while cocaine was on the increase. 
 
Drug-dealing sites 
The Drugs, crime and community survey (Connolly 2003) sought information on 
specific locations in which drug dealing was taking place in the north Dublin inner city. 
Twenty-nine respondents identified specific locations, with five stating that they 
witnessed drug dealing outside their door every day. One recovering drug user, on the 
day of the interview, stated that she had been offered drugs three times that day as she 
returned from the local clinic, less than a mile from her home. 
The recent study conducted by the DMRD of police and drug-user perceptions of the 
drug market sought information on drug dealing sites or locations. The Gardaí 
perceived cannabis as being sold mainly in stairwells at flat complexes, in private 
homes or on the street. Heroin was sold primarily on the street or in private homes. 
Cocaine was sold in bars and discos, on the street and in private homes. 
Benzodiazepines were sold primarily on the street. 
From the perspective of a respondent who worked with drug users, cannabis was sold 
primarily in pubs on specific streets and at flats. Heroin was sold openly on streets at 
only a limited number of Dublin locations in the south inner city in particular. Heroin 
was also sold in specific cafés. Cocaine sales were similar and, for all drugs, the use of 
mobile phones was central to transactions. Only relatively large quantities of cannabis 
were sold over the phone. Benzodiazepines were sold at drug treatment centres or at 
train stations (Personal communication, Tommy Gorman, Drug Forum Co-ordinator, 
UISCE). 
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10.3 Seizures 
The majority of seizures, whether made by Customs or An Garda Síochána, are 
recorded in the annual reports of the Garda Síochána. The seizure statistics published 
in the annual reports of the Revenue Commissioners include only those seizures made 
by customs officers (Customs Drug Law Enforcement (CDLE), personal 
communication, December 2003). However, seizures also result from joint Garda–
Customs operations and investigations. Although the seizure figures in the Garda 
reports will also include most customs seizures, below we will present the figures 
provided by customs separately so as to enhance our overall picture of enforcement 
activities at different stages of the drugs market. Seizures made by customs will usually 
occur at points of access into the country such as sea- and airports, land frontiers, 
postal centres and approved customs premises. 
 
Table 10.3.1 shows the number of drug seizures as reported in the annual reports of 
the Garda Síochána, and Table 1.2 those presented in the annual reports of the 
Revenue Commissioners. 
 
Table 10.3.1   Seizures of specific drugs recorded in garda reports, 1995–2002 
Drug seized 1995 1996 1997 1998 1999 2000 2001 2002 
Heroin 209 664 599 884 767 598 802 714 
Cocaine 42 92 157 151 213 206 300 429 
Ecstasy 571 405 347 466 1064 1864 1485 1027 
Amphetamines 89 217 475 680 467 169 162 243 
Cannabis 3205 3449 4102 4538 4641 4641 6233 3024 
Seizure totals 4178 5244 6182 7030 7318 7703 9169 5603 
 Source: Annual Reports of An Garda Síochána 1995–2002 
 
 
Table 10.3.2   Seizures of specific drugs recorded in Revenue reports, 2000–2003 
Drug seized 2000 2001 2002 2003 
Heroin 6 7 2 4 
Cocaine 12 3 22 27 
Ecstasy 12 13 7 8 
Amphetamines 7 7 2 4 
Cannabis resin 160 211 115 244 
Herbal cannabis 764 957 491 494 
Seizure totals 961 1198 641 781 
Source: Customs Drug Law Enforcement, personal communication, May 2004; Annual Reports of the Revenue 
Commissioners 2000–2003  
 
When we compare Table 10.3.1 and Table 10.3.22 for the years 2000 to 2002, we can 
see that, in the case of heroin, cocaine, ecstasy and amphetamines, seizures made by 
customs represent only a small proportion of the total number of seizures recorded in 
the annual garda reports. However, customs appear to have made a large number of 
seizures of herbal cannabis between 2000 and 2003. Also, many of these seizures do 
not appear to have been included in the garda reports. 
 
The total number of cannabis seizures reported in the garda report for 2002 was 3,024. 
Cannabis seizures are classified under three headings: herbal cannabis, cannabis 
resin and cannabis plants. The vast majority of cannabis seizures made in Ireland are 
of cannabis resin. However, most of the seizures of herbal cannabis made by customs 
between 2000 and 2002 do not appear to have been reported as such in the garda 
reports. Customs reported 764 seizures of herbal cannabis in 2000; the garda report 
presents a figure of 219 for that year. In 2001, customs reported 957 seizures of herbal 
cannabis, while only 253 are recorded in the garda report. In 2002, customs reported 
493 herbal cannabis seizures; only 242 appear in the garda report for that year. 
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This can partly be explained by the fact that many of these seizures by customs, 
particularly of small amounts, might not result in a prosecution or conviction. This might 
occur in cases where there is an absence of sufficient supporting evidence: for 
example, where the drugs came through the mail. However, all seizures will still be 
accounted for and reported as such by customs (CDLE, personal communication, June 
2004). 
 
The total number of drug seizures recorded in the annual reports of the Garda 
Síochána decreased by 39 per cent between 2001 and 2002. Seizures made by 
customs decreased by approximately 46 per cent during this period, down from 1,198 
seizures in 2001 to 641 in 2002. 
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Figure 10.3.1   Trends in seizures of selected illicit drugs in Ireland, 1995–2002  
Source: Annual Reports of An Garda Síochána 1995–2002 
 
Figure 10.3.1 shows the trends in the number of seizures of specific drugs between 
1995 and 2002, the most recent year for which statistics are available. The total 
number of drug seizures more than doubled between 1995 and 2001, increasing from 
4,178 in 1995 to 9,169 in 2001. In 2002 there was a significant decrease of 39 per cent 
in the total number of drug seizures. As can be seen, however, this decrease appears 
to have been caused by a 51 per cent decrease in cannabis seizures and a 31 per cent 
drop in ecstasy seizures.  
 
Figure 10.3.2 shows trends in seizures of heroin, cocaine, ecstasy and amphetamines 
between 1998 and 2002. 
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Figure 10.3.2   Trends in seizures of specific drugs, 1998–2002 
Source: Annual Reports of An Garda Síochána 1998–2002 
 
Heroin seizures appear to have peaked at 884 seizures in 1998, followed by a decline 
to 598 seizures in 2000. In 2001, the number of heroin seizures rose to 802. There was 
a slight decrease in heroin seizures in Ireland in 2002. 
 
In Ireland, cocaine seizures increased steadily to a total of 213 in 1999, dropped 
slightly in 2000, and increased sharply to a total of 429 seizures in 2002. Customs 
report that the biggest single trend observed in 2002 was the increase in frequency of 
seizures and in the amount of cocaine seized. Twenty-two seizures totalling 19,473 kg 
of cocaine, with a reported value of €2,000,000, were made in 2002 (Revenue 2003).  
Ecstasy is the second most commonly seized drug in Ireland. Following a sharp 
increase in the number of ecstasy seizures, from 347 in 1997 to 1,864 in 2000, there 
was a decrease to 1,027 seizures in 2002. 
 
Amphetamines seizures increased from 89 in 1995 to 680 in 1998, followed by a 
continuous decline to a total of 162 in 2001. In 2002 there was an increase in 
amphetamine seizures. 
 
Cannabis remains the principal drug seized in Ireland, accounting for 53 per cent of 
total drug seizures in 2002. There has been a steady increase in cannabis seizures 
since 1995, with a significant increase from 4,641 seizures in 2000 to 6,233 in 2001. 
However, in 2002 there was a 51 per cent decrease, with the number of cannabis 
seizures down to 3,024. 
 
Due to the fluctuations in quantities of drugs seized from year to year, the number of 
separate seizures is regarded as a more useful indicator of drug availability and supply. 
However, identifying the quantities of drugs seized can be a useful indicator of 
enforcement activities. Also, as mentioned above, increasing the volume of drugs 
seized is a commitment within the National Drugs Strategy 2001–2008 (Tourism, Sport 
and Recreation 2001). Quantities of drugs seized are provided in the annual reports of 
the Garda Síochána and in the annual reports of the Revenue Commissioners, which 
record the drug seizures in which the Customs Service is involved. 
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Figure 10.3.3   Trends in the quantity of heroin and cocaine seized, 2000–2002 
Source: Annual Reports of An Garda Síochána 2000–2002 
 
Although the number of heroin seizures increased from 598 in 2000 to 714 in 2002, 
Figure 10.3.3 shows that the total quantity of heroin seized between those years 
decreased by approximately 29 per cent. The total quantity of cocaine seized increased 
by 77 per cent between 2000 and 2002. Following a decrease in the quantity of 
cocaine seized between 2000 and 2001, in 2002, the quantity seized increased from 5 
to 32 kilograms, a rise of approximately 540 per cent. The number of cocaine seizures 
increased by 43 per cent in 2002. 
 
10.4 Price/purity 
Obtaining information on drug prices is important for a number of reasons. Drug price is 
sometimes used as an indicator to quantify seizure trends. In a recent response to a 
parliamentary question on progress towards the national drugs strategy goal of 
increasing the volume of drug seizures, Michael McDowell, Minister for Justice, 
Equality and Law Reform, stated (2004, 26 February): ‘Garda seizures for 2000 
amounted to €20 million; 2001, €45 million; 2002, €49 million and 2003, €100 million. 
Customs and Excise seizures for 2000 amounted to €11 million; 2001, €60 million; 
2002, €34 million; and 2003, €21 million.’ 
 
However, there is no standardised method available in Ireland by which trends in drug 
prices can be identified. The use of price as an indicator of drug availability requires 
repeated, accurate and current data on drug prices, at both import market level and at 
street level. 
 
Another important reason for the collection of regular drug price data is provided by 
section 4 of the Criminal Justice Act 1999, which inserted a new section 15A into the 
Misuse of Drugs Act 1977. This new section introduced the specific offence of 
possession of drugs with a market value of £10,000 (€12,700) and applied for the first 
time the principle of a mandatory minimum sentence with respect to these offences. 
 
The provision of regular drug price data could facilitate consistency in sentencing under 
this legislation. However, the Act does not make clear the stage of the market, retail or 
otherwise, at which the valuation of drugs is to be made. 
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Moran et al. (2001) point to the difficulty of establishing the difference between prices 
at street level and at middle-market or import trafficking level. The authors’ figures are 
based on those supplied by the GNDU, which appear to have remained relatively 
stable over the past five years. The figures for drug prices used below are based on a 
recent ad hoc study conducted by the Drug Misuse Research Division with key 
informants in the Garda Síochána and the drug-using community. These figures, 
although based on a small number of informants, suggest some fluctuation in drug 
prices and also provide a very recent impression of current drug prices. 
 
Once a seizure has been made by the Gardaí or by customs, the drugs are generally 
forwarded to the Forensic Science Laboratory for analysis to determine whether they 
contain illicit substances so as to facilitate a criminal prosecution (J Power, personal 
communication, July 2003). 
  
Tables 10.4.1, 10.4.2 and 10.4.3 show average purity levels for amphetamines, heroin 
and cocaine seized by the Garda Síochána and/or Customs between 1993 and 2001 
and which were analysed and quantified at the Forensic Science Laboratory. By 
analysis, we mean the samples were tested for the presence of an illicit substance; by 
quantified, we mean that the percentage purity of the sample was also examined.  
 
The figures for each drug are based on a small number of cases. For example, in 2002, 
the Forensic Science Laboratory received over 200 suspected amphetamine cases of 
which only 2 were quantified. In 2001, the Laboratory received more than 300 
suspected cocaine cases for analysis, of which 13 were quantified. In 2003, the 
Laboratory received over 600 suspected heroin cases, of which 11 were quantified. (J 
Power, personal communication, April 2004). The figures in Tables 10.4.1, 10.4.2 and 
10.4.3 also represent an average percentage purity from a wide range across the 
cases tested. For example, in 2001, of the 13 cocaine packs quantified, the minimum 
percentage purity was 0.12 per cent, the maximum 49.50 per cent, and the average 
25.78 per cent. In 2002, 53 heroin packs were quantified. The minimum percentage 
purity was 0.10 per cent, the maximum 63.00 per cent, and the average 29.63 per cent. 
  
Cannabis 
The GNDU, in its report for the government’s annual submission to UNODC for 2002 
(Health and Children 2003), reported that the price of one kilogram of cannabis resin at 
wholesale level in that year was €3,250. The average cost of a gram of cannabis at 
street level ranged from €10 to €15. The cost of seven grams (quarter ounce) of 
cannabis resin appeared to remain stable at €25 to €30. These figures suggests that a 
kilogram of cannabis costing €3,250 at wholesale level, when sold for €30 per ‘quarter 
ounce’ at retail level, would return a profit margin of approximately €1,000. 
Cannabis purity levels are not routinely quantified by the Forensic Science Laboratory. 
 
Synthetic drugs – amphetamines, ecstasy and LSD  
The GNDU estimated that amphetamines cost €2 per dosage unit at wholesale level 
and €6 per dosage unit at street level in 2002 (Health and Children 2003).  
The GNDU reported that ecstasy sold at €2 per dosage unit at wholesale level in 2002. 
The price of an ecstasy tablet at street level decreased from €22 in 1995 to between 
€10 and €15 in 2003 (Health and Children 2003; Moran et al. 2001).  
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Table 10.4.1   Average percentage purity of amphetamines seized 1993–2002 
Year Cases quantified 
 
n 
Packs quantified 
 
n 
Purity range 
 
% 
Average purity 
 
% 
1993 3 41 0.4–7.1 4 
1994 - - - - 
1995 2 14 2.5–7 4.7 
1996 3 9 2.1–22.0 9.8 
1997 14 28 1.3–6.4 3.4 
1998 - - 2–18.0 6 
1999 - - 2–4 3 
2000 - - - - 
2001 1 - - 2 
2002 1 2 0.90–2.9 1.9 
Source: Forensic Science Laboratory 
 
Table 10.4.1 shows that in 2002, of the suspected amphetamine cases submitted to 
the Forensic Science Laboratory for analysis, only one case was quantified. This 
involved two packs of amphetamine powder, the average purity of which was 1.9 per 
cent. 
 
Heroin/opiates 
Ireland, and especially Dublin, has been regarded as a sub-market of the London 
heroin market (Lenke and Olsson 1998). The price level is very high and accords with 
similar levels in other peripheral European heroin markets (EMCDDA 2003). Moran et 
al. (2001) report heroin as selling at €190 per gram in 2001. The GNDU believes that 
heroin currently sells at between €180 to €200 per gram at street level. Heroin 
generally sells at street level in €20 bags. 
 
A study conducted by the Forensic Science Laboratory in 2000 analysed the purity of 
diamorphine (heroin) in a sample of 45 street-level packs. The average weight of 
powder in each pack was slightly more than one tenth of a gram (0.113 grams). The 
average purity was 41.3 per cent. A study of 13 cases conducted in the same year, 
where the total weight of the 13 cases was 4,942 grams, suggesting a large seizure 
rather than a street-level one, found an average purity of 45.8 per cent. These findings 
suggest that there may not be a great deal of difference in purity levels between local 
retail market and middle market, with average purity levels roughly similar. As Lenke 
and Olsson (1998) suggest, such relative stability in price and purity levels is found in a 
market ‘characterised by a fairly good balance between supply and demand’. Such a 
situation would raise obvious issues in relation to the impact of supply control efforts. A 
more systematic study of drug purity levels across drug seizures would be required 
before any such conclusions could be reached in relation to the overall drug market. 
Nevertheless, this does highlight the usefulness of regular data on price and purity 
indicators. 
 
The heroin purity results in Table 10.4.2 are based on a combination of bulk seizures 
and smaller seizures at street level. The figures suggest a slightly upward trend in 
heroin purity levels between 1999 and 2001, followed by a drop in purity in 2002. 
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Table 10.4.2   Average percentage purity of heroin seized 1993–2002 
Year 
 
Cases quantified 
 
n 
Packs quantified 
 
n 
Purity range 
 
% 
Average purity 
 
% 
1993 22 121 6–81 39 
1994 - - - - 
1995 15 42 26–76 46 
1996 29 89 26–78 49 
1997 32 78 7–78 46 
1998 - - 18–66 35 
1999 18 74 20–52 32.7 
2000 58 83 11–66 45.83 
2001 29 86 4.3–66 45.40 
2002 32 53 0.10–63 29.63 
Source: Forensic Science Laboratory 
 
Cocaine/crack 
Moran et al. (2001) recorded cocaine prices at €102 per gram in 2001. The GNDU 
reported cocaine being sold at street level in 2002 for between €90 and €110 per gram, 
averaging at €100 (Health and Children 2003). The research by the DMRD with key 
informants suggests street level prices of cocaine at approximately €80 per gram in 
2003. Recent media reports also suggest a similar price (‘Between The Lines’ Irish 
Examiner, 23 July 2003). All of the key garda informants interviewed by the DMRD saw 
some decrease in the price of cocaine during 2003. A similar finding was recorded 
among drug users. 
 
In a recent undercover police operation targeted at street-level drug dealing in a 
number of locations throughout Dublin city, a seizure of crack cocaine was reported. 
The operation, known as ‘Operation Clean Street’, involved garda members purchasing 
drugs from dealers. The operation led to the discovery of three rocks of crack cocaine, 
which were priced at €40 per rock (GNDU, personal communication, 2003). Customs 
also made three small seizures of crack cocaine in recent years (CDLE, personal 
communication, May 2004). 
 
Cocaine purity levels are reported as being lower in Ireland than elsewhere in the EU 
(EMCDDA 2003). However, a more systematic analysis of Irish cocaine purity would be 
required to confirm this. Table 10.4.3 shows cocaine purity levels for a selection of 
cocaine seizures quantified by the Forensic Science Laboratory between 1993 and 
2001. 
 
It should be noted, however, that these figures are based on a small number of 
samples and also that purity levels between different samples tested by the Forensic 
Science Laboratory appear to fluctuate significantly. For example, of the five cases 
tested in 2000, which involved 16 separate packs, the average purity was 22.76 per 
cent. The minimum purity was 1.8 per cent, while the maximum was 75 per cent. 
 93 
 
Table 10.4.3   Average percentage purity of cocaine seized 1993–2003 
Year Cases quantified 
 
n 
Packs quantified 
 
n 
Purity range 
 
% 
Average purity 
 
% 
1993 3 10 33–88 61 
1994 - - - - 
1995 3 5 22–85 47 
1996 2 2 34–90 62 
1997 5 14 33–72 54 
1998 - - 15–68 38 
1999 - - 26–78 41 
2000 5 16 1.80–75 22.76 
2001 4 13 0.12–49.5 25.78 
2002 2 15 15–33 24 
2003 26 - 7–82 36 
Source: Forensic Science laboratory 
 
Figure 10.4.1 shows trends in purity levels since 1993 for a selection of heroin, cocaine 
and amphetamine seizures. 
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Figure 10.4.1   Drug purity trends for specified drugs seized 1993–2002 
Source: Forensic Science Laboratory 
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Part B – Selected Issues 
11.  Buprenorphine: treatment, misuse and prescription 
practices 
 
11.1 Buprenorphine 
Description of new developments 
In June 2001, the Minister of State for Local Development with special responsibility for 
the National Drugs Strategy, asked the National Advisory Committee on Drugs (NACD) 
to undertake a review of the use of buprenorphine as an intervention in the treatment of 
opiate dependence syndrome.  As a result, the NACD commissioned a team of experts 
at the National Medicines Information Centre to conduct this review.  The review 
examined the of effectiveness of buprenorphine as a treatment option, its safety in use, 
as well as the practical and pharmacoeconomic considerations associated with its use 
(National Medicines Information Centre 2002).  Where appropriated the authors 
compared the treatment outcomes, safety issues and costs to methadone the mainstay 
of treatment for opiate dependence in Ireland.   
 
The methods employed in this study were: literature reviews, systematic reviews, case 
histories and an economic evaluation.   
 
The main findings are presented by chapter heading: 
 
Clinical pharmacology 
Buprenorphine is a partial opioid agonist. Its metabolic pathway suggests that there 
might be difficulties with drug interactions either with co-prescribed medications or co-
administered illicit drugs. The clinical relevance of these will be discussed in the other 
sections.  The toxicological studies show an acceptable margin of safety for use of 
buprenorphine in the management of opioid dependence 
 
Clinical outcomes 
Many clinical trials have been undertaken to evaluate the use of buprenorphine in the 
management of opioid dependency. 
In terms of its use in managed withdrawal, the studies were too heterogeneous to 
enable formal meta-analysis, but a systematic review suggested that buprenorphine 
had potential in this area.  
Similarly, the studies investigating the use of buprenorphine as substitution treatment 
used diverse protocols in terms of (a) dosage regimen (daily versus less frequent 
dosing), (b) dosage schedules (fixed versus flexible) (c) total dosage (2-8mg/day or 
higher) and (d) the formulation of buprenorphine used.  Moreover, studies varied in 
their non-pharmacologic treatment regimens, which could affect the endpoints and 
therefore introduce bias. Nevertheless, the results of a formal meta-analysis performed 
on six randomised controlled trials, using methadone as comparator, showed that high 
dose buprenorphine was similar to high dose methadone in terms of treatment 
retention with a small increase in positive urinalysis relative to methadone. Although 
the latter was statistically significant, it was not felt to be clinically relevant. It was not 
possible to determine the optimal dosing regimen although it was noted that less than 
daily dosing was feasible in clinical practice.  
From the data available it was not possible to determine whether buprenorphine was 
more suitable for specific sub-groups. There is some evidence to suggest that those, 
with higher psychosocial and global functioning are more likely to respond to 
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buprenorphine, but more studies are required to substantiate this. Data, available to 
date, on its use in pregnant women showed that buprenorphine was efficacious and 
safe for both women and infants but definitive recommendations on dosing regimens 
could not be deduced from the results of studies undertaken. 
 
Drug safety 
The safety data available to date suggest that buprenorphine has a known and 
predictable toxicity profile, related to its opioid agonist pharmacology and its 
interactions with other medicines. Although causality has not been proven, there is a 
warning regarding possible hepatotoxicity associated with use and it is recommended 
that liver function tests are regularly performed in patients receiving buprenorphine. 
The biggest problem to date appears to be the risk of fatal interaction with 
benzodiazepines. 
 
Buprenorphine has a known potential for abuse, because of its opioid effects. Studies 
from France suggest that abuse may occur in up to 30% of treatment subjects. It would 
appear from these studies that abuse is more likely in those subjects not closely 
supervised either by a physician or dispensing pharmacist.  
 
Costs 
The results from the pharmacoeconomic evaluation of the use of buprenorphine in the 
management of opiate dependence syndrome show that use of buprenorphine appears 
to be less cost-effective than the current methadone system. It may prove to be a cost-
effective treatment option in selected Irish settings (such as general practice), but 
further studies are needed to identify these settings. 
 
11.2 Treatment with buprenorphine 
The Irish Medicines Board authorised use of Subutex R in Ireland in August 2002 
(NACD 2002).  Subutex R is used to assist opiate users withdraw from opiates and is 
not prescribed as an opiate substitute in Ireland.  According to Dr Keenan detoxification 
using buprenorphine is available on request but considered more suitable for young or 
new opiate users (E Keenan, personal communication, 2003).  Data on the exact 
numbers of patients that received Subutex are not available.  The Irish College of 
General Practitioners provide accredited training, at two levels, covering the 
management of opiate users in primary care.  The published guidelines provided during 
this training contain a very brief but succinct overview of buprenorphine and states that 
this drug is an effective substitute and useful to assist withdrawals from opiates (Irish 
College of General Practitioners 2003).  It is also suitable for patients wishing to 
withdraw from methadone following a period of substitution.  The information in the 
document notes the risk of respiratory depression when buprenorphine is used in 
combination with alcohol or benzodiazepines.  There are no other written criteria to 
guide use of buprenorphine nor protocols for its use in Ireland.   
 
11.3 Misuse of buprenorphine 
In Ireland, buprenorphine misuse among the treated population is rare.  Of the 35,632 
cases reported to the National Drug Treatment Reporting System (NDTRS) between 
1998 and 2002, 51 (0.1%) reported that buprenorphine was a problem drug.  Between 
1998 and 2002, the number of cases who reported that buprenorphine was a problem 
drug decreased considerably, from eighteen in 1998 to two in 2002 (Table 11.3.1).   
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Table 11.3.1 Number (%) of cases reporting problem buprenorphine use and reported to the 
NDTRS, 1998-2002 
Treatment status 1998 1999 2000 2001 2002 
 Number (%) 
      
All cases 6048 6206 6933 7900 8596 
Buprenorphine a problem drug 18 (0.3) 18 (0.3) 10 (0.1) 3 (0.0) 2 (0.0) 
      
Source: Unpublished data from the NDTRS 
 
Of the 51 cases reporting buprenorphine as one of their four problem drugs, no case 
reported it as their main problem drug.  Only 32 cases reported a route of 
administration or frequency of use in the month prior to treatment for buprenorphine, 
and of these, half injected it and four had used it in the month prior to treatment.  All 
cases who reported using buprenorphine reported that another opiate (mainly heroin) 
was their main problem drug and this suggests that burpenorphine is use when their 
preferred opiate is not available.  Fourteen cases who reported buprenorphine was one 
of four problem drugs also reported benzodiazepines as a problem drug and this 
highlights a high-risk combination of drugs.  Of the 51 cases reporting buprenorphine 
as a problem drug 49 cases lived in Counties Dublin, Kildare and Wicklow while only 
two lived outside these counties.  Of the 51 cases reporting problem buprenorphine 
use, the vast majority were male (42, 82%), all were aged between 20 and 39 years 
old, two-fifths had left school early (21, 41%) and just under one quarter were 
employed (12, 24%).   
 
There are no data available on buprenorphine-related deaths.   
 
 
12. Alternatives to prison targeting to drug using offenders 
 
12.1 Political, organisational and structural information 
National Policy and Drug Strategy 
The need to develop alternative sanctions to prison has been recognised in many 
policy documents and reports over the past twenty years. Although policy documents 
do not always specify the link between such sanctions and drug using offenders, it has 
been widely accepted that many people are in prison as a result of offences committed 
as a consequence of drug addiction. This has been supported by research among the 
Irish prison population and among offenders known to the police as drug users (Furey 
and Brown 2004; O’Mahony 2004 1997; Millar et al. 1998; Keogh 1997). 
 
The following reports have emphasised the importance of using imprisonment as a last 
resort and encouraged the use of alternative sanctions: 
• The Prison Study Group (1973). An examination of the Irish Penal System 
Department of psychiatry, University College Dublin. 
• The Prisoners Rights Organisation (1980). Enquiry into the Irish penal System – 
The McBride Report. 
• Council for Social Welfare (1983). The Prison System Catholic Bishops 
Conference. 
• National Economic and Social Forum (1984). Criminal justice system – policy 
and performance. 
• The Whittaker Report (1985). Committee of inquiry-The Irish Penal system. 
• Department of Justice (1994). The management of offenders – a five year plan. 
• Department of Justice (1997). Tackling crime – Discussion paper. 
• Prison Service Operating Cost Review Group (1997). Report. 
• National Crime Forum (1998) Final Report.  
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• Expert Group on the Probation and Welfare Service (1999) Final report. 
• Oireachtas Sub-Committee on Crime and Punishment (2000). Report.  
• National Economic and Social Forum (2002) Re-integration of prisoners. 
• Comptroller and Auditor General (2004) The Probation and Welfare Service. 
 
Indeed, it could be argued that there is an overwhelming policy consensus that 
alternatives to prison should be used where possible. This consensus has now been 
placed on a statutory footing, at least for minors, in the recent Children Act, 2001.  
 
The National Drug Strategy 2001-2008 has two relevant references in this area 
(Tourism, Sport and Recreation 2001) With relevance to the pre-trial stage, Action 13 
aims: ‘To monitor the efficacy of the existing arrest referral schemes and expand them, 
as appropriate’. With regard to the trial stage Action 20 aims: ‘To have in Local Drug 
Task Force areas an ‘early intervention system, based on the Drug Court Model, if the 
evaluation of the pilot in the North Inner City of Dublin is positive. This should be 
accompanied by appropriate familiarisation for the judiciary of the role of the Drug 
Court’. 
 
Legislation 
Section 28 of the Misuse of Drugs Act, 1977, called for probation and medical reports 
to be made available to the court prior to sentencing. These reports were obligatory up 
until the Misuse of Drugs Act 1984, when the reports became an option for the trial 
judge. An order under Section 28 could involve the court releasing the offender subject 
to the condition that he or she attend a treatment center. 
 
The Children Act, 2001 sets out a number of general principles to guide courts in 
dealing with children. These principles are biased towards rehabilitation and the 
discouragement of custody for child offenders. The Act emphasizes prevention and the 
diversion of young offenders from prosecution, it raises the age of criminal 
responsibility from seven years to twelve years, puts the Juvenile Diversion Scheme 
currently being operated by the Garda Síochána on a statutory footing and introduces 
elements of a restorative justice approach to the criminal justice system, including 
Family Group Conferencing. Underlying the Act is the principle that detention should 
only be used as a last resort (Dooley and Corbett 2002). Also, judges will be required 
to seek pre-sentencing reports from the Probation and Welfare Service (PWS) in all 
cases involving persons under 18 years of age where the judge is considering a 
custodial sentence or community sanction. Although certain provisions of the Act were 
introduced in May 2002 (SI 2002/151) most of the Act’s provisions await 
implementation. As a consequence, while many commentators have welcomed the 
overall thrust of the Act, the government has come in for criticism due to delays in its 
implementation.  The provisions of the Act relating to functions by officers of the PWS 
have not yet been brought into effect (Comptroller and Auditor General 2004) 
 
O’Mahony (2002, p. 9) suggests that the Children Act could ‘potentially revolutionise 
the area of juvenile justice’. However, he is also critical for what he sees as a 
continuation of criminal justice approaches inconsistent with the principles of the Act. 
For example, in April 2002, following the death of two members of the Garda Síochána 
in a juvenile-related ‘joyriding’ incident, the Minister for Justice announced plans to 
open a new wing in St Patrick’s Institution for 14–15-year-olds (Dooley and Corbett 
2002). O’Mahony (Irish Times  2003, 3 October) stated that this initiative ‘totally 
undermined the basic principle contained in the Act, which was not to jail under 15-
year-olds’. 
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Implementation structure 
The agencies involved in the operation of alternative sanctions in Ireland include the 
Garda Síochána and the Probation and Welfare Service (PWS). The Garda Síochána 
have a role in the operation of juvenile diversion schemes and also in relation to 
restorative justice interventions. The main functions of the PWS in this area are to 
provide the courts with advice and information on offenders to assist in sentencing 
decisions; to implement and enforce community sentences passed by the courts and to 
design and provide effective programmes for supervising offenders safely in the 
community for public protection (Comptroller and Auditor General 2004, Vaughan 
2001, Expert group on the Probation and Welfare Service 1999). 
 
Many of the alternative sanctions in operation in Ireland are not on based on legislation 
but have evolved over time in the form of judicial practice. For example, almost half of 
the offenders referred for supervision by the PWS in 2000 were supervised by the 
Service without formal court orders being made. In these cases sentence is deferred by 
the judge for a stated period. Most reports to courts are also provided on a non-
statutory basis. 
 
12.2 Interventions 
Types of interventions - Pre-trial stage 
Arrest referral and juvenile diversion 
The main aim of arrest referral schemes is to provide information to arrestees about 
appropriate services and to facilitate referral to treatment at the primary points of entry 
into the criminal justice system – usually police cells or court premises. Arrest referral is 
an intervention aimed at people who have been arrested and whose offences may be 
linked to drug use. Such policies are premised on the idea that treatment will lead to a 
reduction or cessation of illicit drug use and thus reduce or negate further drug-related 
offending by the drug user. 
  
Action 13 of the National Drugs Strategy 2000 – 2008 obliges the Garda Síochána to 
‘monitor the efficacy of the existing arrest referral schemes and expand them, as 
appropriate’ (Tourism, Sport and Recreation 2001). A pilot juvenile arrest referral 
scheme has been established in a police station in Dublin’s north inner city. This is a 
joint initiative between the Garda Síochána, the Northern Area Health Board and the 
North Inner City Drugs Task Force. This pilot project is currently in the process of being 
evaluated. It is intended that the evaluation be used ‘as a tool for formalising policy on 
juvenile/adult arrest referral between agencies’ (NICDTF 2003). 
 
Types of intervention - Trial stage 
There are a number of different non-custodial options open throughout the trial process 
to judges to dispose of drug offences and drug-related offences.   
Suspended sentence – Butler Orders and Orders of Recognisance (Misuse of Drugs 
Act 1977)  
A suspended sentence occurs where the court, having passed a sentence of 
imprisonment for a specific term, suspends its operation. Although this option is used 
widely there is no statutory authority in Ireland enabling the court to suspend the 
operation of a prison sentence. Walsh (2002) highlights the fact that a suspended 
sentence must be seen as an alternative to prison. It should not be imposed, therefore, 
‘where the gravity and circumstances of the offence taken by themselves would not 
have warranted a prison sentence’ (p. 1033). There is no publicly available information 
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on the number of suspended sentences imposed in any one year. Usually, a sentence 
of imprisonment will be suspended upon the offender’s entering into a recognisance to 
keep the peace and be of good behaviour for a specified period. A Butler Order, which 
derives its name from the decision of Butler J in State (Woods) v. Attorney General 
(1969, p. 385), arises where a court imposes a lengthy sentence with a direction that 
the offender be brought back to the court having served a portion of the sentence. It is 
then up to the judge to decide what to do with the remainder of the sentence. Walsh 
(2002, p. 1033) makes the observation that this form of suspended sentence has 
become increasingly popular ‘as a means of building in an element of rehabilitation to a 
custodial sentence, particularly in respect of a young person or a person with an 
addiction’. There is some uncertainty as to the constitutional validity of Butler Orders. 
This issue has not been fully determined by the Supreme Court. However, following 
consideration of the orders by the Supreme Court in the People (DPP) v. Finn (Butler 
2001, p. 25), it appears likely that Butler Orders represent a constitutionally invalid 
exercise of judicial power.20  
 
Another form of suspended sentence provided for by statute is an Order of 
Recognisance as set out in Section 28 of the Misuse of Drugs Act 1977. This order 
requires an offender to undergo treatment for his or her drug condition in a residential 
center or in the community. Within Section 28 (MDA 1977) there is also the possibility 
of sentencing a person to a custodial treatment center for up to one year. Under 
Statutory Instrument 30 of 1980, the Central Mental Hospital in Dundrum was 
designated the custodial treatment center. Charleton and McDermott (1998) point out, 
however, that between 1977 and 1998 only two persons were sentenced to custodial 
treatment by an Irish court. The non-custodial option in s.28 has also been used 
infrequently by the courts. Between 1995 and 1999 only five MDA Orders of 
Recognisance were recorded by the Probation and Welfare Service, which has a 
supervisory role in this area (Probation and Welfare Service 2001). 
 
Moran et al. (2001) suggest that the reason the courts have been reluctant to exercise 
this option is because the necessary rules and regulations have not been made. In 
order to facilitate the greater use of this sentencing option, the Expert Group on the 
Probation and Welfare Service has recommended that ‘the necessary Courts Rules 
and Regulations be updated by the various Court Rules Committees’ (Probation and 
Welfare Service 1999, p. 49). 
 
Adjournment of sentence 
The court may adjourn a prison sentence for a certain time to see how the offender 
behaves. Although this practice has no statutory footing, there is usually an expectation 
that the offender will take some intervening action, such as undergoing a treatment 
programme in a drug-related case. The court, when it comes to reconsider the matter, 
may proceed with the originally intended sentence in the event that it is not satisfied 
with the offender’s progress in the interim period. 
 
Probation orders, Intensive Community Supervision (ISP) and Supervision During 
Deferment of Penalty 
A probation order is a formal warning to an offender that if he or she does not abide by 
conditions imposed by the court for a specified period he or she will be brought back by 
the court for punishment. These orders are usually supervised by a probation officer. 
The Probation and Welfare Service was involved in 118 such supervision orders in 
respect of offences under the Misuse of Drugs Act in 1999, the last year for which 
figures are available (Probation and Welfare Service 2001). Intensive Community 
                                                
20 For a discussion of this judgment see Walsh (2002,  p. 1035). 
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Supervision was designed to provide increased controls on the offender in the 
community. Intensive Supervised Probations for young offenders with drug-related 
problems are currently provided via the Bridge project and the Tower project in 
Dublin.21 
 
Although orders for Supervision During Deferment of Penalty have no statutory basis, 
such orders are used where the court is unsure as to an offender’s capacity to 
participate in community-based programmes while avoiding further crime. At a later 
hearing, a report is presented to the court on the progress of the offender. In 1999, 192 
such orders were issued in respect of offences under the Misuse of Drugs Act 1977. 
 
Community Service Orders 
Community Service Orders (CSOs) involve the imposition of a sentence to a 
programme of work in the community as an alternative to imprisonment. The sanction 
is available only in respect of offenders over 16 years of age who have been convicted 
of a criminal offence. Any court exercising a criminal jurisdiction, except for the Special 
Criminal Court, can apply a CSO. However, the vast majority are applied by the District 
Court. 
 
Implementation 
In Ireland, in 2002, there were approximately 4,100 persons under supervision in the 
community, compared to a daily average of approximately 3,200 prisoners – ration of 
1.3 : 1. Between 1995 and 2002, the estimated total number of persons under 
supervision increased by half, and there was a similar increase in the prison 
population. Thus alternatives do not appear to be displacing imprisonment. Despite the 
broad consensus reported earlier, there does not appear to have been any increase in 
the use of alternatives to prison relative to custodial sanctions between 1995 and 2002 
(Comptroller and Auditor General 2004). 
 
Furthermore, if we consider the number of committals, the prison flow, in a given year 
rather than the daily prison population, the prison stock, it is clear that many of those 
sentenced to prison in Ireland have committed minor offences and have received short 
sentences. The National Economic and Social Forum (NESF) report states: ‘while there 
are about 3000 prison spaces, in the region of 11000 committals are made each year’ 
(NESF 2002, p. 37). Almost half of all adults imprisoned receive less than three 
months; in three-quarters of cases the sentence was less than one year. 
 
Although we do not have detailed follow-up data on prisoners to assess recidivism 
rates, a survey of prisoners found that each had accumulated an average of 14 
convictions and 10 separate prison sentences (O’Mahony 1997). A study of 150 young 
offenders found that half were serving their first sentence, of those who had served a 
previous sentence 53 per cent had been in prison on one previous occasion, 19 per 
cent had served two previous sentences and 27 per cent had served three or more 
sentences (Geiran et al. 2000). 
 
Main obstacles to implementation 
Despite the broad consensus that prison should be used as a last resort and that 
alternatives to prison should be used more often, a number of factors have been 
identified in the literature which contribute to an explanation as to why such sanctions 
are not being used more frequently in the Irish criminal justice system. In determining 
whether non-custodial sanctions are replacing imprisonment, we must not lose sight of 
                                                
21 For a description of these projects see http://www.emcdda.eu.int/responses/methods_tools/eddra.shtml 
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the context in which sanctions are applied and the factors which impact both on the 
sentencing process and therefore on the prison rate. We need to be able to isolate 
these other variables on sentencing and imprisonment practice. 
 
The National Economic and Social Forum (NESF) was established by the government 
in 1993 for the purpose of achieving consensus on major economic and social policy 
initiatives. Its membership is drawn from the Irish parliament; An Oireachtas; employer, 
trade union and farm organisations; central and local government; and the voluntary 
and community sector. The NESF has recently considered the possible reasons why 
alternatives to custody have not been introduced more in practice (NESF 2002). 
 
Political influence and the prison rate 
NESF highlight the complexity of policy implementation in the area of criminal justice 
and the particular problems arising here:  
 
On the one hand, there is consensus that prison should be a last resort, while on the 
other, there is strong support for the current prison-building programme, during a period 
when recorded crime is on the decrease, but fear of crime remains high. Policy 
implementation issues in this area tend to be more political than usual, as likely (or 
even more so) to be more influenced by various interpretations of public opinion and 
media reaction rather than by the findings of empirical research, lessons emerging from 
practical experience or financial considerations such as value for money (NESF 2002, 
p.35). 
 
The role of political considerations rather than crime rates or evidence-based analysis 
of sentencing practices in determining the number of prison cells built is a theme taken 
up by other contributors in this area (O’Donnell 2004, O’Sullivan and O’Donnell 2003). 
A recent emphasis on a repressive approach to penal policy during the 1997 election 
campaign was contributed to in particular by the drug-related murder of a high profile 
investigative journalist. A subsequent expansion in prison building was situated within 
the context of a ‘zero tolerance’ approach to crime (O’Sullivan and O’Donnell 2001).  
As a consequence, despite a downward trend in recorded crime figures between 1995 
and 2000, the Irish prison population increased by 40 per cent. 
 
Vaughan (2001, p.12) also points to the high rate of imprisonment in Ireland: ‘What 
does seem indisputable is that Ireland relies upon imprisonment to a far greater degree 
than in most other Western European countries.’  
 
A recent referendum on the bail laws led to the Bail Act, 1997, which increases the 
grounds on which bail can be refused by the courts and which became operational in 
2001 has led to an increase in the prison remand population (O’Donnell 2004, NESF 
2002). A trend towards longer sentences has also been identified recently (O’Donnell 
2004, NESF 2002, Vaughan 2001). As against these negative trends, O’Donnell 
identifies a slight reduction in the number of prison committals under sentence by the 
District Court in the latter half of the 1990s, despite the increase in the prison 
population due to the bail laws and the reduced use of temporary release. He 
questions whether this trend will continue however, given, among other things, the 
increased incarceration of non-nationals in Ireland. 
 
The NESF report also highlights the fact that approximately one quarter of the Irish 
prison population is under 21 years of age. Ireland had, according to Vaughan (2001, 
p. 31) ‘the second highest proportion of prisoners under 18 (6.2%) of 40 Council of 
Europe countries surveyed in 1997.’  Identifying the poor correlation between prison 
population and crime rates, the NESF identifies the need to determine an appropriate 
level of imprisonment and to limit additional prison building. 
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Resource allocation 
The NESF also identifies staff and resource shortages in the Probation and Welfare 
Service. In 2001, the PWS budget was about 15 per cent of the Prison Service 
operations budget - €171 million (excludes €34 million for prison capital spending) 
compared with €25 million. The NESF also identifies significant staff shortages in the 
PWS, with over 3,000 prison officers compared to a staff of only 310 in the PWS. The 
NESF recommends that targets should be set to enhance the resources and functions 
of the PWS, for example reduced staff/client ratio. 
 
Judicial practices and priorities 
Many of the alternative sanctions applied in the Irish Criminal Justice System are not 
based on statute but have evolved as judicial practice. Generally speaking, the 
determination of what sentence to impose in any individual case is an exercise of 
judicial power. In order to assess the degree to which alternative sanctions are being 
applied in relation to custodial sanctions, it is necessary to be aware of the many 
variable factors which influence the judicial process.  
 
The decision of the court in this respect may be influenced by a pre-sanction report 
which is compiled by the Probation and Welfare Service and which might highlight 
factors such as drug addiction as a contributory factor in explaining the offender’s 
behaviour. 
 
The judge is not entirely free to impose whatever decision he or she decides in an 
individual case. Walsh (2002) suggests that the judge must exercise such discretion 
fairly and in keeping with case law and judicial principles and practices as have evolved 
over the years. A failure to follow such principles can lead to successful appeals 
against sentence. A problem which arises in this area, however, is that these principles 
have not been expressly laid out either by statute or in the form of judicial guidelines 
(Bacik 2002). Furthermore, the judiciary has been extremely reluctant to allow itself to 
be circumscribed by the legislature in terms of its freedoms in this area. In The People 
(DPP) v. Gannon22 the Court of Criminal Appeal set itself against the principle of 
sentencing guidelines or tariffs: ‘We put great store on the fact that each case must be 
considered in its individual frame, while being mindful that a sentence must be 
proportionate to the offence in question and to other sentences imposed in similar 
situations – though it needs to be emphasized, that very rarely will two cases be 
exactly alike.’ A survey of 17 District Court Judges conducted by Vaughan (2001, p. 
127) found a ‘general belief among judges that ‘each judge should be left to their own 
devices’ because “circumstances differ so often.”‘ 
 
A number of factors have been seen to impact on the types of sentences handed down 
in relation to drug offences. These might include the type of drug, the quantity of drugs 
found in the offender’s possession, whether the drugs were for personal consumption, 
and the circumstances of the offender. Also, where the accused assists the authorities 
in the investigation and prosecution of further offences, this will be seen as a mitigating 
factor in sentencing. 
 
Cannabis has always been treated differently under the Misuse of Drugs Act 1977. 
Section 3 makes it an offence for a person to have a controlled drug in his possession. 
Section 27 of the Act, as amended by Section 6 of the Criminal Justice Act 1984, 
stipulates that, where the substance is cannabis and the court is satisfied that the 
defendant possessed it for his or her own use, the penalty should be a fine on the first 
                                                
22 Court of Criminal Appeal, 15 December, 1997. Quoted in Charleton P and McDermott (1998) 
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offence up to a maximum of €380 on summary conviction and €635 on indictment 
(Connolly 2004). The supply of drugs within a small circle of friends has been held to 
be a mitigating factor, while the presence of a commercial motive, even where friends 
are involved, has been seen as an aggravating factor (Charleton and McDermot 1998). 
The operation of judicial discretion in this area has caused some controversy in the 
context of the introduction of a mandatory minimum sentence for certain drug offences. 
Section 4 of the Criminal Justice Act 1999 inserted a new section, 15A, into the Misuse 
of Drugs Act 1977. This new section introduced the specific offence of possession of 
drugs with a market value of £10,000 (€12,700) and applied for the first time the 
principle of a mandatory minimum sentence with respect to these offences.23 However, 
from a review of the case law, Ennis (2003) found that the Court of Criminal Appeal 
‘has showed a general reluctance to impose the mandatory minimum sentence in 
practice.’ (see section 1.2).  
The age and other circumstances of the offender may also be a factor in sentencing. 
With regard to offences committed to feed a drug habit, Charleton and McDermott 
(1998, p. 347), in a consideration of the judicial response to such cases, conclude that, 
‘Irish courts have struggled … with the concept of drug addiction as mitigation. 
Differences have been drawn between the cold-blooded non-user of drugs and those 
who commit various crimes in order to finance their needs.’ However, the primary 
concern of the courts has, they suggest, been the criminogenic effects of drugs from 
the point of view of the public, with the personal circumstances of the offender being of 
secondary consideration. 
Another factor which has been identified relates to the reluctance of the judiciary to 
apply alternative sanctions. This has been seen recently in the context of a 20 per cent 
decline in the use of Community Service Orders between 1992 and 2001 (Vaughan 
2001). Vaughan (2001, p. 75) suggests that, although it is unclear why this reduction 
has taken place, ‘some judges have expressed frustration with the difficulty of obtaining 
insurance for these projects, as the state will not cover the cost’. A sample survey of 
seventeen District Court Judges conducted by Vaughan (2001) asked questions about 
the judicial willingness to apply community-based sanctions. Judges appeared to be 
positively disposed to the use of the PWS. However, there was a reluctance to use the 
PWS due to the under-resourcing of the latter, a factor which was seen to undermine 
the efficacy of such sanctions. 
 
Vaughan (2001, p. 28) suggests that the dramatic increase in prison committals since 
1992 must be explained ‘by a greater recourse to custody by the judiciary’. This only 
led to a noticeably larger prison population after 1997, he suggests, due to the 
reduction in the use of temporary release, a discretionary power of the Minister of 
Justice which can affect the number of people retained in prison. This was a 
controversial policy whereby prisoners were being released after serving only a small 
portion of their sentence due to the pressure of space for new inmates. This became 
known as the ‘revolving door’ syndrome. The recent prison-building programme has led 
to a reduction in the use of temporary release. In July 1996, 19 per cent of serving 
prisoners were on full temporary release, compared to seven per cent in 2000 
(O’Sullivan and O’Donnell 2003). O’Donnell (2004, p. 257) also identifies ‘a strong 
orientation towards custody among Irish judges’. Mc Cullagh (1992, p. 17) concludes: 
‘the increased punitiveness of the Irish judiciary…has created the crisis in the prison 
system’. He suggested that their social background renders them unable to understand 
the circumstances of the offenders they routinely confront and more susceptible to 
‘punitive-minded’ views from within their own social circle and in the media, described 
as ‘their major source of access to the nature of “public opinion” ‘. 
                                                
23 Misuse of Drugs Act 1977, Section 27(3B), as inserted by Criminal Justice Act 1999, Section 5. 
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Along with this alleged judicial orientation towards incarceration, another study has 
suggested that the tendency to imprison is directed disproportionately towards specific 
deprived sections of society. A study by Bacik et al. (1998) suggests a degree of bias in 
the way in which Irish courts respond to particular defendants. The study, which sought 
to examine links between economic deprivation and crime, looked at court appearance 
and sentencing patterns. The study found that age, sex and level of community 
deprivation were key factors predicting the likelihood of court appearance. Secondly, 
the study found that defendants from more economically deprived areas were 49 per 
cent more likely to receive a custodial sentence than those from less deprived areas, 
once other variables were accounted for. This study did not focus on specific crimes; 
however, given the acknowledged link between economic deprivation, problematic drug 
use and crime, it can be assumed from the study that many of those sent to prison from 
deprived areas have committed crime as a consequence of their drug addiction. 
 
However, a recent study by Riordan (2000) looked at the practice of the Dublin District 
Courts when dealing with drug-related offenders. As part of his study, he convened a 
focus group of district judges, in order to ascertain their attitudes with regard to 
sentencing in drug-related cases. The study found that the practices in the courts in 
dealing with drug-related offenders is different than where drugs is not an issue with 
judges clearly favouring the adjourned supervision as a way of monitoring drug related 
offenders. 
 
O’Donnell (2004) also identifies differential patterns of sentencing in different parts of 
the country. A comparison of Limerick and Dublin case management found that in 
Limerick, for larceny, assault and public order offences, immediate incarceration was 
more common than probation and community service combined whereas in Dublin, 
probation was more commonly used than immediate imprisonment. O’Donnell (2004, 
259) concludes that either ‘Limerick court is more punitive; or that it deals with more 
serious offences; or that it has less access to community sanctions and measures’. 
Other obstacles 
O’Donnell (2002, p. 84) lists a number of other possible reasons why progress can be 
slow in introducing criminal justice reforms, even where a consensus appears to be 
firmly established. These include: institutional pessimism; bureaucratic inertia; 
problems of definition and measurement; political and moral considerations; the 
disputed nature of social “facts”; unclear lines of accountability; industrial relations 
problems and poorly designed evaluations from which generalisation is difficult.  
 
Funding 
A recent financial assessment of the Probation and Welfare Service, which has 
responsibility for managing offenders in the community, conducted by the Comptroller 
and Auditor General (2004) considered the cost effectiveness of community-based 
sanctions. The report also highlights a number of problems in relation to assessing 
costs. Where for example, supervision in the community is designed as an alternative 
to prison, as in the case of community service orders, and the judiciary imposes such 
sanctions where custodial sentences would not otherwise have been imposed, the 
result is what is referred to as a ‘net widening’ effect. The report points out: ‘In cases 
where a custodial sentence would not have been imposed, there is no financial cost of 
alternative imprisonment’ (Comptroller and Auditor General 2004, p.48). Also, where an 
offender fails to meet the conditions of a supervision order and is subsequently 
imprisoned, both the costs of the supervision order and of imprisonment may be 
incurred. There was insufficient information available to calculate similar estimates in 
relation to probation orders and supervision during deferment of penalty. However, in 
relation to Community Service orders, the report concluded: ‘The cost of imposing 
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community service orders is estimated at around one-third of the cost of custodial 
alternatives’. 
 
Treatment  
Data provided by the National Drug Treatment Reporting System provides information 
on the numbers referred to treatment from the criminal justice system in general. Data 
is not available as to the precise stage of the criminal justice system from which the 
client is referred. Table 12.2.1 provides the total number and percentage of those 
referred to treatment from the criminal justice system. 
 
Table 12.2.1   The number (%) of cases referred to drug treatment from the criminal justice system 
 1998 1999 2000 2001 2002 Total 
Court/ probation/ 
police 
518 (8.8%) 427 (7.1%) 439 (6.5%) 480 (6.4%) 598 (7.4%) 2462 (7.2%) 
Total referrals 5862 5993 6754 7532 8116 34257 
Source: National drug treatment reporting system. 
 
The main types of treatment provided include: de-toxification (opiates/ 
benzodiazepines/ alcohol); substitution (methadone); medication free treatment (12-
step approach); therapeutic communities (medication free – behavioural model); 
counselling (crisis/ psychological – which can and are generally used in conjunction 
with the above treatments) 
 
As shown in Table 12.2.1, in 2002 only 7 per cent of the total number of referrals to 
treatment originated in the criminal justice system. 
 
Procedures for monitoring treatment programmes are not publicly available. However, 
a recent study conducted among drug users suggested the existence of perceptions of 
informal and arbitrary punishments of drug users for non-compliance with programmes 
(UISCE 2003). 
 
A recent evaluation was conducted of a methadone maintenance clinic in Dublin. The 
study attempted to measure the levels of effectiveness in terms of clients outcomes 
while undergoing treatment (Lawless and Cox 2003). A questionnaire was 
administered to clients who were registered at the centre in 1999 and then again to 
those who remained on treatment eighteen months later: 
 
At baseline stage, over half of clients (57%) reported having being in prison at some 
point in time. At follow-up stage the findings included the following: 
• Improvements in the extent of drug using risk behaviour among clients; 
• Reduction in quantity and frequency of both licit and illicit drug consumption; 
• Increase in sexual risk behaviour among clients; 
• Reduction in frequency of criminal activities undertaken by clients; 
• Improvements among clients in relation to social functioning; 
• Marked decrease within a range of psychiatric complaints especially with 
regards to reported levels of anxiety among clients  
 
Specific target groups 
There are procedures in place to enable the Gardaí to divert juvenile offenders (those 
under 18 years of age) found in possession of small quantities of drugs, where drug 
trafficking is not an issue, away from the judicial process. The Garda Juvenile Diversion 
Programme was initiated in 1963. The programme allows that, if certain criteria are 
met, a juvenile offender may be cautioned as an alternative to being prosecuted. In 
order for a juvenile to be eligible for caution he or she must be under 18 years of age, 
 106 
must admit involvement in the crime or offence, must not have been cautioned 
previously (or if so, it must be deemed appropriate to administer a further caution), and 
the parents, guardians or person acting in loco parentis must agree to the terms of the 
caution. Whereas up until 2001 the programme operated on the basis of the common 
law principle of police discretion, the Children Act 2001 has now placed it on a statutory 
footing. 
 
Juveniles cautioned under the programme may be subject to supervision by a juvenile 
liaison officer (JLO). Supervision may involve a range of activities and involve other 
statutory or voluntary organisations with appropriate expertise to respond to the 
particular matter. The Children Act 2001 also introduces restorative justice principles to 
the operation of the system. There is now a process whereby the offender and the 
injured party can be brought together to discuss the offence and its related impact on 
the injured party. In the context of so-called victimless crimes, such as simple 
possession of cannabis for example, identifying the injured party is a matter of some 
controversy. 
 
As these represent early interventions, it is not clear whether they can be described as 
alternatives to custody. Also, data produced annually by the police in relation to 
juvenile diversion programmes does not provide information on whether the offence is 
drug related, as distinct from a drug offence. 
 
Specific projects 
 
The Drug Court 
The Drug Court (Farrell 2002) initiative is based in the District Court. The jurisdiction of 
the Drug Court is confined to persons over the age of 17 years who have been 
convicted of or have pleaded guilty to certain non-violent offences, deemed to have 
been committed in order to feed their drug habit.  The Drug Court was established on a 
pilot basis in Dublin’s north inner city in February 2001. On conviction, the offender is 
offered the alternative of a prison sentence or a supervised drug treatment programme. 
Walsh (2002, p. 54) describes the Drug Court as the District Court operating ‘a novel 
sentencing jurisdiction. The emphasis is on therapeutic rehabilitation as distinct from 
punishment.’ 
 
Monitoring 
Compliance with the Drug Court programme in terms of treatment is generally 
assessed by Drug Courts through urinalysis. One of the conditions of the Drug Court is 
mandatory urine analysis, generally on a weekly basis. As the participant progresses 
successfully through the programme the frequency of the urine testing is reduced. 
 
In the first twelve months the Drug Court Judge imposed numerous sanctions 
including: 
• Registering on a daily basis at the local garda station; 
• Imposition of a curfew, for example from 8pm to 8am;.  
• Revocation of bail for a period of days; 
• Verbal warning of a curfew; 
• Increased court appearances. 
 
The Judge also rewarded the participants for satisfactory progress with a range of 
incentives: 
• Reduces court appearances; 
• Removal of curfew; 
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• Week off court; 
• Gifts appropriate to the participant. 
 
12.3 Quality Assurance 
Guidelines 
Police guidelines 
A series of guidelines have been established for the Garda Youth Diversion Project 
(Ryan et al. 2002). The purpose of these projects is to divert young people from 
becoming involved (or further involved) in anti-social and/or criminal behaviour. They 
should not necessarily be regarded as alternatives to prison. The purpose of the 
guidelines is to act as a benchmark against which applications for new projects can be 
assessed. The guidelines cover four primary areas: 
• the establishment of projects; 
• the ongoing operation of projects including procedures identification; 
• management structures and administrative procedures; 
• monitoring and evaluation structures. 
 
Judicial guidelines 
The principles applied by judges when sentencing have not been expressly laid out 
either by statute or in the form of judicial guidelines. Vaughan’s sample of judges in the 
District Court asked whether judges had statistics regarding sentencing: 
 
Table 12.3.1   Judicial access to statistics regarding sentencing 
 Yes No 
In your own court 4 12 
In other courts 1 14 
Source: Vaughan (2004, p.127) 
 
Vaughan (2001 p. 127) concludes from this survey that ‘not only are the majority of 
judges not able to review their own work, although some judges may operate their own 
review procedures, they are also unable to compare it to those of their colleagues. The 
judges may unwittingly be imposing different sentences for similar offences’.  
  
Evaluation and research 
A major obstacle to evaluating the impact of alternatives to custody is the inadequacy 
of data in the criminal justice system. This is relevant at each stage of the criminal 
justice system. The absence of an integrated data system throughout the different 
stages and between the different agencies of the system is particularly problematic in 
an area where we are seeking to trace the progress of offenders through the system.  
 
Among the problems encountered are the following: 
• It is not possible to track offenders through the system. 
• There is no regular information on sentencing practices. 
• There is no regular data on recidivism rates. 
 
A number of difficulties have been identified in relation to data throughout the criminal 
justice system in Ireland (O’Sullivan and O’Donnell 2003; Bacik 2002; O’Donnell and 
O’Sullivan 2001; O’Malley 2000; McCullagh 1996). Also, the report by the Comptroller 
and Auditor General on the PWS states that: ‘In practice, the Service has very poorly 
developed management information systems. This is compounded by the lack of 
relevant statistical information from other parts of the criminal justice system on a 
consistent basis’ (Comptroller and Auditor General 2004, p. 51). The issue of crime 
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statistics has recently been considered by the government-appointed Expert Group on 
Crime Statistics. This committee has reviewed the data problems throughout the 
system and  presented its recommendations, along with a minority report, to the 
government (Expert Group on Crime Statistics 2004, 2004a). 
 
The report of the Comptroller and Auditor General on the PWS points to the lack of 
evaluations on alternatives to custody: ‘Neither the Department (of Justice, Equality 
and Law Reform) – which oversees the operation of the criminal justice system – nor 
the (Probation and Welfare) Service has carried out evaluations of the relative 
effectiveness of the different forms of sentence’ (NESF 2004, p. 47). Specific studies 
have been conducted on the operation of the Garda Restorative Justice projects 
(O’Dwyer 2001), the pilot Drug Court (Farrell 2002) and the Community Service Orders 
(Walsh and Sexton 1999). Vaughan (2001) conducted a study on the attitudes of a 
small sample of District Court Judges on their attitudes to penalty.  
 
A review of a Garda Sióchána restorative justice pilot programme in 2001 reports that, 
of the 68 cases reviewed, six cases involved drug possession (O’Dwyer 2001). Three 
of these led to a caution and three to a family group conference. Of the 20,647 
offences in respect of which juveniles were referred in 2002; 1,054 (5.1%) were for the 
possession of drugs and 154 (0.7%) were for the sale or supply of drugs (Garda 
Síochána 2004). It can also be assumed that many other referrals were for drug-related 
offences, involving theft or burglary for example. Although serious crimes were dealt 
with, offences which could result in a prison sentence, the study did not specify 
whether restorative justice conferences were used in drug-related offences, as distinct 
from drug offences, or whether it would be appropriate in relation to serious drug users. 
 
As discussed above, an evaluation of the operation of the pilot Drug Court was carried 
out by Farrell (2002). Of the 61 offenders who were referred to the Drug Court in its first 
year of operation, 37 were deemed suitable to enter the programme (Farrell 2002). The 
participants were primarily male, in their late 20s and unemployed, with a low level of 
educational achievement. Between them, 35 of the participants had a total of 872 prior 
convictions and the majority were deemed to present a ‘very high risk of reconviction’ 
(p. 5). The main drug of addiction of the participants was heroin. Overall, participants 
were using an average of five different illicit drugs at the time of entering the 
programme. 
 
The main findings of the Farrell study indicated that, although a number of participants 
continued to offend while in the programme, the rate at which participants were 
arrested, charged and had their bail revoked declined the longer they were in the 
programme. In terms of substance abuse, the percentage of those testing negative for 
opiates increased significantly as the programme progressed, from 42 per cent over 
the first three months to 82 per cent in the last three months. Although no graduations 
had been anticipated during the pilot period, compliance had improved significantly and 
11 of the 37 participants (30%) were clean of all illicit drugs by the end of the evaluation 
period. All of those interviewed as part of the evaluation believed that there continued 
to be a strong rationale for the continuation of the Drug Court. However, the low 
number of referrals and the absence of an agreed mission statement and clear identity 
for the Drug Court were identified as issues which needed to be addressed. 
  
The most significant obstacle to progress identified by the evaluation is the difficulty 
encountered in providing participants with access to full and timely treatment services. 
According to the report, ‘Many stakeholders believed that the Drug Court cannot 
continue to operate without access to full treatment within a reasonable time period’ (p. 
5). A marked decline in offending behaviour and an increase in compliance as the pilot 
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progressed suggest, according to the report, ‘that the Drug Court will have the desired 
impact if it can succeed in retaining participants over the early months’ (p. 6). 
 
Research limitations of the study prevented an adequate examination of the 
programme’s economic benefits. However, the report identified a number of areas 
where the efficiency and effectiveness, and ultimately the economics, of the 
programme could be refined. Furthermore, the authors concluded that, should the Drug 
Court reduce recidivism, significant long-term savings to the criminal justice system 
would be made.  The Minister for Justice, Equality and Law Reform has supported the 
recommendation in the report that the Drug Court should be continued and it has now 
been extended to another part of the city: the Dublin 7 area. 
 
Technically, the Community Service Order (CSO) should only be applied in cases 
where a custodial sanction would otherwise have been applied. However, a study by 
Walsh and Sexton (1999) found evidence of a more flexible approach being adopted by 
the courts and some evidence of a ‘net-widening’ effect whereby people who would not 
have received a prison sentence were being sentenced to CSOs. The authors recorded 
evidence of a ‘feeling among some judges and other practitioners in the field that 
legislation was too restrictive in confining CSOs as a substitute for a prison term’ (p. 
97). Of the 269 offenders they studied who had been served a CSO, they found that 
almost half did not have a previous criminal conviction and the most frequent offences 
committed were road traffic offences, public order offences and less serious assaults. 
 
The Expert Group on the Probation and Welfare Service (1999, p. 46) noted the 
decline in the use of CSOs since the mid 1990s and attributes this in part ‘to the lack of 
suitability of community service for offenders with addictions’. Walsh and Sexton (1999) 
found, however, that drug offences hardly featured in their study sample. Of the 297 
offences involved in the CSO study, only six involved drugs. Three of these were 
convictions for simple possession and three were for possession with intent to supply. 
The simple possession offences involved small quantities of cannabis. Nevertheless, 
the authors concluded, ‘they attracted relatively severe sentences: 120 hours or 4 
months imprisonment; 120 hours or 11 months imprisonment and 159 hours or 10 
months imprisonment’ (p. 40). 
 
However, it is possible that other offences covered by the CSOs were drug-related. 
Walsh and Sexton found, from a sample of CSOs, that 83 per cent were completed 
successfully i.e without the order being revoked because the offender was formally 
found to be in breach of conditions. 
 
Training 
Vaughan’s survey of District Court Judges found that most of the sample felt there was 
a need for training to understand the circumstances surrounding drug misuse. The 
current practice in this area is that new judges attend an induction course and observe 
another judge for a couple of weeks. A handbook on essential matters is circulated to 
new judges on the bench. District Court Judges have two statutory meetings per year 
to discuss sentencing matters.  
 
Farrell’s (2002, p. 51) evaluation of the pilot Drug Court found that: 
 
although members of the Drug court team had been afforded opportunities to attend 
training conferences and visit international Drug Courts, some members of the Drug 
Court Team did not receive any specific Drug Court training prior to the 
commencement of the Drug Court and in some cases Team members had very little 
time to prepare for their new roles. 
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12.4 Public debates 
As we have seen, over the past twenty years, numerous studies and reports, both 
government sponsored and non-governmental, have advocated the use of alternatives 
to prison. 
 
The Expert Group on the Probation and Welfare Service (1999) called for the 
introduction of additional non-custodial sanctions, to include: Treatment Orders, 
Mediation Orders, Reparation Orders, Counselling Orders and Combination Orders.  
 
In a recent survey of public perceptions of crime in Ireland, nearly three-quarters (73%) 
of respondents believed that non-custodial sanctions, such as fines and community 
service, would be more fitting than custodial sanctions for certain crimes (McDade 
1999).  
 
The National Economic and Social Forum (2002, p. 3) report makes a number of 
recommendations designed to reduce the use of imprisonment and encourage the use 
of non-custodial options. These include: 
• the Judicial Studies Board should take a lead role in the dissemination of 
information to its Members regarding non-custodial sanctions; 
• the provisions of the Children Act, 2001 (in relation to prison as a last resort and 
restorative cautioning) should be extended to adults, wherever possible, by 
legislative change; 
• additional resources should be put in place to develop and evaluate these 
sanctions further; 
• a public education programme should be developed by the Department of 
Justice, Equaity and Law Reform to increase awareness of these sanctions 
among the public, the Social Partners and relevant organisations 
 
Other developments 
A recent report of the Expert Group on Crime Statistics (2004, 2004a) has been 
submitted to the Minister for Justice, Equality and Law reform. The implementation of 
the recommendations of the Committee should improve data sources within the 
criminal justice system, thereby enhancing our ability to assess the extent to which 
alternatives to prison are being applied in Irish courts. 
 
 
13.  Public Nuisance: definitions, trends in policies, legal 
issues and intervention strategies 
 
13.1 Definition 
Since the onset of Ireland’s serious drug problem in the late 1970s, a number of local 
studies have sought to highlight the local impact of drug markets and related drug-
related crime (Cullen 2001). The definition used has generally been quite broad, 
encompassing crime, nuisance and anti-social behaviour. Lawless and Cox (2003 204) 
define anti-social behaviour as it has evolved in the Irish context as ‘a dynamic 
phenomenon, involving a broad range of disruptive behaviours, some relatively minor, 
others causing extreme distress and misery to people. In short, neighbourhood 
nuisance and anti-social behaviour includes anything which interferes with the peaceful 
enjoyment of the home and surrounding areas’. Drug specific anti-social behaviour 
includes, they suggest, ‘discarding used injecting equipment, open drug dealing, 
consumption of illicit drugs and any engagement in problem behaviour resulting from 
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such consumption…such behaviour tends to occur in areas where other forms of 
nuisance behaviour also takes place, such as squatting, noise from tenants, vandalism, 
graffiti and general harassment’ (p. 205).   
 
Under the Housing (Miscellaneous Provisions) Act, 1997, the concept of ‘anti-social’ 
behaviour is defined as either: 
a) the manufacture, production, preparation, importation, exportation, sale, supply, 
possession for the purposes of sale and supply, or distribution of a controlled 
drug. 
b) Any behaviour which causes or is likely to cause any significant or persistent 
danger, injury, damage, loss or fear to any person living, working or otherwise 
lawfully in or in the vicinity of a house provided by a housing authority…or a 
housing estate in which the house is situated and without prejudice to the 
foregoing, includes violence, threats, intimidation, coercion, harassment or 
serious obstruction of any person’ 
 
Fahey (1999) accurately describes ‘antisocial behaviour’ as a catch-all term ranging 
from ‘minor incivilities to actual criminal acts’. 
 
 A number of recent Irish studies have sought to give some indication of the extent of 
anti-social behaviour (Connolly 2003, 2001; Lawless and Cox 2003; Murphy-Lawless 
2002). Also, there is significant evidence to suggest that the drugs phenomenon has 
undermined the somewhat romantic historical notion that people do not commit crime 
in the areas in which they live (Connolly 2003). 
 
Many communities throughout Dublin have experienced high exposure to street-level 
drug dealing and local drug-related crime and anti-social behaviour (See section 10.2). 
Studies on drug availability suggest that many drug users have relatively easy access 
to drugs in their own areas. Such drug markets and the crime and nuisance often 
associated with them can create significant internal community tension and conflict. 
 
In a survey of offenders known as hard drug users (Keogh 1997), sixty-six per cent of 
respondents to the study said it was easy to get drugs and that they sourced their 
drugs within their own neighbourhood. When asked where they usually committed the 
crimes to sustain their drug habits, of the 254 people who answered this question, 105 
mentioning their own neighbourhood as a location where they committed crime. While 
the majority of respondents said they used a local dealer as their main supplier, 80 per 
cent said they did not always use the same individual as their supplier, thus suggesting 
multiple sources. Forty-eight per cent of heroin users in the Keogh (1997) study 
admitted to drug dealing themselves or to acting as couriers or ‘look-outs’ for drug 
dealers in order to fund their own drug habit. 
 
A study by Fahey (1999) used a variety of research techniques to assess the living 
conditions in seven local authority estates in Ireland. The estates studied were Fatima 
Mansions, South Finglas and Fettercairn, Tallaght – all in Dublin, Deanrock estate in 
Togher, Cork, Moyross in Limerick, Muirhevnamor in Dundalk and Cranmore in Sligo. 
 
Data were gathered primarily through ethnographic methods such as interaction in the 
everyday life of residents of the estates, participant observation and in-depth 
interviewing. Problems of social disorder were found to be central factors affecting the 
quality of life of the residents of all the estates studied. The authors concluded: ‘Social 
disorder has the greatest impact on residents’ quality of life, through direct experience 
of anti-social behaviour, a general loss of communal space and a sense of personal 
safety, and negative labelling of estates in the wider community’ (Fahey 1999). The 
problems associated with drug use and drug dealing were found to be particularly 
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acute in the Dublin estates. The use and dealing of opiates was found to be a problem 
only in the Dublin estates. In one estate, Fatima Mansions, the researcher concludes 
that, ‘Heroin dealing and heroin use are dominant and oppressive problems’ (O’Higgins 
1999: 156). The problems of drug use and dealing in this estate were found to be 
compounded by the fact that the area drew in a steady stream of drug users from all 
over the city and the greater Dublin area. One resident, in describing the corrosive 
effect of drug abuse on life in the estate, said: ‘Basically, you are not allowed to have a 
life anymore. The children are driven out of the public spaces’ (O’Higgins 1999, p. 156). 
 
A survey of residents of Dublin’s north inner city, conducted as part of an evaluation of 
a community policing scheme in which they were participating, revealed high levels of 
exposure to drug dealing and drug-related crime (Connolly 2001). Forty residents of the 
area were interviewed. The respondents were chosen on the basis of their participation 
in meetings organised as part of the process of establishing the North Inner City 
Community Policing Forum (CPF) (Connolly 2002). The respondents were resident in 
29 different streets or local authority flat complexes throughout the area in which the 
CPF was established; thus they were regarded as representative of the area as a 
whole. Also, they had been involved in local community activity and were therefore 
particularly knowledgeable about the drug issues in their respective areas. The survey 
was conducted in October and November 2000. 
 
Eighty per cent of the sample respondents said that they had witnessed drug selling in 
their area in the past year. The survey found that one in every 10 households had been 
burgled. This contrasted with a national survey conducted by the Central Statistics 
Office, which recorded a rate of one in 30 households reporting being burgled (Central 
Statistics Office 1999). Over 77 per cent of respondents recorded having been 
disturbed or affected by noise late at night, with 30 per cent of those believing the 
disturbance was drug-related. Eighty-five per cent said they were affected or disturbed 
by young people gathering in groups, with 37 per cent believing the disturbance was 
drug-related. 
 
Seventy-eight per cent of respondents stated that they felt they were ‘quite likely’ or 
‘very likely’ to witness drug selling in the following six months. None of the respondents 
stated that it was ‘not at all likely’ that they would witness drug selling in the following 
six months. Sixty per cent stated that they were ‘quite likely’ or ‘very likely’ to witness 
people using drugs in the following six months. 
 
Respondents were asked about whether they had concerns for their safety. The 
national survey (Central Statistics Office 1999) found that 30 per cent of respondents 
felt ‘unsafe’ or ‘very unsafe’ walking in their neighbourhood after dark, while the CPF 
survey recorded double that rate, with 63 per cent of respondents stating that they felt 
‘unsafe’ or ‘very unsafe’ walking in their area after dark. These feelings of insecurity 
were associated with groups of young people gathered together at specific locations 
where respondents believed drugs were available. 
  
Another important factor which arises in this area relates to the fears which drug 
dealers can instil in local communities, something which can operate as a disincentive 
to community engagement in policy responses. Again, we can see that this experience 
is also something which impacts disproportionately on different geographical locations. 
Respondents to the CPF survey were asked for reasons why they might not report a 
crime to the Garda Síochána. The same question was asked in the Central Statistics 
Office survey. In the CSO survey, the most common reason given for not reporting a 
crime to the police was that the crime was not regarded as serious enough to report or 
that there was no financial loss. The second most common response was the belief 
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that the Garda Síochána would not or could not do anything about the offence. Fear of 
reprisal was not a significant factor. 
 
A similar finding to the Central Statistics Office national survey was made by Watson 
(2000). From an analysis of results of a 1996 survey, Survey of victims of recorded 
crime, carried out by the Economic and Social Research Institute for the Garda 
Research Unit, she found that, as reasons for not reporting crime to the Gardaí, ‘fear of 
reprisal, and not wanting to get the offender into trouble were relatively unimportant 
overall, and were given as reasons by fewer than one in twenty of the victims’ (p. 138). 
 
In the CPF survey, on the other hand, by far the most common reason for not reporting 
a crime to the Gardaí was the fear of reprisal from those locally involved in criminal 
activity. This finding reveals the insidious impact of crime, particularly drug-related 
crime, on community life in particular localities as well as the difficulties encountered by 
policy makers in seeking to address these difficulties. 
 
A more recent study conducted in a more focused network of streets in the same area 
of north inner city Dublin involved the use of a variety of research methods to ascertain 
the impact of crime, anti-social behaviour and nuisance, drug use, drug dealing and 
related problems on the quality of life of the area (Connolly 2003).  The study, entitled 
Drugs, crime and community – Monitoring quality of life in the north inner city, 
incorporated a local drugs and crime survey, semi-structured interviews with relevant 
state agency personnel and other relevant individuals, as well as unobtrusive research 
measures. The latter involved co-ordinating with a local authority housing complex 
attendant who monitored the flats so as to identify any discarded drug paraphernalia 
such as abandoned syringes. Dublin City Council provided information on cars 
abandoned in the area during the research period. Data obtained as part of the 
Community Policing Forum process described above, including minutes of meetings 
held under the auspices of the CPF, were also a useful source of information about 
local drug-related problems (Connolly 2002). The survey also included a qualitative 
component so that local residents could add further comment and provide opinions on 
various relevant issues. 
 
The survey asked people about their local crime priorities and whether they had 
recently witnessed crimes or anti-social activities. The results are presented in the 
tables and figure below. 
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Question 1. We would like to know what you regard as the most important policing and 
estate management issues in your immediate area at this time. Please List the Crimes/ 
Anti-Social behaviour in order of importance. 
 
Table 13.2.1   Local Crime Priorities 
Crime/ASB Ranking %24 No. of Respondents 
Heroin Selling 1 64 30 
Cannabis Selling 2 40 30 
Young People (YP) Gathering25 3 32 31 
Joy Riding 4 17 30 
Mugging 5 15 26 
Noise at Night 6 10 30 
Graffiti 7 4.5 22 
Burglary 8 5.5 18 
Source: Connolly (2003) 
 
Question 2. Have you witnessed any of the following crimes or forms of ASB? 
Table 13.2.2   Local Exposure to Crime and Nuisance 
Witness Number % No. of Respondents 
Mugging 21 48 44 
Joy Riding 33 75 44 
Public Nuisance 28 68 41 
Source: Connolly (2003) 
 
 Key: Blue, 1 = Yes; Red, 2  = No. 
  
Figure 13.2.1 Number who witnessed joy-riding  
 
 Key: Blue, 1 = Yes; Red, 2 = No 
 
Figure 13.2.2 Number who witnessed mugging 
                                                
24 Denotes percentage of the total sample who responded to the question. 
25 Denotes Young People gathering in Groups 
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Certainly one of the most striking features of the study is the numbers who reported 
having witnessed a mugging or who have witnessed joy riding. Forty-eight per cent of 
the total number of respondents said that they had witnessed somebody being mugged 
while 75 per cent had witnessed joy riding. The latter is even more striking given that 
joy riding is generally perceived as occurring late at night or early in the morning. 
Eighty per cent of those who responded said they were affected or disturbed by joy 
riding, 78 per cent by public nuisance and 60 per cent by young people gathering in 
groups. Fifty-eight per cent said they were affected or disturbed by noise late at night 
time. 
 
Included among the drug-specific findings were the following: 
16 respondents, or 36 per cent of the total sample, said that they had been offered 
drugs in the past year, while 53 per cent said that they had witnessed drugs being sold 
in the past year. 76 per cent of respondents stated that they were ‘somewhat likely’, 
‘quite likely’ or ‘very likely’ to witness drug selling within the following six months. 
 
The percentages of respondents who said that they were able to identify the type of 
drug being sold was very significant, with 83 per cent and 84 per cent identifying heroin 
and cannabis respectively. Twenty-nine respondents identified five specific locations in 
the immediate area where they claimed drugs were being sold, while five respondents 
stated that drugs were being sold outside their door every day. In general, we can see 
that there is a major issue for residents of this area regarding the general 
environmental conditions in which they live and that this was found to have a significant 
effect on their overall quality of life. 
 
While the seriousness of the local problems being confronted with regard to crime and 
anti-social behaviour are clear, it was also evident from semi-structured interviews 
conducted with respondents that, having witnessed such incidents, they experience a 
sense of powerlessness rooted partially in exasperation and partially in fear. Although 
there was clearly a great deal of reluctance among respondents to become involved in 
local community activity to address the drug problem or anti-social behaviour, due to 
fears of retribution from those involved, it also became apparent that there remained a 
prevailing sense of concern for victims and for the area in general. 
 
13.2 Genesis 
Despite the long history of community fragmentation and disintegration as a 
consequence of drug-related crime and related anti-social behaviour, it was not really 
until the middle of the 1990’s that the experience of local communities became a 
central focus of government policy and that responses became more locally oriented26. 
A number of factors combined to influence policy in this respect. 
 
Community Activity 
One of these factors was that communities began to respond on their own initiative. 
Despite the fears generated by drug dealers described above, another consequence of 
local drug markets and related anti-social behaviour has been that, on many occasions 
throughout the history of Dublin’s drugs problem, many community-based groups and 
individuals have reacted by engaging in, among other types of community activity, 
community self-policing, informal justice and vigilante-type activities (Connolly 2003; 
Murphy-Lawless 2002; McAuliffe and Fahey 1999; Connolly 1998; O’Mahony 1997a; 
Bennett 1988). Such responses have also generated internal community conflict on 
occasion (Connolly 2003; Murphy-Lawless 2002; O’Mahony 1997a). 
                                                
26 For an overview see Butler (2002). 
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This community-based anti-drug activity has taken the form of public meetings in which 
alleged drug dealers have been called to account by local residents, often the parents 
of drug users, for their behaviour. Such action has also led to anti-drug marches and 
demonstrations, either on the homes of alleged drug dealers or on government 
buildings. Such activity has had many positive consequences. Street vigils and public 
meetings have made it difficult for drug dealers to deal drugs openly and united 
community action has helped break down the fear of those involved in the drug trade 
that is often felt in such communities (Connolly 2003).  Community anti-drug activity 
has highlighted the nature of the problems being confronted in such communities, 
thereby raising general public consciousness which, in turn, has brought pressure to 
bear on those in authority to respond (Connolly 2003; Murphy-Lawless 2002). 
 
However, the few studies which have considered the perspectives of those who have 
been involved or directly affected by community responses such as this show that, 
although there is often widespread support for such action, it also has the capacity to 
contribute to further community tensions (Connolly 2003; Murphy-Lawless 2002). 
 
Murphy-Lawless (2002), in her study of women in Dublin’s north inner-city, many of 
whom were active in the anti-drugs movement, situated that activity against a backdrop 
of the perceived failure by the state over a long period to respond to community needs. 
She noted the concern that anti-drugs activism had created divisions in the area ‘with 
additional pressure on women as carers of children/grandchildren and/or as partners of 
users or people accused of dealing’ (p. 58). However, although the women who 
participated in the study were aware of the huge tensions produced in their community 
by marching, they did not feel they had any alternative at the time. ‘Women did not 
define themselves as ‘vigilantes’ but as concerned parents, who felt that their actions 
might help their local communities where drug-dealing was now a commonplace 
everyday activity, observed by their children’ (p. 125). 
 
Connolly’s (2003) survey in the north inner city also sought the attitudes of local 
residents towards anti-drugs activity. Thirty-six (86%) respondents acknowledged that 
there had been an anti-drugs group in the area; 26 respondents claimed to have been 
involved in anti-drugs activity; 12 respondents stated that they had not been involved. 
Of the total of 41 respondents, 35 (85%) stated that they supported the anti-drugs 
movement, while 6 (15%) stated that they did not. 
 
In explaining the reason for their involvement in the anti-drugs movement, respondents 
stated that it was for the benefit of the children of the area or that they were anti-drugs 
or that they became involved out of anger and frustration with how bad things had 
become in the community. Apathy and concerns about the use of violence were 
expressed as the primary reasons for respondents’ non-involvement in anti-drug 
activity. Nevertheless there appeared to be a general acceptance of anti-drug activity, 
even where it was opposed. 
 
Local policing 
In recent years a number of positive developments in local community policing have 
been evident. The improvement in the working relationship in recent years between 
local Garda drug squad and some local communities has been evident. 
 
Also, some senior Gardai began to articulate publicly the need to develop a better 
working relationship with local communities if the drugs problem was to be more 
effectively tackled. In February 1997, then Assistant Garda Commissioner Thomas C. 
King addressing a conference in Dublin castle on the drugs issue acknowledged the 
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part played by the community in the fight against drugs. He also pointed out that there 
was a need for the Garda Siochana to ‘revitalise our contact with the community and to 
create an opportunity for a more pro-active community support for the garda operations 
against drugs in particular’ (Dublin Corporation 1997). 
 
Estate Management 
In a submission to the conference in Dublin Castle, referred to above, Vincent Norton, 
then principal Officer of Dublin Corporation’s housing department also referred to the 
increased efforts being made by Dublin Corporation to work with their tenants in 
improving the quality of life in their estates. He pointed out that the encouragement of 
such tenant involvement required an ‘“integrated approach to dealing with issues’ 
(Dublin Corporation 1997). 
 
National Developments 
These developments at a local level coincided with major policy developments at a 
national level. These included the establishment of local drugs task forces which was 
prompted by the acknowledgement by the 1996 Ministerial Task Force on drugs of the 
need to establish structures for the effective coordinated delivery of services at 
national, regional and local level. The development of inter-agency co-operation and 
the improvement in communication between the state agencies and the community 
they serve became an obvious part of this process. 
 
A second major catalyst was the murder of journalist Veronica Guerin in July 1996 by 
members of a drug gang. This led to an immediate government reaction and put the 
drug issue to the forefront of national policy. 
 
13.3 Measures taken 
Estate management and the Housing (Miscellaneous Provisions) Act, 1997 
In December 1996, the Government introduced the Housing (Miscellaneous 
Provisions) Bill as part of a wide-ranging legislative response to the drug crisis. Specific 
measures were contained in the Housing (Miscellaneous Provisions) Act 1997 to, inter 
alia, facilitate the exchange of information between Dublin Corporation and the Garda 
Síochána in relation to anti-social behaviour27. The Housing (Traveller Accommodation) 
Act 1998 further applied relevant sections of the Housing (Miscellaneous Provisions) 
Act 1997 dealing with anti-social behaviour, such as drug dealing, to halting sites 
provided by local authorities or by voluntary bodies. 
 
This Act provides for a range of measures to give local authorities the powers to deal 
with problems arising on their estates from anti-social behaviour, namely drug dealing, 
violence and intimidation. 
 
Community Policing  
Another development taking place simultaneously with these legislative changes was 
that the government was beginning a process of engaging with the broader community 
on crime issues in general. ln an attempt to ascertain the views of the general public in 
relation to crime problems and responses to crime, in febuary1998, the then Minister 
for Justice, Equality and Law Reform established a National Crime Forum in order to 
‘canvass comment, assessment and suggestions on crime and crime-related issues 
from the general public and from national and international experts’ (National Crime 
                                                
27 Housing (Miscellaneous Provisions) Act, 1997 Section 21. 
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Forum 1998, p. 9). In its report, the forum came out strongly in favour of the 
establishment of community policing fora. This national process dovetailed with the 
developments on the ground described above, both in community self-policing and in 
increase local policing by the gardaí. 
 
In October 2002 the North Inner City Community Policing Forum (CPF) was launched 
by An Taoiseach Bertie Ahern (Connolly 2003a). A report describing the establishment 
and evaluation of the CPF was also launched (Connolly 2002). The primary purpose of 
the CPF is to co-ordinate a common strategy in response to drug dealing between the 
local community, the Garda Síochána and Dublin City Council. 
 
13.4 Results / Evaluation 
Housing (Miscellaneous Provisions) Act 1997 
Since the passage of the Housing (Miscellaneous Provisions) Act, 1997, the Act has 
been the subject of debate and research in relation to its perceived effectiveness and 
broader social implications.  
 
A study by Memery and Kerrins (2000) concluded that people excluded from public 
housing can also find themselves discriminated against in seeking hostel 
accommodation and that such exclusions lead to a loss of essential family supports 
and a detachment from community-based drug services. The report stated that ‘street 
homelessness resulting from exclusion leads to open drug taking and riskier drug- 
taking practices’ (p. 33). A study of out-of-home drug users (Cox and Lawless 1999) 
suggested that the housing legislation had contributed to the rise in homelessness 
among drug users. 
 
A study commissioned by Dublin County Council and the South Western Area Health 
Board focused on those who were evicted from Dublin Corporation housing units in 
1997 and 1998 for anti-social behaviour (within the provisions of the 1997 Act and the 
1966 Housing Act) (Rourke 2001). By means of interviews with a number of people 
who had been evicted and with Dublin Corporation community welfare officers, and an 
analysis of eviction case files, the study tracked the progress of a selected number of 
clients who were evicted from local authority housing units in 1997 and 1998.  The 
study concluded that the Act had become an effective instrument in evicting Dublin 
Corporation tenants for anti-social behaviour. The author found that, of the evictions 
expedited by Dublin Corporation in 1997 and 1998, 50 per cent involved single women 
with children. On the basis of interviews and file analysis, the study concluded that the 
high proportion of this category may be accounted for, in part, ‘by the fact that they 
were co-habiting/living with drug using/dealing partners and boyfriends’ (p. 11). When 
considering the number of people affected by the eviction process, the study found that 
more children than adults suffered as a result of the implementation of the eviction 
legislation. The study also found that the eviction process placed particular pressure 
and strain on families with children, that it contributed to family break-up and separation 
following eviction as subsequent short-term hostel or bed and breakfast 
accommodation was unsuitable for normal family life. 
 
The report expressed concern that the application of the legislation was an ‘overly 
“blunt instrument” which serves to penalise innocent parties (adult family members who 
are not engaged in anti-social behaviour and/or children) as well as targeting the 
identified culprit/offender’ (p. 33). The study also found that people who had been 
evicted were confused and uncertain about what they needed to do to be considered 
for re-housing. 
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A study by Murphy-Lawless (2002), which sought the views of residents of the north 
Dublin inner city on this issue found that, whereas there was significant community 
support for such measures, with some saying it was not leading to enough evictions, 
others expressed disquiet about due process issues and the potential for the legislation 
to be used in a discriminatory manner. A further study of the north inner city by 
Connolly (2003) also considered the practical operation of this legislation in the local 
area and sought the views of local residents in relation to it. Many residents of this 
community were at the forefront of original demands for the introduction of this 
legislation. 
 
The study sought to describe the procedure by which complaints about anti-social 
behaviour are dealt with locally by Dublin City Council. Issues to do with anti-social 
behaviour are dealt with by the project estate officer and the assistant community 
officer for the area in question. Any complaints about local tenants received are logged. 
The alleged offenders and the complainants are interviewed. A file is then set up. 
Further complaints lead to further interviews. Recurring complaints could lead to the 
executive manager of the Housing Department seeking a Notice to Quit to be served 
on the tenant and family in question. Following the expiry of the Notice to Quit, a court 
order for possession is sought at the District Court. The tenant can appeal the warrant 
for possession. This appeal is heard at the Circuit Court. The decision of the Circuit 
Court can be appealed further. This would lead to a judicial review, which is heard in 
the High Court. A judicial review can be sought on a point of law only. If this is 
overturned the eviction is proceeded with. 
 
Alternatively, under the legislation, the Gardaí can be empowered to remove illegal 
occupants from a Dublin City Council dwelling.28 An exclusion order can also be sought 
by the tenant against a sub-tenant who is engaging in anti-social behaviour at the same 
premises. This will result in the sub-tenant being excluded from the premises 
completely. 
 
During the period of the study, from June 2001 to December 2001, 10 interviews 
regarding anti-social behaviour were carried out in the research area by City Council 
officials. In the same period, there were no notices to quit served and no warrants for 
possession applied for. Twenty-four respondents out of a total survey sample of 44 
were asked whether they agreed with the legislation. Among those who agreed 
unequivocally, concerns were expressed about the perceived delay in the process. 
Others were concerned with the influence the presence of drug dealers had on the 
area if permitted to remain.  Nobody disagreed with the policy, although most of the 
respondents’ agreement was conditional on the certain concerns being addressed. A 
strong feeling was expressed that the needs of drug users, other family members and 
the position of mothers needed to be considered. A second concern related to issues of 
due process, with some respondents expressing concern that people might be moved 
out for the wrong reasons. Others questioned the long-term results of the policy, 
questioning whether or not it was simply moving the problem to another area. 
 
A review of the Act conducted by Lawless and Cox (2003, p. 214) which was 
conducted during 2000/2001 concluded that ‘the direct and indirect use of the Act has 
contributed to the further marginalisation of those already excluded from society, 
resulting in an increase of homeless drug users in Dublin’. However O’Sullivan (2004, 
p. 23), in a recent consideration of the Housing (Miscellaneous Provisions) Act 1997 
concluded that ‘the degree to which the Act contributed to the recorded increase in 
homelessness is questionable’. 
 
                                                
28 Section 20, Housing (Miscellaneous Provisions) Act 1977 
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Community Policing Forum 
An evaluation of the North Inner City Community Policing Forum (Connolly 2002) used 
a number of methods to assess the progress achieved by the CPF. These included: 
 
• Performance indicators: Input, Process, Output and Impact measurements; 
• Semi-structured interviews: Conducted with members of the management 
board to ascertain their views on the process. The Board included police 
officers, a representative of the housing authority, a public representative, a 
local community representative and a member of the local drug task force; 
• Meeting minutes: A review of over 200 meetings held under the auspices of the 
CPF; 
• Incident reports: Incidents of drug-related crime were monitored and reviewed; 
• Panel survey: A local survey was conducted with 40 local residents from 29 
different streets or local authority flat complexes to ascertain their views on 
various aspects of the CPF (Connolly 2001). 
 
The evaluation identified a number of positive outcomes, including regular and 
consistent attendance at local meetings held under the auspices of the CPF. This is 
regarded as an important indicator of success given the serious concerns among 
residents, outlined above, about co-operating with Gardaí on drugs-related issues due 
to fears of reprisal from those involved in drug dealing. Significant progress was also 
identified as having been made in relation to a series of local drug-related incidents. 
The evaluation also reported increased cooperation between State agencies as a result 
of the CPF. 
 
The survey found that 72 per cent of the 44 local residents who participated in the CPF 
stated that they would be more willing to co-operate with the Gardaí in relation to drug-
related crime as a result of the CPF, while all of those surveyed wished to see the CPF 
continued into the future. Also, 45 per cent stated that they were less worried about 
drug-related crime as a result of the CPF. However, 55 per cent stated that there was 
no change in this respect. 
 
The CPF is in the process of being mainstreamed and extended to other areas of the 
city. The Community Relations Section of the Garda Síochána is currently preparing 
proposals for a new model for Community Policing Forum. The establishment of these 
Fora is occurring within the context of broader developments in police accountability as 
outlined in the Garda Síochána Bill 2004.   
 
The Garda Síochána Bill 2004 includes new provisions dealing with the organisation, 
management, performance and accountability of the Garda Síochána. The Bill provides 
for the establishment in each local authority area of a ‘joint policing committee’, 
representative of the police and the local authority. It is proposed that the local policing 
committee shall act as a general forum for discussion and consultation on matters 
affecting the policing of the area. In particular, the committee shall keep under review 
the levels and patterns of crime and disorder in the area; the levels and patterns of the 
misuse of alcohol and drugs in the area; and formulate and oversee the implementation 
of measures of co-operation between the local authority concerned and the police 
aimed at reducing crime and disorder and combating the misuse of alcohol and drugs 
in the area. 
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